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I. 
ABSTRACT 
Given the critical role of lymphokines as transient signals which 
mediate the proliferation, differentiation and function of haemopoietic cells in 
response to immunological stress, the regulation of the temporal expression of 
their genes by activated T lymphocytes is central to the coordination of 
immune responses to provide a "balanced" network of mediators , without 
chronic and potentially deleterious stimulation of specific target cells. 
This thesis describes studies which investigate and compare the 
mechanisms which regulate the expression of the IL-5 gene and a variety of 
other different lymphokine genes in murine T lymphocytes. Lymphokine 
mRNA accumulation patterns were compared in the murine helper T clone 
D1 O.G4.1 in response to cellular stimulation by various agents which either 
activate or inhibit known specific steps in several key T cell activation 
pathways. Northern blot analysis suggests that the accumulation of the IL-3, 
IL-4 and GM-CSF mRNAs are predominantly regulated by a cyclosporin A 
(Cs A)-sensitive ca2+-dependent pathway emanating from T cell receptor 
(TCR)/CD3 stimulation. The accumulation of the IL-5 , IL-6 and IL-1 O mRNAs 
appear, in contrast, to be largely regulated by Cs A-resistant signalling 
pathways. Signals mediated by protein kinase C activation may selectively 
and independently regulate IL-6 and IL-10 mRNA accumulation , and appear 
to predominantly regulate the accumulation of IL-5 mRNA. The accumulation 
of the IL-5, IL-6 and IL-10 mRNAs appear to be additionally regulated by 
mechanisms independent of direct TCR/CD3 stimulation. These include 
signalling pathways emanating from the CD45 and CO2 cell surface 
molecules, the IL-1 receptor and adenylate cyclase activation. These studies 
suggest that the expression of a number of lymphokine genes may be 
differentially regulated by intracellular pathways emanating from distinct T cell 
surface events. 
l 
Studies conducte,d in 01 O.G4.1 cells and also in the transformed 
murine T cell line EL4.23 suggest that the accumulation of each different 
lymphokine mRNA species is dynamically and differentially regulated by 
distinct and specific sets of transcriptional and post-transcriptional control 
mechanisms. Although no lymphokine mRNAs are detectable in unstimulated 
T cells by Northern blot analysis, nuclear run-off analysis indicated that the 
IL-6, IL-1 O and GM-CSF genes are transcribed at low levels, while other 
lymphokine genes appear transcriptionally inactive in the absence of stimuli. 
The accumulation patterns of IL-5 , IL-6 and IL-10 mRNAs appear to be 
predominantly regulated by changing rates in transcription of their genes in 
response to Cs A-resistant signals. IL-4 mRNA accumulation appears to be 
largely regulated at the transcriptional level by Cs A-sensitive Ca2+_ 
dependent signals. In contrast to the IL-4, IL-6 and IL-1 O genes, activation of 
IL-5 gene transcription requires obligatory de nova protein synthesis. 
Transcription of the IL-2 gene appears to involve the coordinate actions of 
labile Cs A-sensitive activators and labile repressors. The accumulation of 
IL-3 mRNA, and in particular that of GM-CSF mRNA, appear to largely involve 
their enhanced stabilization by Cs A-sensitive Ca2+-dependent signals. The 
accumulation of these two species and those of IL-2, IL-6 and IL-1 O mRNAs 
also appear to be dynamically regulated by a constitutively active labile 
mechanism which mediates their specific degradation. 
While the activation of IL-5 gene transcription in response to T cell 
activation signals was observed by nuclear run-off analysis, such 
responsiveness was not observed in transcriptionally competent cell-free 
systems. This suggests that IL-5 gene transcription is dynamically regulated 
by higher order chromatin structures. DNase I hypersensitivity analysis was 
conducted to identify the locations of putative regulatory regions of the I L-5 
gene. The region surrounding a hypersensitive site induced just 5' of the 
,., 
I 
TATA box of the ll-S gene was identified by subsequent DNase I footprinting 
and gel shift analyses to contain two discrete elements (mil-SA and mil-SB) 
which independently bind distinct inducible nuclear proteins. The strong 
correlation between the cell-specificity and signal-dependent modulation of 
the transcriptional activity of the I l-S gene, and of protein interactions with 
these two elements suggests that they may be involved in regulating ll-S 
gene transcription. Sequences of mil-SB appear unique to the ll-S gene, 
while sequences of mil-SA are highly conserved in corresponding locations 
in the GM-CSF and ll-4 genes. Closely related, but possibly not identical, 
inducible nuclear proteins appear to interact with the conserved elements of 
these three genes, and may function to cooperatively link the core promoter 
machinery with other regulatory elements further upstream. 
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CHAPTER 1: 
INTRODUCTION 
The sequential patterns of cell growth and differentiation , which 
ultimately manifest in Metazoan form , may be essentially ascribed to the 
coordinated expression of genetic information in both spatial and temporal 
dimensions, and its interaction with information external to the genomic micro-
environm ent. This involves a dynamic hierarchy of integrated regulatory 
mechanisms which, at one level , control expression of any single gene and at 
another, coordinately modulate expression of networks of genes. 
In addition to the structural information encoding functional gene 
products, nucleic acids contain a multiplicity of regulatory information which 
determine the parameters within which the structural information is expressed. 
It is this molecular "program" of regulatory information that converts the linear 
array of genetic messages contained in the DNA into the three-dimensional 
Metazoan form. As communication of the regulatory information involves 
specific proteins which are themselves encoded in the structural information, 
the whole process of cell growth and differentiation may be envisaged as a 
self-controlling morphogenetic "information cycle" which , as wil l be elaborated 
upon later, is dynamically influenced by the cellular environment and inter-
cellular communication (Fig. 1.1.). 
While the early period of molecular biology has largely focused upon 
elucidating the genetic code which deciphers the structural information , a 
fundamental objective in current molecular biology is the elucidation of the 
putative "regulatory code", namely, mechanisms wh ich decipher and 
implement the regulatory information. 
Fig. 1.1. Schematic representation of the "information cycle" 
illustrating the nexus between structural and regulatory 
information encoded in the DNA and information external to the 
genomic micro-environment. 
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1.1. REGULATION OF EUKARYOTIC GENE EXPRESSION 
Eukaryotic gene expression may be regulated at several levels 
including organisation of chromatin structure and transcription, processing 
and export of m RNA from the nucleus, translation and post-translational 
processing. Of these, transcriptional control appears to be a major mode of 
eukaryotic gene regulation. 
1.1.1. Transcriptional control 
The process of gene transcription may be separated into three distinct 
stages: initiation, elongation and termination. Transcriptional initiation is 
generally believed to be mediated by the coordinate interactions between 
specific regulatory proteins and modular arrangements of multiple DNA 
control elements (reviewed in Breathnach & Chambon, 1981; Nevins, 1983; 
Yaniv, 1984; Serfling et al., 1985; Maniatis et al., 1987; Johnson & McKnight, 
1989; Mitchell & Tijan, 1989), which may be distinguished operationally into 
two classes. Accurate initiation of transcription appears to be mediated by the 
interactions of "core promoter" elements, which comprise of the cap site and 
"TATA" box and are characteristic of almost all eukaryotic promoters , with a 
number of "general" or "basal" initiation factors (Mermelstein et al., 1989; 
Saltzman & Weinmann, 1989; Sawadogo & Sentenac, 1990; Conaway & 
Conaway, 1991 ). Selective modulation of the rate or efficiency of transcription 
appears, however, to be mediated by the interactions of sequence-specific 
regulatory factors with upstream promoter elements and enhancers, the latter 
which are characterized by their ability to modulate transcriptional activity in 
an orientation- and distance- independent manner relative to the "TATA" box 
(Khoury & Gruss, 1983; Serfling et al. , 1985; Atchison , 1988; Muller et al., 
1988). The activity and/or expression of many of these specific trans-
,, 
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activating regulatory factors, as will be subsequently discussed, appear to be 
differentially modulated in specific cell types and/or in response to different 
developmental or environmental signals. 
Transcriptional "programs" for modulating inducible, spatial or temporal 
expression patterns of individual, or subsets of, eukaryotic genes may 
therefore be "conferred" by the particular sequence, unique composition and 
spatial organisation of upstream promoter elements and enhancers 
constituting the complex set utilized by a given gene. Such a molecular 
"program" appears to be "implemented" by the interaction of such cis-acting 
elements with sequence-specific trans-activating factors. These factors are 
believed to associate with the general or basal transcriptional machinery at 
the "core promoter", either directly or via interactions with certain adaptor 
proteins or "co-activators", to assemble preinitiation complexes (Ptashne, 
1986; Atchison, 1988; Muller et al., 1988; Marriott & Brady, 1989; Saltzman & 
Weinmann, 1989; Sawadogo & Sentenac, 1990; Conaway & Conaway, 1991 ; 
Roeder, 1991 ). Under this model, transcriptional initiation is a complex 
mechanism which requires both specific DNA-protein and protein-protein 
interactions. This model has been supported by a number of 
structure/function "domain-swapping" studies which demonstrate (i) that DNA-
binding is essential but alone insufficient to mediate transcript ional activation 
and (ii) that DNA-binding and activation properties of a transcripti on factor 
reside independently in spatially and functionally distinct domains (Hope & 
Struhl, 1986; Keegan et al. , 1986). These domains often contain distinct 
structural motifs which have been found to be common in many eukaryotic 
transcription factors (reviewed in Ptashne, 1988; Brennan & Matthews, 1989; 
Struhl, 1989; Berg, 1990; Harrison & Aggarwal , 1990; Latchman, 1990). 
I r 
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Transcriptional regulation of eukaryotic gene expression may also be 
mediated at the level of elongation. One well-characterized example is the 
rapid down-regulation of c-myc mRNA biogenesis during differentiation of 
promyelocytic leukemia cells which appears to be mediated by mechanisms 
that prematurely attenuate transcription within the first exon of the c-myc gene 
(Bentley & Groudine, 1986; 1988; Eick & Bornkamm, 1986). 
1.1.2. Chromatin structure and DNA methylation 
The coordinated interactions between cis-acting elements and trans-
activating factors which mediate transcriptional initiation may be modulated by 
the synthesis and/or activity of the sequence-specific transcription factors 
(discussed in section 1.1.4.). A large body of structural and functional 
evidence over the past decade suggests, however, that the transcriptional 
regulation of gene expression may ultimately be controlled by the packaging 
of DNA with histones into nucleosomes and higher order chromatin structures, 
an intrinsically dynamic phenomenon specific to eukaryotes (reviewed in 
Reeves, 1984; Eissenberg et al., 1985; Pederson et al., 1986; Hansen & 
Ausio, 1992). Studies using in vitro chromatin assembly systems have 
demonstrated that assembly of nucleosomes over promoter regions may 
render a DNA template refractory to transcription (Knezetic & Luse, 1986), 
while formation of transcriptional preinitiation complexes on DNA templates 
prior to or during nucleosome assembly may alleviate promoter repression by 
nucleosomes (Matsui, 1987; Workman & Roeder, 1987). Depletion of 
nucleosomes has also been shown in vivo to activate normally repressed 
promoters (Han & Grunstein, 1988), suggesting that histones may play a 
fundamental role in the repression of basal level transcription. 
5 
The high degree of sensitivity of transcriptionally active chromatin to 
non-specific nucleases such as DNase I has been generally attributed to 
local displacement of nucleosomes (reviewed in Eissenberg et al., 1985; 
Yaniv & Cereghini, 1986; Elgin, 1988; Gross & Garrard, 1988; Grunstein , 
1990). Such "hypersensitive" sites are often induced in response to specific 
signals or in specific tissues, and are frequently associated with protein-
binding regulatory regions of genes which are responsive to such spatial , 
environmental or developmental cues (Wu, 1980; Zaret & Yamamoto , 1984; 
Siebenlist et al., 1986). Such strong correlation between transcriptional 
activity and local disruptions in chromatin structure has supported the notion 
that chromatin structure is dynamic and may play a fundamental role in 
regulating the accessibility of cis-acting elements to trans-activating factors. 
While the underlying mechanisms of active chromatin structure are as yet 
unclear, one model suggests that certain regulatory factors may activate 
repressed promoters by directly disrupting existing chromatin structure 
(Workman & Roeder, 1987; Grunstein, 1990; Pham et al. , 1991 ). Given , 
however, that alterations in chromatin structure may be a requirement for, as 
well as a consequence of, the process of establishing transcriptional 
competence, the relationship between these two inextricably linked events 
may not necessarily be a simple issue of cause and effect. 
While a direct correlation between transcriptional activity and nuclease 
hypersensitivity has been demonstrated, an inverse correlation has been 
shown between transcriptional activity and the presence of methylated 
cytosines in CpG dinucleotides in regulatory regions of higher eukaryotic 
DNA. Methylation may, furthermore , suppress formation of nuclease 
hypersensitive sites, while hypomethylation appears to create a permissive 
environment for generating hypersensitivity (reviewed in Doerfler, 1983; Bird , 
1984; Gross & Garrard, 1988; Dynan , 1989; Lewis & Bird , 1991 ). Whether 
I 
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under-methylation is a cause or consequence of transcriptional activation is a 
subject of some dispute. Given that DNA methylation potentially disrupts 
DNA-protein interactions, methylation may Qe an integral component of a 
general gene silencing system which could influence the linear and spatial 
organisation of chromatin (Cedar, 1988; Watt & Molloy, 1988). 
1.1.3. Post-transcriptional and translational regulation 
An inherent consequence of two fundamental differences that exist 
between the organisation of prokaryotic and eukaryotic genetic information is 
increased complexity in the modes by which eukaryotic gene expression is 
regulated. The first difference is the "split" organisation of the majority of 
eukaryotic genes into exon and intron regions, although a few prokaryotic 
genes appear to possess a similar organisation (Belfort, 1989). The second 
difference is the segregation of eukaryotic genetic material in the nucleus and 
consequent spatial separation of transcription from translation. The post-
transcriptional processing of the primary transcript, which involves stability of 
the intranuclear RNA precursor, splicing of intrans , 5 ' capping , 3' 
polyadenylation and the subsequent transport of the mature transcript into the 
cytoplasm, potentiate distinct levels at which eukaryotic gene expression may 
be regulated (reviewed in Breathnach & Chambon , 1981 ; Nevins , 1983). 
Flexibility in the selection of splice sites forms the basis for alternative splicing 
of the primary transcript and allows plasticity of gene expression without 
affecting the transcriptional event. Different mRNA species and hence related , 
but structurally and functionally distinct protein isoforms, may be generated in 
different tissues and/or in response to different developmental and 
environmental signals (reviewed in Breitbart et al. , 1987; Smith et al., 1989). 
I 
7 
Eukaryotic mRNAs display heterogenous cytoplasmic stability in a wide 
variety of cell types and also in response to different signals. One example of 
a relatively stable species is p-globin mRNA which has a half-life of greater 
than 17 h (Lowenhaupt & Lingrel, 1978). Many inducible eukaryotic genes 
associated with regulation of cell growth and differentiation, including 
oncogenes (Dani et al. , 1984; Mitchell et al. , 1985; Rabbitts et al. , 1985) and 
cytokines (Raj & Pitha, 1981; Lindsten et al., 1989; Yamato et al., 1989), 
encode mRNAs with short half-lives of between 0.5 to 2 h, which may be 
modulated in response to specific cellular signals in specific cell types. The 
rates and selectivity of mRNA degradation are therefore variable and 
regulation of these processes potentiate control points of gene expression 
(reviewed in Brawerman, 1987; 1989; Raghow, 1987; Hentze, 1991 ). 
Poly(A) addition to non-adenylated mRNAs and poly(A) elongation of 
adenylated mRNAs have been shown to enhance stabilization of these 
mRNAs, suggesting that the rate of mRNA turnover may be influenced by 
poly(A) metabolism (Green & Dove, 1988; Zingg et al., 1988). The poly(A) tail , 
the degradation of which appears to precede that of the mRNA body (Brewer 
& Ross, 1988; Wilson & Treisman, 1988; Swartwout & Kinniburgh , 1989), 
appears to be protected from nuclease attack by virtue of its association with a 
specific poly(A) binding protein (PABP) into a nucleosome-like 
ribonucleoprotein complex (Baer & Kornberg , 1983; Bernstein & Ross, 1989; 
Bernstein et al., 1989). The association of poly(A) tails of most mRNAs with 
PABP, whose structure is highly conserved during evolution (Adam et al., 
1986; Sachs et al., 1986; Grange et al., 1987) is , however, insufficient to 
explain the heterogeneity of cytoplasmic mRNA stability. The selectivity of 
mRNA degradation has been postulated to be mediated by interactions 
between certain sequences, often found in the 3'-untranslated regions 
(3'-UTRs) of many short-lived mRNAs, with specific cytoplasm ic factors . These 
I 
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interactions are believed to destabilize the association of PABP with the 
poly(A) tail, thus enhancing degradation of the poly(A) tail and ultimately the 
mRNA body. (Bernstein & Ross, 1989; Brewer & Ross, 1989; Bohjanen et al. , 
1991; Hentze, 1991). 
Control at the translational level may be functions of the efficiency of 
ribosome binding and of interactions between ribosomes, initiation factors and 
tRNA. Several recent lines of evidence implicate a regulatory role of certain 
3'-untranslated sequences in the initiation of translational activation (Ch'ng 
et al., 1990; Jackson & Standart, 1990). Post-translational modification 
potentiates the generation of related, but structurally and functionally distinct, 
proteins without affecting the translational event, and plays an important role 
in modulating the activity of transcription factors as discussed below. 
1.1.4. Regulation of the "regulators" 
The mediation of highly regulated spatial, temporal or inducible 
eukaryotic gene expression by sequence-specific trans-activating factors 
inherently necessitates a second "tier" of regulatory mechanisms to ensure 
that such factors are active only in the particular tissue and/or become active 
only in response to the particular developmental or environmental signal . 
Observations that transcriptional activation of certain genes requires de nova 
protein synthesis has suggested two possible mechanisms by which such 
regulatory factors may themselves be regulated , namely, (i) control of the 
synthesis of the factor so that it is expressed only when required and (ii ) 
control of the activity so that a pre-existing factor becomes activated only when 
required (reviewed in Berk, 1989; Johnson & McKnight, 1989; Mitchell & Tijan , 
1989). 
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Control of the synthesis of a transcription factor may be mediated by 
regulating transcription of the gene encoding the factor. Expression of the 
gene encoding the liver-specific factor C/EBP, for example, appears to be 
regulated by tissue-specific transcriptional control mechanisms (Xanthopoulos 
et al., 1989; 1991 ). Control of synthesis may also be exerted at the level of 
RNA splicing. One example is the thyroid hormone gene, where alternative 
splicing yield two species, one of which lacks the hormone-binding domain. 
This inactive form acts as a repressor which binds to the same DNA motif as 
the active repressor but cannot activate transcription in response to hormone 
(Koenig et al., 1989). Translational efficiency of mRNA encoding the yeast 
factor GCN4 may be modulated by differential usage of translational initiation 
codons in response to specific signals (Fink, 1986). 
Two well-characterized post-translational mechanisms which modulate 
the activity of pre-existing regulatory factors include phosphorylation and 
ligand-induced conformational changes. Interconversion of regulatory 
proteins between phosphorylated and dephosphorylated forms is a major 
versatile mechanism for reversibly modulating their activities in response to 
alterations in cellular biochemistry, and is due to a dynamic equilibrium 
resulting from the actions of kinases and phosphatases which often 
demonstrate pleiotropy and broad specificity (reviewed in Cohen, 1985). 
Phosphorylation appears, for example, to stimulate the DNA-binding ability of 
serum response factor (Prywes et al., 1988) and the transcriptional activation 
potential of the cAMP-responsive element binding protein (CREB) (Yamamoto 
et a I. , 1 9 8 8) . 
Several transcription factors appear to be associated in the cytoplasm 
with specific inhibitory proteins which dissociate from the factor in response to 
particular signals. This dissociation induces a conformational change which 
I 
I 
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converts the factor into an active form. Addition of hormone, for example, 
releases certain steroid receptors from specific inhibitory proteins, enabling 
the receptors to bind DNA and activate transcription (Sanchez et al. , 1987; 
Howard & Distelhorst, 1988). Other examples include the "unmasking" of the 
activation domain of the yeast factor GAL4 by dissociation of an inhibitory 
factor in response to galactose (Johnston et al., 1987) and the "unmasking" of 
the nuclear translocation signal of the glucocorticoid receptor by dissociation 
of an inhibitory factor in response to hormone (Picard & Yamamoto, 1987). 
The complex mechanisms which modulate the activity of the pleiotropic factor 
NF-KB, which is involved in regulating inducible expression of a variety of viral 
and cellular genes (reviewed in Lenardo & Baltimore, 1989), have been 
extensively investigated over recent years. NF-KB appears present in an 
inactive form in the cytoplasm, associated with an inhibitory protein, IKB 
(Baeuerle & Baltimore, 1988a,b). Following cellular activation with a variety of 
stimuli, including mitogens, cytokines, viral trans-activators or double-stranded 
RNA (Sen & Baltimore, 1986, Lowenthal et al., 1989; Osborn et al. , 1989; 
Visvanathan & Goodbourn, 1989), the inhibitory IKB protein becomes 
phosphorylated and dissociates from NF-KB. This enables the latter to 
translocate to the nucleus where it interacts with its DNA recognition 
sequence to mediate gene transcription (Baeuerle & Baltimore, 1988a,b; 
Ghosh & Baltimore, 1990). 
1.1.5. Integration of gene regulation and the "macro-
environment" 
The genomic DNA sequence plays a vital determinative role in the 
regulation of eukaryotic gene expression. All levels of control described 
above involve specific nucleotide sequences, either 5' and/or 3' to (and 
sometimes within) a gene (transcriptional control) , at boundaries of introns 
(splicing) or at specific sites within the mature transcript (mRNA stability and 
1 1 
translational control). The regulatory functions of these specific nucleotide 
sequences in the expression of a given gene product may be mediated by 
other gene products, for example, transcription factors , initiation and 
elongation factors, small ribonucleoprotein particles, poly(A) binding protein 
or specific mRNA stabilizing/destabilizing factors. The expression of any 
given group of genes, and alterations in cellular biochemistry that result , are 
thus dependent on prior expression of other groups of genes. The 
relationship between structural and regulatory information depicted earlier in 
the "information cycle" (Fig. 1.1.) , is therefore not only dynamic, but also 
hierarchical. 
While the sequential patterns of cell growth and differentiation may be 
viewed quite validly, at the molecular level, in terms of a genetic program , 
such patterns may ultimately be influenced by interactions between the 
genetic information and the outer environment. The mediation of spatial , 
temporal or inducible gene expression, which give rise to changing patterns of 
cell growth and differentiation and morphogenesis , inherently involves (i) the 
recognition of an external cue at the cell surface, which may include those 
generated as a consequence of cell-to-cell interactions, (ii) transduction of this 
signal into the cytoplasm and subsequently to the nucleus , and (iii) 
modulation of gene expression in response to the transduced signal. The 
process of cell growth and differentiation may be, therefore, more broadly (and 
correctly) envisaged as involving not only a dynamic hierarchy of interactions 
between structural and regulatory infomation , but also dynamic interactions 
between regulatory information and information external to the genomic 
micro-environment (Fig. 1.1.). 
I 
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1.2. REGULATION OF THE "CYTOKINE NETWORK' 
Investigating the dynamic molecular mechanisms which integrate 
"inter-", "extra-" and "intra-" cellular communication with the genetic programs 
which control the plasticity and specificity of eukaryotic cellular growth and 
differentiation requires a model experimental system which is amenable to 
genetic analysis, which demonstrates sufficient, but not overwhelming, 
complexity of gene expression, and for which variations in gene expression 
may be assayed. In this regard, the T lymphocyte, which expresses a battery 
of transient mediators of haemopoietic cell proliferation, differentiation and 
function in response to antigen, presents a challenging, yet ideal , multi-
dimensional model system. 
1.2.1. Cytokines as pleiotropic mediators of 
haemopoiesis 
Blood cell growth and differentiation is a dynamic process which is 
maintained continuously in adults by the self-renewal of pluripotent stem cells 
and their subsequent proliferation and differentiation through the various 
myeloid and lymphoid cell lineages. Such "constitutive" haemopoiesis 
appears to be governed by a developmental program that proceeds in the 
absence of immunological stress in the bone marrow micro-environment, and 
may be differentiated, both temporally and spatially, from haemopoiesis 
induced in response to cellular recognition of antigen. The proliferation and 
differentiation of all blood cell types involved in "inducible" haemopoiesis is 
regulated by numerous soluble glycoprotein factors , collectively termed 
cytokines. These include colony-stimulating factors (CSFs) , interleukins (lls), 
interferons (IFNs) , tumour necrosis factor (TNF) and transforming growth factor 
(TGF). A number of these factors also play a major role in regulating 
"constitutive" haemopoiesis, along with complex cell-cell interactions 
l 
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(reviewed in Clark & Kamen, 1987; Balkwill & Burke, 1989; Nicola, 1989; Arai 
et al., 1990; Whetton, 1990; Metcalf, 1992). 
Cytokines are encoded by single copy genes which demonstrate 
considerable homology between human and mouse at the nucleotide and 
amino acid levels. Despite the overall poor homology between different 
cytokine genes, these genes appear to share similar structural (i.e. 
exon/intron) organisation, and many appear to be "clustered" within certain 
chromosomal regions. Such features have given rise to considerable 
speculation as to their evolution by ancestral gene duplicat ion (reviewed in 
Arai et al., 1990). The IL-3 and GM-CSF genes, for example , are located 
only 9 kb and 14 kb apart on human chromosome 5 and mouse 
chromosome 11 respectively (Yang et al., 1988; Lee & Young , 1989) , to 
which the IL-4, IL-5, M-CSF and M-CSF receptor genes have also been 
mapped (Le Beau et al. , 1986; Lee et al., 1989; Chandrasekharappa et al. , 
1990). 
While the T lymphocyte is a maJor source of cytok ines, other 
haemopoietic and non-haemopoietic cells , including B cells , macrophages, 
fibroblasts, mast and endothelial cells also express overlapp ing, as well as 
distinct, sets of factors. Apart from the complexity of their expression patterns, 
cytokines are characterized by the specificity and pleiotropy of the ir biological 
actions, for example: 
(1) a single cytokine may interact with more than one cell type 
(2) a single cell type may interact with more than one cytokine 
(3) a single cytokine may possess multiple biological activities 
(4) many cytokines possess overlapping biological activities 
(5) the biological activity of one cytokine may be modulated by that of 
another cytokine. 
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Such complex patterns of cytokine expression and activity have given 
rise to the notion of haemopoiesis as a dynamic system of "inter-" cellular 
communication coordinated by an integrated "cytokine network". Regulation 
of both the activity and expression of this "cytokine network" is therefore critical 
for the correct implementation of the genetic programs of proliferation and 
differentiation of target cells. Key determinants of the specificity and pleiotropy 
of cytokine activity may involve its interaction with specific receptors, which are 
expressed on the surfaces of target cells, and the nature of the coupling 
between the receptor and signal transduction pathways of the target cell 
(reviewed in Nicola, 1989; Arai et al. , 1990). 
Central to the initiation and coordination of "inducible" haemopoiesis is 
the activation of quiescent helper T cells by antigen and the consequent 
expression of a battery of lymphokine genes. These processes must be tightly 
regulated to provide a balanced network of mediators at the appropriate time, 
without the chronic and potentially deleterious stimulation of specific target 
cells which may contribute to the development of numerous disorders. 
Several lines of clinical evidence , for example, have suggested a link 
between the enhanced expression of the gene encoding IL-5 , a lymphokine 
which stimulates growth , differentiation and activation of eosinophils 
(Campbell et al., 1987; 1988; Sanderson et al. , 1988), with the cell-specific 
nature of the hypereosinophilic syndrome and the eosinophil ia associated 
with helminth infections and allergic disorders (Coffman et al. , 1988; Limaye 
et al., 1989; Owen et al., 1989; Yamaguchi et al. , 1990). 
1.2.2. Activation of helper T cells 
Central to the process of T cell activation is the specific recognition by 
the T cell receptor (TCR)/CD3 complex of antigen presented by B cells and 
I 
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macrophages in association with major histocompatibility complex molecules. 
This interaction rapidly triggers the activation of certain protein tyrosine 
kinases (PTKs) associated with CD4 and the TCR/CD3 complex, which 
couples the latter to phospholipase C activation and consequent hydrolysis of 
phosphatidylinositol 4,5- bisphosphate (PIP2) (Samelson et al. , 1986; June 
et al., 1990a; Mustelin et al., 1990; Klausner & Sam el son, 1991 ). The 
hydrolytic products, diacylglycerol and inositol triphosphate , respectively 
activate protein kinase C and induce elevation in levels of intracellular 
calcium (Ca2+i) (Nishizuka, 1984; Imboden et al., 1985; Imboden & Stobo, 
1985; Weiss et al., 1986; Berridge, 1987). ca2+ i, as well as protein 
kinase C, may also modulate the phosphorylation state of numerous 
intracellular proteins by the activation of Ca2+/calmodulin- dependent protein 
kinases and phosphatases (reviewed in Cohen , 1985). 
A second signal provided by IL-1, a product of activated monocytes, is 
generally believed to be required, in addition to those mediated by antigenic 
stimulation of the TCR/CD3 complex, to fully activate the T cell in vivo (Mizel , 
1982). Several lines of evidence suggest that the activation pathway 
mediated via the IL-1 receptor is independent of the PIP2 signal transduction 
pathway and may involve adenylate cyclase-mediated elevation of 
intracellular cyclic AMP levels and consequent protein kinase A activation 
(Abraham et al., 1987; Shirakawa et al., 1988; Chedid et al. , 1989; Chedid & 
Mize I, 1990; Macchia et al. , 1990; Dornand et al., 1992). Several other cell 
surface molecules appear to be involved in mediating T cell activation . These 
include "accessory molecules", such as CD28, which initiate and/or regulate 
signal transduction pathways that are distinct and independent from those 
mediated via the TCR/CD3 complex (June et al. , 1987; 1989; 1990b), or "co-
receptors", such as CD4, which appear to augment TCR/CD3-dependent 
signalling (Fleischer & Schrezenmeier, 1988; Janeway, 1989; Mustel in & 
L 
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Altman, 1989; Rudd, 1990). CD45 , a phosphotyrosine phosphatase 
abundantly expressed on the surfaces of most T cells , appears to play a 
critical role in coupling the TCR/CD3 complex with the PIP2 signal 
transduction pathway by activating, by tyrosine dephosphorylation , certa in 
TCR/CD3- and CD4- associated PTKs (Mustelin et al. , 1989; 1992; Koretzy 
et al., 1990; Ashwell, 1991; Klausner & Samelson, 1991 ). 
Mechanisms involving the subsequent transduction of intracellular 
signals downstream of these early membrane events have, as yet , eluded 
discovery, but may presumably involve phosphorylation (and 
dephosphorylation) of key regulatory proteins. This problem has been 
addressed in recent years by a "backwards" approach . The general scheme 
of this approach has involved identification and characterization of DNA 
sequences which may be involved in regulating the inducible expression of 
specific lymphokine genes, and of the specific proteins which interact with 
these control regions and which may be potential intracellular targets for 
signals emanating from the early membrane events. This approach has been 
greatly facilitated by the establishment of stable murine and human 
transformed T cell lines and the derivation of antigen-specific murine helper T 
cell clones, which have been classified into two major subsets based on their 
heterogenous patterns of lymphokine secretion after mitogen ic st imulation . 
While both subsets express I L-3, granulocyte-macrophage colony-stimulating 
factor (GM-CSF) and TNF-a, Th1 clones selectively express IL-2 , IFN-y and 
lym photoxin and Th2 clones selectively express I L-4 , I L-5 , I L-6 and I L-1 O 
(reviewed in Mosmann & Coffman , 1989a,b). 
' 
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1.2.3. Regulation of lymphokine gene expression 
In keeping with the role of lymphokines as transient signals which 
mediate the proliferation, differentiation and function of haemopoietic cells in 
response to immunological stress, it might be expected that their genes 
should only be expressed as long as the T cell is in contact with the antigen , 
and that their mRNAs should be short-lived so that they are degraded soon 
after removal of the antigenic stimulus. Lymphokine mRNAs are usually 
undetectable in quiescent T cells and reach maximum steady state levels after 
several hours of stimulation (reviewed in Taniguchi, 1988; Arai et al., 1990). 
The mechanisms which regulate the kinetics of induction and decay of mRNA 
levels appear, however, to be unique to each lymphokine gene. The IL-2 
gene, for example, appears to be regulated by specific sets of transcriptional 
and post-transcriptional mechanisms (Efrat & Kaempfer, 1984; Shaw et al. , 
1987; 1988a; Ohmura & Onoue, 1990). GM-CSF gene expression appears , 
however, to be predominantly regulated at the post-transcriptional level in a 
variety of T and non-T cell models (Thorens et al., 1987; Bickel et al. , 1990; 
Wodnar-Filipowicz & Moroni, 1990; Akahane & Plutznik, 1992; lwai et al., 
1992). These mechanisms appear to vary between different cell systems and 
may be differentially modulated by different signalling pathways. The 
transcription of the IL-2 and GM-CSF genes, for example, may be activated in 
response to signals mediated via the TCR/CD3 complex, while their mRNAs 
appear to be stabilized by CD28-mediated signals (Lindsten et al., 1989). 
In recent years, a number of DNA elements have been identified in the 
proximal 5'-flanking regions of several lymphokine genes which appear to 
specifically interact with numerous constitutive or inducible DNA-b in ding 
nuclear proteins and regulate the transcription of these genes in response to T 
cell activation signals. The transcriptional activation of the IL-2 gene, for 
' 
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example, appears to involve cooperative interactions between numerous 
transcription factors, which interact with their respective recognition elements 
located within a 300 bp region 5' of the TATA box. This proposal has been 
supported by the dramatic alterations in chromatin structure observed within 
this region which parallel transcriptional activation of the IL-2 gene (Siebenlist 
et al., 1986; Brunvand et al., 1988; Durand et al., 1988). These trans-
activators include ubiquitous factors such as NF-KB, Oct-1 and AP-1 (Emmel 
et al., 1989; Hoyos et al., 1989; Serfling et al., 1989; Shibuya et al. , 1 989; 
Kamps et al., 1990) , which regulate the inducible expression of numerous 
genes in a variety of cell types. Regulation of IL-2 gene transcription also 
involves more specific factors such as NF-AT, which is activated when the 
Ca2+-dependent signal generated by antigenic stimulation induces a pre-
existing T cell-specific cytoplasmic subunit to translocate to the nucleus and 
associate with a newly synthesized nuclear subunit (Shaw et al., 1988b; 
Flanagan et al. , 1991; Clipstone & Crabtree, 1992). 
Post-transcriptional control of lymphokine gene expression appears to 
be largely mediated at the level of cytoplasmic mRNA stability. This may 
involve certain AU-rich sequences which are present in the 3'-UTRs of many 
labile mRNAs (Caput et al., 1986) and appear to bind specific cytoplasmic 
factors (Malter, 1989; Bohjanen et al., 1991; 1992; Vakapoulou et al. , 1991 ). 
Insertion of these sequences from the 3'-UTR of the GM-CSF mRNA into the 
3'-UTR of the ~-globin mRNA has been demonstrated to destabilize the 
normally stable ~-globin mRNA (Shaw & Kamen, 1986). The instability 
conferred by such AU-rich sequences in the GM-CSF mRNA has been shown 
to be alleviated by cellular treatment with protein synthesis inhibitors and 
cellular activators (Shaw & Kamen , 1986; Akashi et al. , 1991 ). A recent 
report suggests , however, that other elements , apart from the conserved 
AU-rich sequences , may also regulate GM-CSF mRNA stability (lwai et al., 
I 
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1991 ). These studies suggest that the regulation of lymphokine gene 
expression at the post-transcriptional level, as well as at the transcriptional 
level, may involve the interactions of multiple cis-acting elements with specific 
trans-acting factors, whose activities and/or syntheses may be modulated by 
specific activation signals. 
1.3. SCOPE OF THIS THESIS 
If alterations in patterns of cellular growth and differentiation may be 
manifestations of interactions between information external to the genomic 
micro-environment and the dynamic hierarchy of interactions between 
structural and regulatory genetic information (section 1.1.5.), understanding 
the molecular bases of such processes involves several fundamental 
questions including: 
(1) how is the expression of an individual gene regulated? 
(2) how are regulatory mechanisms of groups of genes integrated? 
(3) how do these coordinated regulatory networks interact with the external 
information to modulate the parameters within which the structural 
information is expressed? 
In respect of understanding the molecular basis of T cell activation 
which forms the fundamental core of "inducible" haemopoiesis, numerous 
studies over recent years have provided considerable insight into the 
molecular mechanisms which regulate expression of specific lymphokine 
genes. Many of these studies have, however, restricted their attention to the 
regulation of expression of an individual lymphokine gene, in response to 
activation of a specific signalling pathway in a particular cell system. 
Comparison of the molecular mechanisms which control the expression of 
different lymphokine genes, and which may be modulated by different signal 
: 
I 
I 
' 
l 
20 
transduction pathways have been limited. Understanding how the molecular 
mechanisms which regulate expression of one lymphokine gene integrate 
with, and are coordinated with respect to, those which regulate expression of 
other lymphokine genes, is therefore essential in order to extend ou r 
understanding of how lymphokines, as transient mediators , coordinate 
"inducible" haemopoiesis as a network. 
This thesis describes the initial phase of a long-term project aimed at 
investigating the molecular basis of T cell activation , in particular the link 
between early events at the cell membrane and the consequent modulation of 
genetic events in the nucleus. The bulk of this thesis concerns two major 
molecular studies: 
(1) a comparative investigation of the involvement of , and inter-
relationships between, multiple signal transduction mechanisms in the 
induction of expression of a battery of lymphokine genes in activated murine T 
lymphocytes, and, 
(2) a comparative investigation of the modes by which the temporality of 
expression of different lymphokine genes may be regulated in response to 
activation of these multiple signalling pathways. 
The second part of this thesis focuses upon investigat ing th e as yet 
largely uncharacterized molecular mechanisms which regulate expression of 
the murine gene encoding IL-5, a lymphokine which promotes B cell growth 
and stimulates growth, differentiation and activation of eosinophils (Kinash i 
et al. , 1986; Campbell et al. , 1987; 1988; Sanderson et al., 1988). IL-5 has 
been the subject of particular interest in the laboratory in recent years , 
particularly given the linkage between the cell-specif ic nature of eos inophil ia 
and IL-5 gene expression (Coffman et al., 1989; Lima ye et al., 1989; Owen 
et al. , 1989; Yamaguchi et al. , 1990; Sanderson , 1992). Such cl ini ca l 
11 
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observations imply the possible existence of specific molecular "programs" 
which may be unique to the regulation of expression of the IL-5 gene, but 
which must ultimately be integrated with those which regulate other 
lymphokine genes. 
I 
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CHAPTER 2: 
DIFFERENTIAL INDUCTION OF LYMPHOKINE GENE 
EXPRESSION IN ACTIVATED MURINE T LYMPHOCYTES: 
2 .1. 
INVOLVEMENT AND INTER-RELATIONSHIPS OF 
MULTIPLE SIGNALLING PATHWAYS 
INTRODUCTION 
Activation of quiescent T lymphocytes is a complex process, involving 
the initial interaction of certain cell surface molecules with their specific 
ligands and the activation of multiple intracellular second messanger 
pathways, ultimately leading to the induction of lymphokine gene expression 
and specific processing of gene products. 
Central to the process of T cell activation is the specific recognition by 
the T cell receptor (TCR)/CD3 complex of antigen presented by accessory 
cells in association with major histocompatibility complex molecules. The 
conformational alterations of the TCR/ CD3 complex induced by antigen 
presentation rapidly triggers a dynamic interplay between CD45 , a 
phosphotyrosine phosphatase , and protein tyrosine kinases (PTKs ) 
associated with CD4 and the TCR/ CD3 complex. This interplay coup les the 
TCR/CD3 complex to phospholipase C activation and consequent hydro lys is 
of phosphatidylinositol 4 5-bisphosphate (Pl P2 ) (Same Ison et a l., 1986; 
Fleischer & Schrezenmeier 1988; Mustelin et a l., 1989· 1990; 1992; M uste li n 
& A ltman 1989· June et al. , 1990a; Koretzy et al. , 1990; Rudd , 1990; 
Ashwell 1991 · Klausner & Same Ison 1991 ) . The regu latory ro le of G 
proteins in these early TCR/ CD3-mediated signal transduct ion events 
remains as yet ambiguous (Imboden et a l., 1986· June et a l., 990a). The 
products of PIP2 hydrolysis namely diacylglycerol and inos itol tr iphosphate 
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respectively activate protein kinase C (PKC) and induce elevation in levels of 
intracellular calcium ([Ca2+]i). These processes may be mimicked by cellu lar 
treatment with mitogenic lectins, monoclonal antibodies directed against the 
TCR or CD3, or by the combined actions of phorbol esters, which activate 
PKC, and calcium ionophores, which raise [Ca2+]i (Nishizuka, 1984; Imboden 
et al., 1985; Imboden & Stobo, 1985; Weiss et al. , 1986; Berridge, 1987). 
Activation of T lymphocytes also appears to involve several other cell 
surface molecules. CD28 appears to be involved in mediating T cell 
activation as an "accessory molecule", which initiates and/or regulates signal 
transduction pathways that are distinct and independent from those mediated 
by antigenic stimulation of the TCR/CD3 complex (Hara et al. , 1985; Moretta 
et al., 1985; June et al., 1987; 1989). Early proposals of CO2 as a classical 
"accessory molecule" are somewhat controversial in the light of recent reports 
which demonstrate the TCR/CD3-dependence of CO2 signalling and the 
physical association between these two receptors and CD45 in activated T 
cells (Meuer et al., 1984; Breitmeyer et al. , 1987; Bockenstedt et al., 1988; 
Holter et al., 1988; Brown et al., 1989; Schraven et al., 1990). CO2, like the 
TCR/CD3 complex, appears to be coupled to the PIP2 pathway by a 
mechanism involving CD45-mediated modulation of PTK activity (Pantaleo 
et al., 1987; Danialien et al. , 1991; Koretzy et al. , 1991 ). 
The "antigen-independent" signal provided by IL-1 , a product of 
activated monocytes, is generally believed to be required , 1n addition to 
signals mediated by antigenic stimulation of the TCR/CD3 complex, to fully 
activate the T cell in vivo (Mizel, 1982). Reports of the nature of the IL-1 
signal transduction pathway are varied. Several studies have demonstated 
that the IL-1 signal requirements for optimal T cell activation may be replaced 
by phorbol ester treatment (de Vries et al. , 1982; Zlotnik & Daine, 1986). 
I 
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Other lines of evidence indicate, however, that the I L-1 signal transduction 
pathway may be independent of PKC activity and [Ca2+]i elevation (Abraham 
et al., 1987; Macchia et al., 1990; Dornand et al., 1992), and may involve 
adenylate cyclase-mediated elevation in levels of intracellular cyclic AMP 
([cAMP]i) and consequent protein kinase A (PKA) activation (Shirakawa 
et al., 1988; Chedid et al., 1989; Chedid & Mizel, 1990). 
Mechanisms involving the subsequent transduction of signals 
downstream of these early events are, as yet, poorly understood, but 
presumably may involve modulation of the phosphorylation states of key 
intracellular regulatory factors. The possibility that intracellular signals 
emanating from the different early membrane events may independently 
modulate the expression of different lymphokine genes has been raised by 
several reports which demonstrate that expression of certain lymphokine 
genes may be selectively inhibited by the immunosuppressive agent 
cyclosporin A (Cs A) (June et al. , 1987; Bickel et al., 1988; Bohjanen et al. , 
1990). Cs A has recently been demonstrated to block a pathway involving 
the Ca2+/calmodulin-dependent phosphatase calcineurin (Clipstone & 
Crabtree, 1992; Fruman et al., 1992; O'Keefe et al., 1992). 
In the present study, the modulation of expression of a variety of 
different lymphokine genes by several key signalling pathways was 
investigated in the antigen-specific murine T helper Type 2 (Th2) clone 
D1 O.G4.1 (Kaye et al., 1983) as a model experimental system. Lymphokine 
mRNA levels were compared in response to cellular stimulation by mitogenic 
lectin , IL-1, Ca2+ ionophore, activators of PKC and adenylate cyclase and a 
monoclonal antibody directed against specific antigen recognition sites of the 
TCR. The effects of Cs A and inhibitors of specific protein kinases and of 
protein synthesis upon the induction of different lymphokine m RNAs were 
; 
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examined to "dissect" the signalling pathways leading to expression of these 
various genes. Furthermore, given recent suggestions of the physical and 
functional inter-relationships between CO2, C045 and the TCR/C03 complex, 
the modulation of lymphokine gene expression by CO2 and C045 stimulation 
was also investigated. 
I\ 
I 
26 
2.2. MATERIALS AND METHODS 
2.2.1. Reagents, cell lines and cDNA clones 
( 1) Reagents 
Phorbol 12-myristate 13-acetate (Sigma), forskolin (Calbiochem), 
A23187 (Boehringer), Calphostin C (Calbiochem) and H-89 (Calbiochem) 
were dissolved in DMSO (dimethylsulfoxide) at 1 mg/ml, 1 O mM, 1 O mg/ml, 
2 mM and 1 O mM respectively and diluted with H20 prior to use. Cs A was 
a gift from Dr. C. Simeonevic (JCSMR) and was dissolved in ethanol at 
1 mg/ml and diluted with H20 prior to use. Cycloheximide (Sigma) was 
dissolved in H20 at 1 O mg/ml. Concanavalin A (Pharmacia) and 
recombinant I L-1 a (Promega) were dissolved in PBS (phosphate-buffered 
saline) at 1 mg/ml and 1 O µg/ml respectively. 303 monoclonal antibody was 
provided by Dr. P. Hodgkin (JCSMR). Monoclonal antibodies (mAbs) directed 
against CO2 and CD45 were provided by Dr. J. Altin (JCSMR). 
(2) Cell Lines 
01 O.G4.1 is a conalbumin-specific Th2 clone derived from AKR/J mice 
(Kaye et al., 1983) and was obtained from DNAX. 01 O.G4.1 cells were allo-
stim u lated at 5 x 1 o5 cells/m I every 1 O days with a 10-fold excess of 
irradiated C57Bl/6 spleen cells, and maintained in RPMI 1640 medium 
(GIBCO) supplemented with 10°/o fetal calf serum (CSL), 1 mM sodium 
pyruvate, 2 mM glutamine, 0.05 mM p-mercaptoethanol, 100 units/ml 
penicillin, 100 µg/ml streptomycin and recombinant IL-2 (50 units/ml). 
Recombinant IL-2 was obtained from culture supernatants of C127 
mammary tumour cells stably transformed with the murine IL-2 cDNA cloned 
into a modified bovine papilloma virus-based expression vector (Harasuyama 
' 
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& Melchers, 1988). This cell line was obtained from Dr. F. Melchers (Basel 
Institute for Immunology, Basel) and maintained in IMDM medium (GIBCO) 
supplemented with 5°/o fetal calf serum (CSL), 2 mM glutamine, 0.05 mM 
~-mercaptoethanol, 100 units/ml penicillin and 100 µg/ml streptomycin , and 
selected with G418 (1 mg/ml) (Geneticin, Sigma). After antibiotic selection fo r 
a minimum of 2 weeks, cells were washed in HBSS (Hanks Balanced Salt 
Solution) and cultured in G418-free medium for 2 days at 1 x 1 o5 cells/ml . 
The biological activity of IL-2 in the conditioned medium was assayed by Mrs. 
S. Chin (JCSMR) by measuring IL-2-dependent proliferation of HT-2 cells. 
(3) cDNA clones 
The murine IL-3 and IL-5 cDNA probes were 588 bp and 600 bp 
Eco RI fragments respectively derived from plLM21 (Fung et al., 1984) and 
pEDFM-15 (Campbell et al. , 1988). The murine GM-CSF cDNA probe was a 
700 bp Eco RI/Hind Ill fragment derived from pGM38 (Gough et a l., 1984) 
and provided by Dr. A. Dunn (Ludwig Institute for Cancer Research , 
Melbourne). The murine IL-4, IL-6 and IL-10 cDNA probes were 373 bp 
Rsa I, 945 bp Nia IV/Ssp I and 594 bp Sac I fragments respectively 
derived from pCD IL-4 (Lee et al. , 1986), pCD IL-6 (Ch iu et al., 1988) and 
pCD IL-1 O (Moore et al. , 1990). These plasmids were provided by DNAX. 
The Nia IV/Ssp I fragment derived from pCD IL-6 was recloned into pBCB07 
and provided by Dr. I. Ramshaw (JCSMR). The ~-actin cDNA probe, used as 
a control for constitutive gene expression , was a 2.1 kb Xho I fragment 
derived from pHF~A-1 (Gunning et al., 1983) and provided by Dr. P. Gunn ing 
(Children 's Hospital & Medical Research Foundation , Sydney). 
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2.2.2. Preparation and analysis of plasmid DNA 
( 1) Small scale plasmid DNA isolation 
Plasmid DNA was isolated on a small scale according to the alkaline 
lysis method modified from Maniatis et al. (1989). Bacterial cells, harvested 
from a 1 ml overnight culture were lysed in 100 µI of 50 mM glucose; 
25 mM Tris-Cl [pH 8.0]; 1 O mM EDTA (ethylene diaminetetraacetic acid) and 
4 mg/ml lysozyme for 5 min at room temperature. 200 µI of 0.2 M NaOH; 
1.0°/o SOS (sodium dodecyl sulphate) was added and the suspension 
incubated on ice for 5 min. 150 µI of 5 M potassium acetate [pH 4.6] was 
added and the suspension incubated on ice for 15 min. Following 
centrifugation at 12,000 x g for 5 min at 4°C, the supernatant was extracted 
with phenol:chloroform:isoamylalcohol (25:24:1). Plasmid DNA was 
precipitated by addition of an equal volume of isopropanol, and recovered by 
centrifugation at 12,000 x g for 1 O min at 4°C. The DNA pellet was washed 
in 70°/o ethanol, vacuum-dried and resuspended in 1 O mM Tris-Cl [pH 8.0]; 
1 mM EDTA containing 20 µg/ml RNase A (Boehringer). 
(2) Large scale plasmid DNA isolation 
Plasmid DNA was isolated on a large scale according to the rapid 
boiling method modified from Maniatis et al. (1989). Bacterial cells were 
harvested from a 500 ml overnight culture, amplified in the presence of 
chloroamphenicol (170 µg/ml), and lysed in 1 O ml STET (100 mM NaCl ; 
10 mM Tris-Cl [pH 8.0]; 1 mM EDTA; 5°/o Triton X-100) containing 2 mg/ml 
lysozyme (Sigma). The suspension was heated until boiling, immersed in 
boiling water for 40 sec and cooled in ice-cold water. The suspension was 
centrifuged at 25,000 rpm for 30 min at 18°C in an SW41 rotor. Nucleic 
acids were precipitated by the addition to the supernatant of 0.1 volume of 
3 M sodium acetate [pH 5.2] and an equal volume of isopropanol , and 
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recovered by centrifugation at 15,000 x g for 20 min at 4°C. The pellet was 
vacuum-dried and resuspended in 10 mM Tris-Cl [pH 8.0]; 0.1 mM EDTA 
with cesium chloride and ethidium bromide at 1 g/ml and 800 µg/ml , 
respectively. The suspension was centrifuged in Quick Seal tubes (Beckman) 
at 42,000 rpm for 40 h at 18°C in a Ti75 rotor. The plasmid band was 
withdrawn, repeatedly extracted with water-saturated isopropanol and 
dialyzed overnight at 4°C against 1000 volumes of 1 O mM Tris-Cl [pH 8.0]; 
0.1 mM EDTA. 
(3) Restriction digestion and agarose gel electrophoresis of 
DNA 
Restriction enzyme digestion of DNA was carried out under conditions 
specified by the manufacturers. Reactions were terminated by addition of 
bromophenol blue, xylene cyanol and Ficoll (Type 400; Pharmacia) to 0.05°/o, 
0.05°/o and 3°/o respectively. Samples were heated at 65°C for 5 min and 
cooled on ice prior to electrophoresis on 0.8 to 2.0°/o agarose gels in 40 m M 
Tris-acetate [pH 7.8]; 2 mM EDTA containing 0.5 µg/ml ethidium bromide. 
( 4) Isolation of DNA fragments 
Electrophoresis of digested DNA was carried out as described above 
using low melting temperature agarose gels (SeaPlaque). The DNA 
fragment(s) of interest was excised from the gel, melted at 65°C, extracted with 
phenol and precipitated by addition of sodium acetate [pH 5.2] and ethanol to 
0.3 M and 70°/o respectively. 
( 5) Ligations and transformations 
1 µg/ml of digested vector DNA and 8 µg/ml of insert DNA were 
incubated in 50 mM Tris-Cl [pH 7.4] ; 10 mM MgCl2 ; 1 mM OTT 
(dithiothreitol); 1 mM ATP; 100 µg/ml BSA (bovine serum albumin) and 
II 
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1 mM spermidine with 5 units of T4 DNA Ligase (Pharmacia) overnight at 
4°C. Preparation and transformation of competent bacterial cells were carried 
out according to Chung et al. (1989). An early log phase culture of host cells 
in LB was added to an equal volume of 2 x TSS (1 x TSS: LB with 10°/o 
(wt/vol) PEG (polyethylene glycol) 3350; 5°/o (vol/vol) DMSO; 50 mM MgS04 
at a final pH of 6.5). A 100 µI aliquot of cells was incubated with 100 pg of 
plasmid DNA at 4°C for 30 min. 0.9 ml LB was added, cells grown at 37°C 
for 1 h and aliquots plated onto LB plates containing the appropriate 
antibiotic( s). 
2.2.3 Preparation and Northern blot analysis of RNA 
Solutions used in RNA preparations (excluding any containing Tris) 
were treated overnight with 0.1 °/o (vol/vol) DEPC (diethylpyrocarbonate) 
(Sigma) and then autoclaved. 
( 1) Preparation of Total RNA 
Total cellular RNA was prepared according to Chomczynski & Sacch i 
(1987) with modifications. 1 to 2 x 1 o7 tissue culture cells were washed with 
PBS and lysed in 500 µI of 4 M guanidinium isothiocyanate and 25 mM 
sodium citrate [pH 7.0] containing 0.2 M sodium acetate [pH 4.0] and 0.72°/o 
(vol/vol) ~-mercaptoethanol. The suspension was extracted with 500 µI 
phenol and 100 µI chloroform:isoamylalcohol (24: 1 ), incubated on ice for 
20 min and centrifuged at 12,000 x g for 20 min at 4°C. An equal volume of 
isopropanol was added to the supernatant. Following precipitation at -20°C, 
RNA was recovered by centrifugation at 12,000 x g for 20 min at 4°C, 
washed in 70°/o ethanol, vacuum-dried and resuspended in DEPC-treated 
H20. 
11 
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(2) Formaldehyde gel electrophoresis of RNA 
20 µg of RNA sample was heated at 65°C for 15 min in a mixture 
containing 2.2 M formaldehyde, 50°/o deionized formamide (vol/vol) ; 
1 x MOPS electrophoresis buffer (20 mM MOPS (3-[N-morpholino]-
propane-sulfonic acid) [pH 7.0]; 5 mM sodium acetate; 1 mM EDTA) and 
1 x RNA loading buffer (10°/o glycerol, 0.2 mM EDTA; 0.05°/o bromophenol 
blue; 0.05°/o xylene cyanol). RNA was electrophoresed on 1.2°/o agarose gels 
containing 1 x MOPS electrophoresis buffer and 2.2 M formaldehyde. 
(3) Northern transfer of RNA 
RNA was transferred to nitrocellulose membrane (BA85, Schleicher & 
Schuell) according to Maniatis et a/.(1989) with modifications. Following 
electrophoresis, the gel was soaked in several changes of DEPC-treated H20 
and then in 2 changes of 1 Ox SSC (1 x SSC: 150 mM NaCl; 15 mM 
sodium citrate [pH 7.0]) for 15 min. The gel was placed on a wick prepared 
from 3 sheets of Whatman 3MM paper soaked in 20 x SSC on a horizontal 
glass plate and smoothed to remove air bubbles. A nitrocellulose membrane, 
cut to the same dimensions as the gel and pre-soaked in 2 x SSC, was 
placed on the gel, followed by a piece of 3MM paper saturated in 2 x SSC. 
Two pieces of dry 3MM paper and a 5 cm thickness of paper towels were 
stacked on the gel, followed by a glass plate and weight. After overnight 
transfer, the filter was baked for 2 h at 80°C under vacuum. 
( 4) Prehybridization, hybridization and washing conditions 
The nitrocellulose fliter containing immobilized RNA was prehybridized 
at 42°C for 2-16 h in hydridization solution containing 50°/o formamide 
(vol/vol); 25 mM KH2P04 [pH 7.4]; 5 x SSC; 5 x Denhardt's solution 
(0.1 °/o BSA; 0.1 °/o Ficoll (Type 400) ; 0.1 °/o polyvinylpyrrolidone) and 
200 µg/ml sonicated and denatured salmon sperm DNA. Fresh hybridization 
' ;) 
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solution was added prior to addition of the 32P-labeled probe 
(-2 x 1 06 cpm/m I) and hybridization allowed to proceed for 16-24 h at 
42°C. Following hybridization, the filter was washed successively in 
1 X SSC/0.1 °/o sos and 0.1 X SSC/0.1 °/o sos at 65°C for 30 min, and 
exposed to Kodak XAR-5 film at -70°C with intensifying screens. Filters were 
stripped of hybridizing material by washing at 70°C in 0.1 °/o SOS and 
exposed to XAR-5 film at -70°C to check completeness of removal. Filters 
were re-hybridized with different probes as described above. All Northern blot 
analyses were conducted in two independent experiments, one filter being 
successively hybridized with various probes in the opposite order of sequence 
as a second duplicate filter. 
( 5) Synthesis of 32P-labeled DNA probes by random priming 
100-200 ng of linearized template DNA and 1 pmole of synthetic 
random decamers were boiled for 5 min, snap-chilled on ice and incubated in 
a total volume of 50 µI containing 20 mM Tris-Cl [pH 7.5]; 1 O mM MgCl2 ; 
10 mM OTT; 50 µg/ml BSA; 100 µCi [a-32p] dATP (3000 Ci/mmole , 
Amersham) and 40 µM each of dGTP, dCTP and dTTP with 5 units of DNA 
Polymerase (Kienow) (Pharmacia) for 2-4 h at room temperature. The 
reaction was terminated by addition of EDTA to 20 mM and unincorporated 
labeled nucleotides were removed by chromatography on a Sephadex G-50 
Nick column (Pharmacia) in 1 O mM Tris-Cl [pH 7.9]; 1 mM EDTA. The probe 
was denatured by boiling for 5 min prior to addition to the hybrid ization 
solution. 32P-labeled DNA probes were also synthesized using the Prime-a-
Gene Labeling System (Promega). 
( 6) Quantitation of Hybridization Signals 
The relative intensities of hybridization signals on Northern blots were 
quantitated using the Phospholmager (Molecular Dynamics). 
I 
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RESULTS 
Induction of lymphokine gene expression by 
lectin, antigen recognition site-specific antibody 
and IL-1 stimulation, PKC and adenylate cyclase 
activation and Ca2+ mobilization 
The differential induction of lymphokine gene expression was 
investigated by Northern blot analysis of total RNA, prepared from 01 O.G4.1 
cells stimulated in culture with a variety of agents. These included the 
mitogenic lectin concanavalin A (Con A), the phorbol ester phorbol 
12-myristate 13-acetate (PMA) , an activator of PKC (Nishizuka, 1984) , 
recombinant IL-1 a , the antigen recognition site-specific antibody 303 (Kaye 
et al., 1983), forskolin, a specific activator of adenylate cyclase (Seamon & 
Daly, 1983) or the calcium ionophore A23187. 
As shown in Fig. 2.1., no lymphokine mRNAs were detected in 
unstimulated 01 O.G4.1 cells (Lane 1 ). IL-3 IL-4 IL-5 IL-6 IL-10 and 
' ' ' ' 
GM-CSF mRNAs were detected after stimulation with either Con A, 303 or 
A23187 (Lanes 2,5, 7). Stimulation with A23187 induced levels of IL-3, IL-4, 
IL-6, IL-1 O and GM-CSF mRNAs comparable to those optimally induced by 
Con A. Only low levels of IL-5 mRNA, however, accumulated in response to 
A23187 stimulation (Lane 7). This suggests that signals other than ca2+ 
mobilization may be required to fully potentiate IL-5 gene expression. 303 
stimulation induced levels of IL-5, IL-6 and IL-1 O mRNAs comparable to levels 
induced by Con A. Low levels of IL-3 and IL-4 mRNAs and a barely 
detectable level of GM-CSF mRNA were induced by 303 compared to levels 
induced by Con A (Lanes 2,5). 
Fig. 2.1. Induction of lymphokine gene expression in 01 O.G4.1 
cells by lectin, antigen recognition site-specific antibody or IL-1 
stimulation, PKC or adenylate cyclase activation or elevation in 
[ Ca 2+] i. 
Total cellular RNA was prepared from unstimulated 01 O.G4.1 cells (Lane 1) 
or 01 O.G4.1 cells stimulated for 3 h at 2 x 106 cells/ml with either Con A 
(5 µg/ml), PMA (1 Ong/ml), IL-1 a (1 ng/ml), 303 (1: 1000 dilution), forskolin 
(20 µM) or A23187 (1 µg/ml) (Lanes 2-7). 20 µg of RNA was used to 
prepare Northern blots which were hybridized with the indicated 32P-labeled 
murine lymphokine cONA probes as described in Materials and Methods. 
Northern blots were also hybridized with a 32P-labeled ~-actin cONA probe 
as a control for constitutive mRNA accumulation. Equalization of RNA content 
was confirmed by visualization of 28S and 18S ribosomal RNAs (rRNA) on 
ethidium bromide-stained RNA gels. The results shown are representative of 
two independent experiments. 
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As shown in Fig. 2.1., IL-5, IL-6 and IL-10 mRNAs, but not IL-3, IL-4 nor 
GM-CSF mRNAs, were induced in D1 O.G4.1 cells in response to stimulation 
with either PMA, IL-1 a or forskolin (Lanes 3,4,6). These observations 
suggest that the expression of the IL-5, IL-6 and IL-10 genes may be 
selectively and independently regulated by either the PKC-, IL-1- or cAMP-
dependent signalling pathways. Futhermore, these results suggest that the 
IL-1 signal transduction pathway may share a mechanism common to both the 
PKC- and cAMP-dependent pathways in D1 O.G4.1 cells. 
2.3.2. Effect of protein synthesis inhibition upon 
induction of lymphokine mRNAs 
D1 O.G4.1 cells were stimulated with the various activators in the 
continual presence of cycloheximide (CHX), a commonly used protein 
synthesis inhibitor. As shown in Fig. 2.2., the induction of IL-5 mRNA by 
either Con A, PMA, forskolin, A23187 , IL-1 a or 303 was inhibited by CHX 
when present from the outset of stimulation by these agents 
(Lanes 2, 7, 12, 17,23,28). This suggests that the induction of IL-5 gene 
expression by a number of different signalling pathways requires obligatory 
de nova protein synthesis. 
The effect of CHX upon the induction of the other lymphokine mRNAs 
differed, however, depending on the mode of stimulation. The addition of 
CHX at the outset of stimulation with either Con A or A23187 inhibited the 
induction of GM-CSF mRNA and partially inhibited levels of IL-4 mRNA 
(Fig. 2.2., Lanes 2, 17). The induction of IL-3 mRNA by Con A or A23187 
was, in contrast, not significantly affected by CHX. These observations 
suggest that the induction of GM-CSF and IL-3 mRNAs by the ca2+ signal 
may, respectively, involve newly synthesized and pre-existing factors. 
I 
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Maximal induction of IL-4 mRNA in response to the Ca2+ signal may require 
protein synthesis. 
Although stimulation with IL-1 a did not induce GM-CSF and IL-4 
mRNAs, the addition of CHX at the outset of IL-1a stimulation induced 
significant levels of these two species (Fig. 2.2., Lanes 22,23). The 
accumulation of IL-3 mRNA, which is not responsive to IL-1a stimulation 
alone, was not induced by CHX under the same conditions. CHX did not 
induce the GM-CSF, IL-4 or IL-3 mRNAs in cells stimulated with either PMA or 
forskolin which alone, like IL-1a, were unable to induce these mRNAs 
(Lanes 6,7, 11, 12). These observations suggest that a labile mechanism may 
selectively suppress the induction of GM-CSF and IL-4 mRNAs in IL-1-
stimulated cells. 
Levels of IL-6 mRNAs induced by PMA, IL-1a or 3D3 were noticeably 
enhanced by CHX, while levels induced by Con A, forskolin or A23187 were 
not significantly affected (Fig. 2.2.). Levels of IL-10 mRNA induced by PMA, 
forskolin or A23187 were partially inhibited by CHX, while reduction in levels 
induced by either Con A, IL-1a or 3D3 were not noticeable. The addition of 
CHX at the outset of 3D3 stimulation led to small increases in levels of 
GM-CSF, IL-3 and IL-4 mRNAs. 
2.3.3. Effect of cyclosporin A upon the induction of 
lymphokine mRNAs 
D1 O.G4.1 cells were stimulated with the various activators in the 
continual presence of Cs A from the outset of stimulation. As shown in 
Fig. 2.2., the induction of the IL-3, IL-4 and GM-CSF mRNAs by either Con A, 
3D3 or A23187 was completely abolished by Cs A (Lanes 3,29, 18). This 
suggests that signals mediated by a Cs A-sensitive Ca2+-dependent 
Fig. 2.2. Effect of cyclosporin A, inhibition of protein synthesis 
and inhibition of protein kinase activity upon induction of 
lymphokine gene expression by different signalling pathways. 
Total cellular RNA was prepared from 01 O.G4.1 cells stimulated for 3 h with 
Con A (Lanes 1-5, 21) , PMA (Lanes 6-10), forskolin (Lanes 11-15), A23187 
(Lanes 16-20), IL-1 a (Lanes 22-26) or 303 (Lanes 27-31) in the absence or in 
the continual presence, from the outset of stimulation, of CHX (20 µg/ml), 
Cs A (1 µg/ml) , Cal C (0.5 µM) or H-89 (30 µM). Exposure of 01 O.G4.1 
cells to the inhibitors under these conditions was observed not to exert any 
cytotoxic effects. Cells were stimulated with the activators under the 
conditions previously indicated in Fig. 2.1. , and mRNA accumulation 
analysed by Northern blot analysis as previously described. 
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pathway are obligatory for the expression of the IL-3, IL-4 and GM-CSF genes 
in 01 O.G4.1 cells. 
In contrast to the IL-3, IL-4 and GM-CSF mRNAs, the induction of the 
IL-5, IL-6 and IL-1 O mRNAs by either Con A or 303 was relatively resistant to 
Cs A (Fig. 2.2., Lanes 3,29). The selective induction of the IL-5, IL-6 and 
IL-10 mRNAs by either PMA, forskolin or IL-1a was almost completely 
resistant to Cs A (Lanes 8, 13,24). These observations suggest that the 
expression of the IL-5, IL-6 and IL-10 genes is predominantly regulated by 
Cs A-resistant pathways in 01 O.G4.1 cells. 
As shown in Fig. 2.2., the induction of the IL-5, IL-6 and IL-10 mRNAs 
by A23187 was partially inhibited by Cs A (Lane 18). This suggests that the 
ca2+ signal may regulate their accumulation via Cs A-sensitive and Cs A-
resistant pathways. IL-5 mRNA, in contrast to the IL-6 and IL-10 mRNAs, was 
only weakly induced by A23187 (Lane 16). Furthermore, the induction of IL-5 
mRNA by either Con A or 303 demonstrated greater resistance to Cs A than 
the induction of IL-6 and IL-10 mRNAs (Lanes 3,29). These observat ions 
suggest that Cs A-resistant, ca2+-independent pathways play a predominant 
role in regulating I L-5 gene expression. 
2.3.4. Effect of protein kinase inhibitors upon induction 
of lymphokine mRNAs 
01 O.G4.1 cells were stimulated with the various activato rs in the 
presence, from the outset , of the protein kinase (PK) inhibitors Calphostin C 
(Cal C) and H-89 which are reported to demonstrate high specificity for PKC 
and PKA respectively (Kobayashi et al., 1989; Ch ijiwa et a l., 1990). Cal C 
interacts with the diacylglycerol/phorbol ester-b inding regulatory domain of 
PKC. Other more commonly used PKC inh ibitors such as stau rospo rin e or 
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H-7 interact with the nucleotide-binding catalytic domain and therefore may 
not demonstrate a high degree of specificity over other PKs which also contain 
similar domains (Ruegg & Burgess, 1989; Tamaoki, 1991 ). Cal C inhibited 
PMA-induced IL-5 mRNA levels by -70°/o and H-89 reduced forskolin-induced 
levels by -80°/o as determined by quantitation of the relative intensities of 
hybridization signals using Phospholmager analysis. Conversely, the 
inhibitory effects of Cal C upon forskolin-induced IL-5 mRNA levels and H-89 
upon PMA-induced levels were significantly smaller (-5°/o). These 
observations suggest that these inhibitors demonstrate reasonably high 
specificity for their respective known cellular targets. Cal C nor H-89, 
furthermore, did not significantly affect A23187-induced mRNA accumulation 
(Lanes 19,20), suggesting that the ca2+ signal may independent of PKC and 
PKA activity. 
Although PMA stimulation alone appeared insufficient to induce 
GM-CSF mRNA (Fig. 2.2., Lane 6), Cal C significantly inhibited Con A- and 
3D3- induced accumulation of GM-CSF mRNA (Lanes 4,30). This suggests 
that PKC activation may be required, along with other obligatory signals , to 
fully potentiate GM-CSF gene expression. Levels of IL-3 and IL-4 mRNAs 
induced by Con A and levels of IL-4 mRNA induced by 3D3 were, however, 
relatively resistant to Cal C, while 3D3-induced IL-3 mRNA levels were 
slightly reduced. H-89 did not significantly inhibit Con A- or 3D3- induced 
expression of any of the six lymphokine genes (Lanes 5,31 ). Although PMA 
or I L-1 a alone were unable to induce the I L-3, I L-4 and G M-CSF m RN As , low 
levels of IL-3 and IL-4 mRNAs, but not GM-CSF mRNA, were detected in PMA-
or IL-1 a- stimulated cells which were co-treated with Cal C (Lanes 9,25). 
Co-treatment with H-89, however, did not enhance accumulation of these 
mRNAs (Lanes 10,26). These observations give rise to the possibility that 
PKC signals may negatively modulate the expression of the IL-3 and IL-4 
I 
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genes. While it cannot be discounted that Cal C may possibly influence other 
cellular activities apart from PKC inhibition, the observations suggest that the 
GM-CSF gene is differentially regulated from the IL-3 and IL-4 genes. 
Cal C significantly inhibited accumulation of IL-5 mRNA levels induced 
by Con A, PMA or 303, while IL-6 mRNA levels were inhibited by Cal C to a 
lesser degree (Fig. 2.2., Lanes 4,9,30). The induction of IL-10 mRNA by 
these activators was relatively resistant to Cal C. Levels of I L-5 and IL-6 
mRNAs induced by IL-1a were partially inhibited by either Cal C or H-89 
(Lanes 25,26), suggesting that the IL-1 signal transduction pathway may 
involve both PKC and PKA activation. The induction of IL-1 O mRNA by IL-1 a 
was, however, relatively unaffected by the two inhibitors. This gives rise to the 
possibility that other kinases may be involved in the I L-1 signal transduction 
pathway. Notwithstanding other possible actions of these inhibitors, the 
observed differences in responses to these inhibitory agents suggest that the 
IL-1 O gene may be differentially regulated from the IL-5 and IL-6 genes. 
2.3.5. Modulation of lymphokine gene expression 
patterns by synergy between signalling pathways 
To further exam 1ne the signal requirements for the expression of 
different lymphokine genes, the effects of co-stimulation with different 
combinations of activators upon induction of their mRNAs were investigated. 
Although the IL-5, IL-6 and IL-10 mRNAs are coordinately induced in 
response to either PMA or IL-1 a, co-stimulation with these two agents, either 
together or in combination with other activators, differentially modulated their 
accumulation patterns. As shown in Fig. 2.3., co-stimulation with PMA and 
IL-1 a induced significant levels of IL-5 mRNA (Lane 8), the hybridization 
signal of which was over two-fold the sum of IL-5 mRNA hybridization signals 
induced by PMA and IL-1 a alone (Lanes 3,4). Such synergistic increases in 
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Fig.2.3. Modulation of lymphokine gene expression patterns by 
co-activation of different signalling pathways. 
Total cellular RNA was prepared from unstimulated 01 O.G4.1 cells (Lane 1) 
or cells stimulated for 3 h with either Con A, PMA, IL-1a, 303, forskolin or 
A23187 (Lanes 2-7). 010.G4.1 cells were also stimulated for 3 h with 
different combinations of activators (Lanes 8-17). Cells were stimulated with 
the various activators under the conditions previously indicated in Fig. 2.1., 
and mRNA accumulation analysed by Northern blot analysis as previously 
described. 
1 . unstimulated 
2. Con A 
3. PMA 
4. IL-1 a 
5. 3D3 
6. Forskolin 
7. A23187 
8. PMA + IL-1 a 
9. PMA + 3D3 
. - 10. PMA + Forskolin 
11. PMA + A23187 
12. IL-1a + 3D3 
13. IL-1 a + Forskolin 
14. IL-1 a + A23187 
15. 3 D3 + Forskolin 
16. 3D3 + A23187 
1 7. Forskolin + A23187 ",M._ ,_ 
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I L-6 and I L-1 O m RNA levels were not observed. I L-1 a in com bi nation with 
303 also induced an approximately two-fold synergistic increase in I L-5 
mRNA levels, but not IL-6 nor IL-1 O mRNA levels (Lane 12). Co-stimulation 
with PMA and A23187 induced synergistic increases in IL-5 , IL-6 and 
GM-CSF mRNA levels (Lane 11 ). This observation provides further evidence 
that PKC activation, although alone insufficient to induce the GM-CSF gene, 
may be required to fully potentiate its expression. Secondly, these results 
suggest that the IL-5, IL-6 and GM-CSF genes may be differentially regulated 
from the IL-3, IL-4 and IL-1 O genes by their requirement for both the PKC and 
Ca2+ signals for optimal induction. IL-1 a also synergized with A23187 in the 
induction of the IL-5, IL-6 and GM-CSF mRNAs (Lane 14). This suggests that 
PKC activation may be involved in the IL-1 signalling pathway. Co-stimulation 
with other combinations of activators induced only additive increases in 
lymphokine mRNA levels. 
01 O.G4.1 cells were also stimulated with different combinations of 
activators in the presence of either Cal C or H-89 to further dissect the 
signalling requirements for induction of the various lymphokine genes. As 
shown in Fig. 2.4., the synergy between PMA and IL-1 a in the induction of 
IL-5 mRNA was dramatically inhibited by Cal C (Lane 6). The induction of 
IL-5 mRNA by A23187 in combination with either PMA or 303, or by IL-1 a in 
combination with either A23187 or 303, was also significantly inhibited by 
Cal C (Lanes 3,9, 12, 15). These observations suggest that the PKC signal 
may play a predominant role in inducing expression of the IL-5 gene. 
As shown in Fig. 2.4., the synergy between A23187 and either PMA or 
IL-1 a in the induction of IL-5, IL-6 and GM-CSF mRNAs was significantly 
inhibited by Cal C (Lanes 3, 12). This suggests that the IL-1 signal 
transduction pathway may involve PKC activation. The synergy between 
Fig. 2.4. Effect of protein kinase inhibitors upon lymphokine 
gene expression patterns induced by co-activation of different 
signalling pathways. 
Total cellular RNA was prepared from 01 O.G4.1 cells stimulated for 3 h with 
either Con A (Lane 1) or different combinations of PMA, IL-1 a, 303 or 
A23187 in the absence or in the continual presence, from the outset of 
stimulation , of either Cal C or H-89, and analysed by Northern blot analysis. 
Cells were treated with the various activators and inhibitors at the 
concentrations previously indicated in Figs. 2.1. and 2.2. 
1 . Con A 
2. PMA + A23187 
3. PMA + A23187 + Cal C 
4. PMA + A23187 + H-89 
5. PMA + IL-1a 
6. PMA + IL-1a + Cal C 
7. PMA + IL-1a + H-89 
8. 303 + A23187 
9. 303 + A23187 + Cal C 
10. 303 + A23187 + H-89 
11. IL-1a + A23187 
12. IL-1a + A23187 + Cal C 
13. IL-1a + A23187 + H-89 
14. IL-1a + 303 
15. IL-1a + 303 + Cal C 
16 . IL-1a + 303 + H-89 
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A23187 and IL-1 a in the induction of IL-5 and IL-6 mRNAs was also 
significantly inhibited by H-89 (Lane 13). This suggests that PKA activation 
may also be involved in the IL-1 signal transduction pathway. Synergy 
between A23187 and IL-1 a in the induction of GM-CSF mRNA was, however, 
only slightly inhibited by H-89. This is consistent with previous observations 
indicating that PKA-dependent pathways may not be involved in regulating 
the induction of GM-CSF mRNA (sections 2.3.1. , 2.3.4.). The PKC component 
of the IL-1 pathway appears to play a greater role than the PKA component in 
the induction of IL-5 mRNA, as the synergy between IL-1 a and either PMA or 
303 was not significantly inhibited by H-89 (Lanes 7, 16). 
2.3.6. Modulation of lymphokine gene expression by 
CD45 and CD2 
The possibility that signals mediated by the CD45 and CO2 molecules 
may modulate the expression of different lymphokine genes, independently of 
direct TCR/CD3 stimulation, was investigated by examining lymphokine 
mRNA levels in 01 O.G4.1 cells stimulated with either 303, anti-CD45 mAb or 
mAbs directed against two putatively different CO2 isotypes. These were 
tentatively termed CD2(1) and CD2(2) , the former being distingu ished by its 
ability to co-precipitate with CD45 (J. Altin , pers. comm.). As shown in 
Fig. 2.5., stimulation of D10.G4.1 cells with either anti-CD45, ant i-CD2(1 ) or 
anti-CD2(2) induced low levels of IL-5 mRNA and moderate levels of IL-6 and 
IL-1 O mRNAs. Co-stimulation with the two anti-CO2 mAbs induced additive 
increases in the levels of these three species. In contrast, the I L-3, I L-4 and 
GM-CSF mRNAs were not induced in response to stimulation with ant i-CD45 
or either of the two anti-CO2 mAbs. Given that the IL-5, IL-6 and IL-1 O mRNAs 
may also be selectively induced by the I L-1- , PKC- or cAMP- dependent 
pathways (section 2.3.1.) , these observations suggest that some common 
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Fig. 2.5. Modulation of lymphokine gene expression by CD45 or 
CD2 stimulation. 
Total cellular RNA was prepared from 01 O.G4.1 cells stimulated for 3 h with 
either 303 (1 : 1000 dilution) , anti-CD45 mAb (5 µg/ml) or two different anti-
CO2 mAbs ((1) and (2)) (5 µg/ml), or co-stimulated with different combinations 
of these mAbs, and analysed by Northern blot analysis as previously 
described. Concentrations of the mAbs used were those which demonstrated 
maximal binding to their respective ligands (J. Altin, pers. comm.). 
1 . 3D3 
2. CD2(1) 
3. CD2(2) 
4. CD45 
5. CD2(1) + (2) 
6. 3D3 + CD2(1) 
7. 3D3 + CD2(2) 
8. 3D3 + CD45 
9. 3D3 + CD2(1) + (2) 
10. 3D3 + CD2(1) + (2) + CD45 
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mechanism may exist between these activation pathways and those mediated 
by CD45 and CO2. 
To investigate whether the CD45 and CO2 molecules may modulate 
the expression of the lymphokine genes induced by TCR/CD3 stimulation , 
lymphokine mRNA levels were examined between 01 O.G4.1 cells stimulated 
with 303 alone, or with 303 in combination with anti-CD45 and/or either one 
or both of the two anti-CO2 mAbs. At the concentrations used in this study, no 
interference between these mAbs in their binding to their respective ligands 
could be detected (J. Altin, pers. comm.) . As shown in Fig. 2.5. , stimulation 
with either or both of the two anti-CO2 mAbs did not appear to significantly 
affect the levels of all six lymphokine mRNAs induced by 303 stimulation. 
Levels of all six lymphokine mRNAs induced by 303 were, however, reduced 
when 01 O.G4.1 cells were co-stimulated with anti-CD45 (Lanes 8, 10). This 
negative effect of anti-CD45 upon 303-induced gene expression appeared to 
differ between lymphokine genes. CD45 stimulation substantially inhibited 
303-induced levels of IL-3, IL-4 and GM-CSF mRNAs, while inhibition of IL-5, 
IL-6 and IL-10 mRNA levels was less marked. These observations suggest 
that CD45 stimulation may (1) negatively modulate lymphokine gene 
expression induced in response to TCR/CD3 stimulation , and (2) also mediate 
positive signals to a distinct group of lymphokine genes, independently of 
direct TCR/CD3 stimulation. 
I 
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2.4. DISCUSSION 
A number of recent studies in T cell clones have demonstrated the 
inducibility of expression of a variety of lymphokine genes in response to 
TCR/CD3 stimulation. Studies described in this chapter suggest that the 
I 
intracellular signalling pathways emanating from the TCR/CD3 complex may , 
differentially regulate the expression of a number of lymphokine genes in the 
murine Th2 clone D1 O.G4.1. The studies also reveal that the expression of 
these lymphokine genes may be differentially and independently regulated by 
intracellular signalling pathways emanating from the IL-1 receptor and the 
CD45 and CO2 cell surface molecules. 
2.4.1. Coordinate and differential regulation by the two 
TCR/CD3-mediated second messanger pathways 
Studies described in section 2.3.1. indicated that the GM-CSF, IL-3, 
IL-4, IL-5, IL-6 and IL-1 O genes are coordinately expressed in response to 
cellular stimulation by the lectin Con A, the antigen recognition site-specific 
antibody 3D3 or the calcium ionophore A23187. The expression of the IL-5, 
IL-6 and IL-10 genes could, however, be selectively and independently 
induced by the phorbol ester PMA. This suggests that the two para llel second 
messanger pathways activated by TCR/CD3-mediated Pl P2 hydrolysis may 
differentially regulate the expression of two distinct groups of lymphokine 
genes (Fig. 2.6.). While either PKC activation or ca2+ mobilization may 
' I 
I 
I 
I 
: 
I 
I 
l 
I 
I 
I 
independently induce the expression of the IL-5 , IL-6 and IL-10 genes, the 1 
Ca2+ signal appears obligatory for induction of GM-CSF, IL-3 and I L-4 gene 
expression. Furthermore, the ca2+ signal appears to be mediated via distinct 
pathways which also differentially modulate the expression of these two 
groups of genes. Expression of the GM-CSF, IL-3 and IL-4 genes appears to 
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Fig. 2.6. Schematic representation of the inter-relationships 
between different signal transduction mechanisms which regulate 
the expression of different lymphokine genes in 01 O.G4.1 cells. 
The postulated linkage between different signal transduction pathways and 
the regulation of expression of individual, or distinct groups of, lymphokine 
genes are indicated by broken lines. The signalling pathways which are 
proposed to emanate from the IL-1 receptor, CO2 or CD45 molecules are 
indicated by dotted lines. Agents used in this study which either activate • or 
inhibit "v distinct steps in these multiple activation pathways are denoted 
close to their sites of action. "P-protein" refers to intracellular proteins 
phosphorylated by protein kinases. Abbreviations include: IL-1 R: IL-1 
receptor; G: G protein; PLC: phospholipase C; AC: adenylate cyclase; DAG: 
diacylglycerol; IP3: inositol triphosphate; ER: endoplasmic reticulum. Other 
abbreviations are refered to in the text. 
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be predominantly regulated by a Cs A-sensitive Ca2+-dependent pathway 
(section 2.3.3.). Such a pathway may involve the Ca2+/calmodulin-
dependent phosphatase calcineurin, whose activity has recently been 
demonstrated to be inhibited by a complex formed between Cs A and its 
intracellular target cyclophilin (Takahashi et al., 1989; Liu et al., 1991 ; 
Clipstone & Crabtree, 1992; Fruman et al., 1992; O'Keefe et al., 1992). 
Regulation of the IL-5, IL-6 and IL-1 O genes by the Ca2+ signal may, however, 
involve both Cs A-sensitive and Cs A-resistant pathways. 
Synergy between phorbol esters and Ca2+ ionophores in inducing T 
cell proliferation and lymphokine synthesis has been extensively reported and 
generally ascribed to the requirement of activating both PKC and 
Ca2+/calmodulin-dependent kinases in order to fully trigger T cells (Truneh 
et al., 1985; Kumagai et al., 1987; Macchia et al., 1990). Several reports 
have further extended the basis of this synergy to involve enhanced PKC 
activation by positive cooperative binding of Ca2+ and diacylglycerol 
analogues to PKC (May et al., 1985; Wolf et al., 1985a,b ). This "two-signal 
requirement" appeared to differ between lymphokine genes in 01 O.G4.1 cells. 
PKC activation, although alone insufficient to induce the GM-CSF gene, 
appeared to be required in addition to the obligatory Ca2+ signal to fully 
potentiate its expression (section 2.3.5.). This requirement was not observed 
for the IL-3 and IL-4 genes. PMA and A23187 also synergized for optimal 
induction of the IL-5 and IL-6 genes, but not the IL-1 O gene. The IL-5 , IL-6 and 
GM-CSF genes therefore appear to be differentially regulated from the IL-3, 
IL-4 and IL-10 genes by their "two signal requirement". Furthermore, the IL-5 
gene appears to be differentially regulated from other genes by the obligatory 
requirement of the PKC signal for its inducibility. The inducibility of the IL-5 
gene in response to the Ca2+ signal alone was significantly weaker than 
observed for the other lymphokine genes, and the synergy between PMA and 
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A23187 in the induction of IL-5 mRNA was severely inhibited by the PKC 
inhibitor Cal C (section 2.3.5.). 
The absence of synergy between PMA and A23187 in the induction of 
the IL-3, IL-4 and IL-10 genes appears to correlate with the slightly stimulatory 
effect of Cal C upon accumulation of their mRNAs (section 2.3.4.). This may 
suggest that PKC signals may negatively modulate IL-3 and IL-4 gene 
expression, and coordinately exert positive and negative influences upon 
IL-10 gene expression. Such pleiotropic modulation may be possibly 
mediated by different PKC isoenzymes (Nishizuka, 1988; Huang et al., 1989). 
Although the observations raise the possibility that suppression of PKC activity 
may slightly enhance expression of these genes, the converse implication, 
namely that PKC activation may inhibit their induction by the ca2+ signal , was 
not observed (section 2.3.5.). One explanation may be that the weak 
negative effect of the PKC signal may be overcome by the stronger positive 
effect of the Ca2+ signal. The possibility that Cal C may influence other 
cellular activities cannot, however, be discounted. Future investigations of the 
regulatory role of PKs in modulating lymphokine gene expression may require 
comparison between several other chemical PK inhibitors, and the use of T 
cells transfected with cDNAs encoding specific protein inhibitors of PKs 
(Chedid & Mizel, 1990) or T cell mutants deficient in a specific PK signal 
transduction pathway (Peyron et al., 1991 a). 
2.4.2. Regulation of lymphokine gene expression by the 
IL-1 signalling pathway 
The results of the current study indicate that the IL-5, IL-6 and IL-1 O 
genes may also be selectively and independently induced in response to 
stimulation of IL-1 receptor or activation of adenylate cyclase, as well as PKC 
activation (section 2.3.1.). It was observed that IL-1 a can replace PMA in 
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synergizing with A23187 for optimal induction of the GM-CSF, IL-5 and I L-6 
genes and that this synergy is significantly inhibited by Cal C 
(sections 2.3.4., 2.3.5.). Synergy between IL-1 and A23187 in the induction 
of the IL-5 and IL-6 genes, which are responsive to cAMP, was also inhibited 
by H-89, a PKA inhibitor. These observations suggest that the I L-1 signal 
transduction pathway may share a mechanism common to both the PKC- and 
PKA- dependent pathways in D1 O.G4.1 cells (Fig. 2.6.). The PKC component 
of the I L-1 signal transduction pathway appears, however, to play a greater 
role than PKA in the regulation of these genes, in particular that of IL-5. 
Synergy between PMA and IL-1 a was observed only in the induction of IL-5 
mRNA and was severely inhibited by Cal C. This provides further evidence 
that the IL-5 gene may be differentially regulated from the other lymphokine 
genes by the obligatory requirement of the PKC signal for its induction. 
Reports of the nature of the IL-1 signal transduction pathway are varied . 
The possibility that the interaction of IL-1 with its receptor may modulate PKC 
activity has been implied by several studies which demonstrate that the IL-1 
signal requirement may be replaced by phorbol ester stimulation (de Vries 
I 
I 
et al., 1982; Zlotnik & Daine, 1986). Other lines of evidence have, however, i 
indicated that the IL-1 signal transduction pathway may be independent of 
PKC activation (Macchia et al., 1990; Dornand et al. , 1992) and may involve 
adenylate cyclase-mediated elevation in [cAMP]i and consequent PKA 
activation (Shirakawa et al. , 1988; Chedid et al. , 1989; Chedid & Mizel , 
1990). A recent study in D1 O.A cells, a sub-line of the parental clone used in 
the present study, demonstrated that I L-1 stimulation may induce transient 
increases in both cAMP and diacylglycerol , PKC activation and 
phosphorylation of an intracellular target for PKC (Munoz et al. , 1990). 
I 
I 
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Results of this study are also consistent with reports indicating that the 
IL-1 signal transduction pathway is independent of Ca2+ mobilization 
(Abraham et al., 1987). The IL-3, IL-4 and GM-CSF genes, which require the 
ca2+ signal for induction, were not inducible by IL-1 a stimulation alone 
(section 2.3.1.). IL-1 has been demonstrated to stimulate diacylglycerol 
production from phosphatidylcholine in the absence of PIP2 hydrolysis in T 
cells (Rosoff et al., 1988). The IL-1 signal transduction pathway in D1 O.G4.1 
cells may involve PKC (and PKA) activation without concommitant ca2+ 
mobilization (Fig. 2.6.). The possibility that the IL-1 signal transduction 
I 
I 
I pathway may involve other kinases as well as PKC and PKA cannot, however, t 
be discounted. Studies described in section 2.3.2. suggest that a labile 
mechanism selectively suppresses the induction of the GM-CSF and IL-4 
mRNAs in D1 O.G4.1 cells stimulated with IL-1 a, but not with activators of PKC 
or adenylate cyclase. Furthermore, in contrast to the IL-5 and IL-6 mRNAs, the 
induction of I L-1 O m RNA by I L-1 a was relatively unaffected by either Cal C or 
H-89. These observations suggest that the intracellular pathways emanating 
from the IL-1 receptor in D1 O.G4.1 cells may involve other kinases apart from 
PKC and PKA. Furthermore, these different signal transduction pathways 
appear to differentially regulate the expression of a number of lymphokine 
I 
I 
I 
I 
genes. The use of signal transduction mutants will be of potentially enormous I 
value in future studies in defining the components of the IL-1 signal 
transduction pathway and their roles in regulating the expression of different 
lymphokine genes. 
The antagonistic relationship between the PKC and PKA pathways has 
been extensively reported in a number of cell types (Nishizuka, 1986) , 
although positive cross-talk between these two signalling pathways has been 
observed (Yoshimasa et al., 1987). Elevation of [cAMP]i in T cells has been 
reported to inhibit TCR/CD3- or CO2- mediated PIP2 hydrolysis, IL-2 and IL-2 
I 
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receptor gene expression and T cell proliferation (Novogrodsky et al. , 1983; 
Mary eta!., 1987; Patel eta!. , 1987; Bismuth eta!., 1988; Lerner eta!., 
1988; Rincon et al., 1988), [cAMP]i elevation has been induced in these T 
cell models by various means including permeant cAMP analogues, direct 
stimulation of adenylate cyclase by forskolin, activation of the adenylate 
cyclase stimulatory G protein by cholera toxin, inhibition of phosphodiesterase 
which degrades intracellular cAMP or by use of physiological agonists such 
as prostaglandin E2. The role of cAMP in IL-1 signal transduction has been 
argued against on the basis that activators of [ cAM P]i elevation have been 
sometimes unable to mimic the action of IL-1 in several systems and are 
inhibitory to T cell activation (O'Neill et al., 1990). This notion has been 
countered by the argument that IL-1 induces small transient increases in 
[cAMP]i which are rapidly turned over by phosphodiesterase, while mimicking 
agents, such as those described above, may dramatically induce high, often 
non-physiological cAMP levels in a sustained fashion which may be ultimately 
inhibitory (Mizel, 1990). This is analogous to the negative feedback regulation 
mediated by sustained PKC activation induced by prolonged PMA stimulation 
(Cantrell et al., 1985; Bijsterbosch & Klaus, 1987). Negative modulation of 
lymphokine gene expression patterns by co-stimulation with forskolin was , 
however, not observed in this study (section 2.3.5.). Conversely, increases in 
[Ca2+]i have been reported to attenuate cAMP-mediated signals via the action 
of Ca2+/calmodulin-dependent phosphatases and phosphodiesterases 
(Cohen, 1985). Negative modulation of forskolin-induced lymphokine gene 
expression by [Ca2+]i elevation also was not observed. 
2.4.3. Regulation of lymphokine gene expression by the 
CD45 and CD2 cell surface molecules 
The results of the current study indicate that stimulation of either the 
CD45 or CO2 cell surface molecules may selectively induce expression of the 
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IL-5, IL-6 and IL-10 genes, but not the IL-3, IL-4 nor GM-CSF genes, in 
01 O.G4.1 cells. The ability of either C045 or CO2 to induce the expression of 
a specific group of lymphokine genes, independently of one another and of 
direct TCR/C03 stimulation, is a novel and controversial finding in the light of 
recent studies which propose the existence of dynamic physical and 
functional inter-relationships between these cell surface molecules. 
Firstly, the existence of a functional inter-relationship between C045, 
CO2 and the TCR/C03 complex has been implicated by several cross-linking 
studies which demonstrate physical association between these molecules on 
the surfaces of activated T lymphocytes (Brown et al., 1989; Sch raven et al. , 
1990; Volarevic et al., 1990). Secondly, more recent lines of evidence have 
implicated the role of C045 in T cell activation as that of an integral 
intermediary in a linear progression of signalling events emanating from 
stimulation of the TCR/C03 complex and also CO2. C045 has recently been 
demonstrated to activate, by tyrosine dephosphorylation, two PTKs of the src 
family, namely p59fyn and p55lck, which are respectively associated with the 
TCR/C03 complex and C04 (Veillette et al. , 1988; Samelson et al., 1990; 
Mustelin et al., 1989; 1992). These PTKs are highly expressed in T cells and 
are active during, and appear critical for, TCR/C03-mediated T cell activation 
(Marth et al., 1985; 1989; Cooke et al., 1991 ). These two PTKs have been 
proposed to be likely candidates to phosphorylate , among other substrates, 
the signal transducing s chain of C03 (Mustelin & Altman , 1989; Irving & 
Weiss, 1991; Koretzy et al., 1991; Klausner & Samelson , 1991 ). This tyrosine 
phosphorylation event appears critical for coupling the TCR/C03 complex to 
phospholipase C activation and consequent PIP2 hydrolysis (June et al., 
1990a; Koretzy et al., 1990; Mustelin et al. , 1990; Peyron et al., 1991 b; 
Strauss & Weiss, 1992). 
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CO2, like the TCR/CD3 complex, also appears to be coupled to the 
PIP2 pathway by a similar mechanism involving CD45-mediated modulation 
of PTK activity, possibly that of p56/ck (Pantaleo et al., 1987; Danielian et al. , 
1991; Koretzy eta!., 1991). The existence of a direct functional inter-
relationship between CO2 and the TCR/CD3 complex is controversial. While 
early studies proposed that CO2 regulates an alternate "antigen-independent" 
pathway (Meuer et al., 1984), recent reports have demonstrated that CO2 
signalling is dependent upon TCR/CD3 expression and function (Breitmeyer 
et al., 1987; Bockenstedt et al., 1988; Holter et al., 1988; Moingeon et al. , 
1992). 
The ability of either CD45 or CO2 to selectively regulate the expression 
of a specific group of lymphokine genes, independently of one another and of 
direct TCR/CD3 stimulation, suggests that pathways mediated via either of 
these two cell surface molecules may not involve Pl P2 hydrolysis. 
Observations described in section 2.3.6. indicated that stimulation of either 
CD45 or CO2 could selectively induce the expression of the IL-5 , IL-6 and 
IL-1 O genes, which are also selectively inducible by PMA. Stimulation of 
CD45 or CO2 did not, however, induce the expression of the IL-3, IL-4 or 
GM-CSF genes which are predominantly regulated by the ca2+ signal. This 
suggests that the signal transduction pathways emanating from either the 
CD45 or CO2 molecules may involve PKC activation without concommitant 
Ca2+ mobilization. PKC activation may be possibly induced by diacylglycerol 
derived from sources other than PIP2, such as phosphatidylcholine (Rosoff 
et al., 1988). Given that CO2, unlike CD45, does not appear to possess 
intrinsic tyrosine phosphatase activity, activation of their putatively common 
downstream target(s) may be converged upon by different upstream events 
independently mediated by these two cell surface molecules. 
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The observation that co-stimulation with anti-CD45 mAb inhibits 303-
induced expression of all six lymphokine genes (section 2.3.6.) appears , at 
first instance, difficult to reconcile with the critical role that CD45 plays in 
regulating TCR/CD3- (and CO2-) mediated signal transduction . 
lmmunofluorescent binding studies appear to negate the possibility that the 
observed negative effects of anti-CD45 mAb, under the conditions used in this 
study, may be due to its steric hinderance of interactions between 303 (and 
CO2 mAb) and their respective targets (J. Altin, unpublished results). Early 
observations of negative modulation by anti-CD4 and anti-CDS mAbs of 
TCR/CD3-mediated responses have been explained by a similar proposal 
(Emmrich et al., 1987; Jonsson et al., 1989). Several recent lines of 
evidence have demonstrated, however, that co-stimulation with anti-CD45 
mAb may inhibit TCR/CD3- or CO2- mediated PIP2 hydrolysis and ca2+ 
mobilization (Ledbetter et al., 1988; 1991; Kiener & Mittler, 1989; Goldman 
et al., 1992; Turka et al., 1992). The tyrosine phosphatase activity of CD45 
may conversely be negatively regulated by elevation in [Ca2+]i (Ostergaard & 
Trowbridge, 1991 ). These observations together suggest that the functional 
inter-relationship between CD45 and ca2+ mobilization is one of mutual co-
modulation and may not necessarily be inconsistent with the role that CD45 
plays in regulating the PIP2 signal transduction pathway. The negative 
modulation by CD45 stimulation upon the PIP2 signalling pathway observed 
in these previous studies, and upon 303-induced expression of all six 
lymphokine genes observed in the current study, may be attributable to some 
form of negative feedback regulation. The weaker inhibitory effect exerted by 
anti-CD45 mAb upon 303-induced expression of the IL-5 , IL-6 and IL-10 
genes may be attributable to their expression being selectively and positively 
modulated by activation signals emanating from CD45 , independently of, and 
notwithstanding, its negative modulation of TCR/CD3-mediated activation . 
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Given the dynamic nature of the physical and functional inter-
relationships that appear to exist between the TCR/C03 complex, C045 , 
CO2 and C04 molecules, the ability of C045 to activate various pathways 
which may be inter-dependent or independent of those mediated via the 
TCR/C03 complex or CO2 raises several intriguing questions. These include 
whether the triggering of these different pathways by C045 is due to its 
phosphatase activity per se or to some other, yet unknown, feature of this 
complex molecule, and whether these various pathways may be activated by 
different C045 isoforms. 
This study provides evidence that lymphokine genes may be 
differentially regulated by (i) the two parallel second messanger pathways 
activated by stimulation of the TCR/C03 complex, and (ii) signalling pathways 
activated by other cell surface molecules such as CO2, C045 and the IL-1 
receptor, which may involve mechanisms distinct from those emanating from 
TCR/C03 stimulation. Certain intracellular pathways may induce the 
synthesis of specific factors which regulate the expression of specific 
lymphokine genes such as those of IL-5 and GM-CSF. The regulation of other 
lymphokine genes such as those of IL-3 or IL-6 appear, however, to involve 
pre-existing factors which are presumably activated by modification , for 
example, by phosphorylation or dephosphorylation, in response to specific 
signals. These factors may be involved in regulating the expression of the 
different lymphokine genes at either the transcriptional or post-transcriptional 
levels. Investigations of the molecular mechanisms by which T cell activation 
signals may regulate expression of different lymphokine genes are discussed 
in the following chapter. 
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CHAPTER 3: 
DIFFERENTIAL REGULATION OF LYMPHOKINE GENE 
EXPRESSION BY MULTIPLE TRANSCRIPTIONAL AND 
POST-TRANSCRIPTIONAL MECHANISMS 
3.1. INTRODUCTION 
Regulation of the temporality of lymphokine gene expression is critical 
to the role of lymphokines as transient signals which mediate the proliferation, 
differentiation and function of haemopoietic cells in response to 
immunological stress. It might therefore be expected that lymphokine genes 
should only be expressed as long as the T cell is in contact with the antigen 
and that their expression should cease soon after removal of the antigenic 
stimulus. 
The temporal expression of the lymphokine genes studied to date 
appear to be regulated by multiple , different sets of transcriptional and post-
transcriptional mechanisms. These mechanisms may vary depending on the 
specific cell type and stimulus. Increases in GM-CSF gene transcription , for 
example, have been observed upon stimulation of human fibroblasts with 
phorbol esters or TNF-a (Koeffler et al. , 1988), murine T cell lines with lectin 
or specific antigen (James & Kazenwadel , 1989; Brorson et al., 1991) or 
endothelial cells with IL-1 (Kaushansky, 1989). GM-CSF gene expression 
appears, however, to be regulated at the post-transcriptional level in B cells 
stimulated with IL-1 (Akahane & Plutznik, 1992), certain murine T cell lines 
stimulated with phorbol esters (Bickel et al. , 1990; lwai et al. , 1992) or mouse 
macrophages stimulated with lipopolysaccharide (Thorens et al. , 1987) and 
I 
I 
I 
I 
53 
at both the transcriptional and post-transcriptional levels in mast cells 
stimulated with ca2+ ionophores (Wodnar-Filipowicz & Moroni, 1990). 
Lymphokine-specific mRNAs, like many which encode inducible 
regulators of cellular growth and differentiation, including other cytokines (Raj 
& Pitha, 1981; Yamato eta!., 1989) and oncogenes (Dani eta!. , 1984; 
Mitchell et al., 1985; Rabbitts et al., 1985), are relatively short-lived. 
Regulation of mRNA stability appears to be a predominant mode of post-
transcriptional control of the lymphokine genes studied to date. Apart from 
activating transcription of their respective genes, T cell activation signals also 
appear to stabilize IL-2 and IL-3 mRNAs (Shaw et al., 1987; 1988a; Ohmura 
& Onoue, 1990; Ryan et al., 1991 ). Stabilization of GM-CSF mRNA by 
cellular signals has been extensively reported in a variety of cell types which 
express its gene (Thorens et al., 1987; Koeffler et al. , 1988; Bickel et al., 
1990; Wodnar-Filipowicz & Moroni, 1990; Akahane & Plutznik, 1992; lwai 
et al., 1992). Several studies have reported that cellular treatment with 
protein synthesis inhibitors may enhance the stabilization of certain cytokine 
and oncogene m RN As. This phenomenon, often referred to as 
"superinduction", has generally been ascribed to the suppression by protein 
synthesis inhibitors of a labile mechanism which mediates the degradation of 
these specific mRNAs (Dani et al., 1984; Mitchell et al. , 1985; Shaw & 
Kamen, 1986; Shaw et al. , 1987; 1988a; Brewer & Ross, 1989). 
While previous reports have provided considerable insight into the 
transcriptional and post-transcriptional mechanisms which regulate the 
expression of several specific lymphokine genes, these studies have, 1n 
general, focused their attention upon regulation of an individual gene 1n 
isolation and have been conducted in a variety of different cell systems. 
Comparison of regulatory mechanisms which control the expression of 
'· 
' 
I 
I 
I 
I 
I 
I 
I 
I 
I 
54 
different lymphokine genes in the same cell system has been limited. The 
current study sought to be a comparative investigation of the molecular bases 
of regulation of a number of different lymphokine genes, in particular that of 
I L-5 , whose regulatory mechanisms have, to date, not been extensively 
characterized. Furthermore, previous studies have largely investigated 
regulatory mechanisms in transformed cell lines. In the present study, 
mechanisms which regulate the express ion of a variety of lymphokine genes 
were investigated in the murine Th2 clone 01 O.G4.1. Regu latory mechanisms 
were also compared in the transformed murine T cell line EL4.23, variants of 
which have been used in several previous studies (Shaw et al. , 1987; 1988a; 
Bickel et al. , 1990; lwai et al., 1991; 1992). 
Several recent lines of evidence suggest that different stimuli may 
modulate the expression of lymphokine genes at different levels in a given cell 
type. C03 st imulation , for examp le, appears to activate transcript ion of 
several lymphokine genes in human peripheral blood T cells , while C028-
mediated s igna ls appear to stab ili ze their mRNAs (Lindsten et al. , 1989). 
Stud ies descr ibed in Chapter 2 suggested that a number of intracellular 
s igna llin g pathways emanat ing from various cell surface-med iated events 
may d ifferent ial ly regulate the accumulation of lymphokine mRNAs in 
01 O.G4.1 cells. The poss ibility that these different signa lling pathways may 
regul ate the expression of d ifferent lymphok ine genes at e ither the 
transcriptional and/or post-transcriptiona l levels in 01 O.G4.1 ce ll s was also 
invest igated in the current study. 
The molecu lar bases of lymphokine gene regu la ion were inves iga ed 
by two techniques: (i) orthern blot ana lys is: to measure s eady state leve ls of 
mR· A accumulat ion. and (ii) nuclear run -off transcr ipt ion ana lys is: which 
involves measurem en of nascent R A ini ia ed in vivo and elonga ed in vi ro 
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1n isolated nuclei, to assess the relative contribution of transcriptional and 
post-transcriptional mechanisms to mRNA accumulation (reviewed in Marzluff 
& Huang, 1985). 
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3.2. MATERIALS AND METHODS 
Isolation and Northern blot analysis of total cellular RNA has been 
previously described in section 2.2.3. Each Northern blot analysis was 
conducted in two independent experiments, one filter being successively 
hybridized with various probes in the opposite order of sequence as a second 
duplicate filter. The relative intensities of hybridization signals were 
quantitated using the Phospholmager (Molecular Dynamics). 
3.2.1. Cell lines, reagents and cDNA clones 
( 1) Cell Lines and reagents 
The source and maintenance of the murine Th2 clone D1 O.G4.1 (Kaye 
et al., 1983) has been previously described in section 2.2.1. (2). EL4.23 is a 
sub-line of the murine T lymphoma cell line EL4 (Farrar et al., 1980) and was 
provided by Dr. C. Sanderson (National Institute for Medical Research, Mill 
Hill, London). EL4.23 cells were maintained in RPMI 1640 medium (GIBCO) , 
supplemented with 10°/o fetal calf serum (Cytosystems), 1 mM sodium 
pyruvate, 2 mM glutamine, 100 units/ml penicillin and 100 µg/m I 
streptomycin. Actinomycin D and a-methyl mannoside were obtained from 
Sigma and were dissolved in H20 at 200 µg/ml and 1.0 M respectively. The 
sources and preparation of other reagents used to treat tissue culture cells in 
this study have been previously described in section 2.2.1.(1 ). 
(2) cDNA clones 
The sources and details of the munne IL-3 IL-4 IL-5 IL-6 IL-10 
' ' ' ' ' 
GM-CSF and ~-actin cDNA probes used for Northern blot analysis have been 
previously described in section 2.2.1.(3). The murine IL-2 cDNA probe was a 
563 bp Sac I/Ace I fragment derived from pCD IL-2 (Yokota et al. , 1985) 
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and was provided by DNAX. As a positive control for constitutive gene 
expression, in addition to the p-actin cDNA, a 1040 bp Ora 1/Bam HI 
fragment, containing the three coding units of the human ubiquitin gene UbB 
(Baker & Board, 1987), was used as a probe. This fragment was derived from 
pRB130 which was provided by Dr. R. Baker (JCSMR). Sequences used as 
unlabeled targets in nuclear run-off transcription analysis were also derived 
from these plasmids. As these cDNAs were originally cloned into various 
different vectors, cDNA sequences, indicated in the figures, were individually 
sub-cloned by the present investigator into the same vector, pBluescript SK-
(Stratagene ), to enable comparison between different nuclear run-off 
transcripts of any potential non-specific hybridization to vector sequences. 
Subcloning, isolation, restriction digestion and agarose gel electrophoresis of 
plasmid DNA has been previously described in section 2.2.2. 
3.2.2. In vitro nuclear run-off transcription analysis 
( 1 ) Isolation of Nuclei 
Nuclei were isolated from unstimulated or stimulated cells according to 
Greenberg & Ziff (1984) with modifications. 5 x 1 O 7 cells were harvested, 
washed in ice-cold PBS and lysed in 5 m I ice-cold lysis buffer ( 1 O m M Tris-Cl 
[pH 7.4]; 1 O mM NaCl; 3 mM MgCl2; 0.2°/o Nonidet P-40). Following 
centrifugation at 800 x g for 5 min at 4°C, the nuclei were resuspended in 
100 µI nuclear storage buffer (40°/o glycerol; 50 mM Tris-Cl [pH 8.0]; 5 mM 
MgCl2; 0.1 mM EDTA) and frozen in liquid nitrogen until use. 
( 2) Transcription reactions and isolation of transcripts 
Thawed nuclei were incubated for 30 min at 30°C in a total volume of 
200 µI containing 20°/o glycerol; 30 mM Tris-Cl [pH 8.0]; 5 mM MgCl2 ; 
150 mM KCI; 2 mM MnCl2; 1 mM OTT; 0.5 mM each of ATP and CTP; 
I 
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50 µCi each of [a-32p] UTP and [a-32p] GTP (3000 Ci/mmole, Amersham ) 
and 40 units of RNasin (Promega). Transcripts were isolated by the modified 
single-step guanidinium isothiocyanate method (Chomczynski & Sacchi , 
1987) previously described in section 2.2.3.(1 ). 
( 3) Southern transfer of DNA 
cDNA plasmids were digested with the appropriate restriction enzymes, 
electrophoresed on 2.0°10 agarose gels and transferred on to nitrocellulose 
(BA85, Schleicher & Schuell) or nylon (Hybond N+, Amersham) membranes 
according to Maniatis et al. (1989) with modifications. Following 
electrophoresis, the gel was treated in 0.25 M HCI for 5 min , rinsed in H20 
and denatured in 1.5 M NaCl; 0.5 M NaOH for 30 min with shaking. The gel 
was subsequently rinsed with H20 and neutralized in 1.5 M NaCl ; 0.5 M 
Tris-Cl [pH 7.2]; 1 mM EDTA for 30 min with shaking. Procedures for 
capillary blotting and fixation of nucleic acids to membranes have been 
previously described (section 2.2.3.(3)). 
( 4) Hybridization of 32p.fabeled run-off transcripts 
Digested cDNA plasmids, immobilized on filters , were hybridized to the 
run-off products according to Linial et al. (1985) with modifications. Filters 
were pre-hybridized at 65 °C for 2 to 16 h in 1 m I hybridization solution 
(10 mM Tris-Cl [pH 7.4]; 0.2°10 SOS ; 10 mM EDTA; 0.3 M NaCl; 
1 x Denhardt's solution and 200 µg/ml denatured yeast RNA). Fresh 
hybridization solution was added prior to addition of the 32P-labeled run-off 
products and hybridization allowed to proceed for 36 h at 65°C. Following 
hybridization, the filter(s) was washed as previously described for Northern 
blot analysis (section 2.2.3.(4)) or, alternatively, were washed in 2 x SSC at 
65°C for 1 h, then incubated at 37°C in 2 x SSC containing 20 µg/m I 
RNase A for 30 min and subsequently washed in 2 x SSC at 37°C for 1 h. 
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Each nuclear run-off transcription analysis was repeated in three 
independent experiments, using new filters containing immobilized cDNA for 
each experiment. 
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3.3. 
3.3.1. 
RESULTS 
Kinetics of lymphokine mRNA accumulation and 
gene transcription in D1 O.G4.1 cells. 
60 
Studies described in Chapter 2 demonstrated that the GM-CSF, IL-3, 
IL-4, IL-5, IL-6 and IL-1 O mRNAs are coordinately and optimally induced in 
D1 O.G4.1 cells in response to Con A stimulation. The kinetics of steady state 
accumulation of these lymphokine mRNAs in D1 O.G4.1. cells in response to 
Con A were investigated by Northern blot analysis. As shown in Fig. 3.1. , the 
levels of IL-3, IL-4 and IL-5 mRNAs rose rapidly to peak after 6 h stimulation. 
The low levels of GM-CSF mRNA accumulation peaked earlier at 3 h. IL-3, 
IL-4 and GM-CSF mRNA accumulation declined after 9 h, while the decline in 
IL-5 mRNA levels was significantly slower. The levels of IL-6 and IL-10 
mRNAs rose rapidly within 1.5 h of Con A stimulation , and were maintained 
for approximately 6 h before slowly declining. Significant levels of IL-5 , IL-6 
and IL-10 mRNAs were still detectable after 15 h stimulation. 
To determine whether the changing patterns of accumulat ion of these 
lymphokine mRNAs are attributable to alterations in the transcriptiona l activity 
of their respective genes, nuclear run-off assays were performed. While none 
of the six lymphokine mRNAs were detected by Northern blot analysis in 
unstimulated D1 O.G4.1 cells (Fig. 3.1. , Lane a) , low levels of GM-CSF and 
IL-6 gene transcription and a significant level of IL-1 O gene transcription were 
detected in unstimulated D1 O.G4.1 cells by nuclear run-off analysis 
(Fig. 3.2.(a)). Transcription of the IL-3, IL-4 and IL-5 genes was not observed 
in unstimulated D1 O.G4.1 cells. Following Con A stimulation , transcription of 
the IL-4, IL-5, IL-6 and IL-10 genes increased and then declined with kinetics 
broadly similar to their respective steady state m RNA accumulation patterns 
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Fig. 3.1. Northern blot analysis of the kinetics of steady state 
lymphokine mRNA accumulation in D1 O.G4.1 cells. 
Total cellular RNA was prepared from unstimulated 01 O.G4.1 cells (Lane a) 
or cells stimulated at 2 x 106 cells/ml with Con A (5 µg/ml) for the variable 
periods of time indicated (Lanes b-i). 20 µg of RNA was used to prepare 
Northern blots which were hybridized with the indicated 32P-labeled murine 
lymphokine cDNA probes as described in Materials and Methods. Northern 
blots were also hybridized with 32P-labeled p-actin and ubiquitin cDNA 
probes as controls for constitutive mRNA accumulation. Equalization of RNA 
content was confirmed by visualization of 28S and 18S ribosomal RNAs 
(rRNA) on ethidium bromide-stained RNA gels. The results shown are 
representative of two independent experiments. 
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Fig. 3.2. Nuclear run-off analysis of the transcriptional activity 
of lymphokine genes in D1 O.G.4.1 cells. 
Nuclei were isolated from unstimulated 01 O.G4.1 cells (Lane a) or cells 
stimulated with Con A (5 µg/ml) for the variable periods of time indicated 
(Lanes b-e). Nuclei were also isolated from D10.G4.1 cells which were 
stimulated for 6 h with Con A in the presence, from the outset of stimulation, of 
Cs A (1 µg/ml) (Lane f) or CHX (20 µg/ml) (Lane h). 01 O.G4.1 cells were 
also stimulated for 6 h with Con A and subsequently incubated for a further 
3 h with the addition of Cs A and/or CHX (Lanes g,i,j) in the continuing 
presence of Con A. Nascent RNA, initiated in vivo, were 32P-labeled by 
elongation in isolated nuclei in vitro, extracted and hybridized to 
approximately 500 ng of the indicated cDNA sequences. The IL-3, IL-4, IL-5, 
GM-CSF, IL-6, IL-1 O and ~-actin target sequences were, respectively, 280 bp 
8am HI/Nco I, 146 bp Rsa I/Sac I, 304 bp Sty I, 334 bp Hae Ill, 945 bp 
Nia IV/Ssp I, 594 bp Sac I and 2.1 bk Xho I fragments, which were derived 
from the original plasmids described in section 2.2.1.(3) and sub-cloned into 
the pBluescript SK vector (pSK). These cDNA target sequences were 
isolated by restriction digestion and agarose gel electrophoresis, as shown, 
and immobilized on filters. Pvu I-digested pSK DNA (1.91 kb and 1.05 kb) 
was also included as a negative control. The results shown are 
representative of three independent experiments. 
Although hybridization of the run-off transcripts to their respective cDNA 
targets was conducted under the stringent conditions described in 
section 3.2.2.(4), data-base searches of the cDNA target sequences were 
conducted to additionally ensure that the hybridization signals were not 
attributable to repeated sequences or homology with abundant species such 
as ribosomal RNA. 
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(Fig. 3.2.(b-e)). Only modest increases in transcription of the IL-3 and 
GM-CSF genes in response to Con A stimulation were observed. IL-3 and 
GM-CSF mRNAs remained, however, detectable by Northern blot analysis at 
times when IL-3 gene transcription became undetectable and the rate of 
GM-CSF gene transcription had declined to the level observed in 
unstimulated cells. These observations raise the possibility that mRNA 
stabilization may be involved in regulating the accumulation of the IL-3 and 
GM-CSF mRNAs in D1 O.G4.1 cells. 
3.3.2. Kinetics of lymphokine mRNA accumulation and 
gene transcription in EL4.23 cells 
The kinetics of steady state lymphokine mRNA accumulation were also 
investigated in the transformed T cell line EL4.23, in which T cell activation 
signals may be replaced by phorbol ester treatment (Farrar et al. , 1980). 
Preliminary experiments indicated that a number of lymphokine mRNAs, 
including those of IL-2, IL-3, IL-5 , IL-10 and GM-CSF, are coordinately and 
optimally induced in response to PMA stimulation, while their accumulation in 
response to other activators such as Con A or A23187 was barely detectable. 
The kinetics of lymphokine mRNA accumulation in EL4.23 cells were slower 
compared to those observed in D1 O.G4.1 cells. As shown in Fig . 3.3. , the 
levels of IL-2, GM-CSF and IL-5 mRNAs rose steadily to peak after 8 to 12 h 
PMA stimulation. IL-2 and GM-CSF mRNA accumulation declined after 16 h 
while significant levels of IL-5 mRNA were still detectable after 20 h. Only 
very low levels of IL-3 and IL-1 O mRNAs were detectable after 12 h 
stimulation , which were maintained for approximately 4 h before dec lin ing. 
While none of the lymphokine mRNAs were detectable in unst imulated 
EL4.23 cells (Fig. 3.3 ., Lane a), a sign if icant level of GM-CSF gene 
transcription and a low level of I L-1 O gene transcr ipt ion were detectab le in 
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Fig. 3.3. Northern blot analysis of the kinetics of steady state 
lymphokine mRNA accumulation in EL4.23 cells 
Total cellular RNA was prepared from unstimulated EL4.23 cells (Lane a) or 
cells stimulated at 2 x 106 cells/ml with PMA (50 ng/ml) for the variable 
periods of time indicated (Lanes b-f). 20 µg of RNA was used to prepare 
Northern blots which were hybridized with the indicated 32P-labeled cDNA 
probes. 
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Fig. 3.4. Nuclear run-off analysis of the transcriptional activity 
of lymphokine genes in EL4.23 cells. 
Nuclei were isolated from unstimulated EL4.23 cells (Lane a) or cells 
stimulated with PMA (50 ng/ml) for either 12 or 20 h (Lanes b,e). Nuclei 
were also isolated from EL4.23 cells which were stimulated for 12 h with PMA 
in the presence, from the outset, of CHX (20 µg/ml) (Lane c) or Cs A 
(1 µg/ml) (Lane d), or stimulated for 12 h with PMA and subsequently 
incubated for a further 8 h with addition of CHX and/or Cs A (Lanes f,g,h) in 
continuing presence of PMA. Nascent RNA, initiated in vivo, were 32p_ 
labeled by elongation in isolated nuclei in vitro, extracted and hybridized to 
approximately 500 ng of the indicated sequences. The IL-2, IL-6, IL-3, IL-10, 
IL-4, Ubiquitin, IL-5, ~-actin and GM-CSF target sequences were, respectively, 
251 bp Bgl 11/Rsa I, 945 bp Nia IV/Ssp I, 280 bp 8am HI/Nco I, 594 bp 
Sac I, 242 bp Rsa I/Sac I, 1.04 kb Ora 1/Bam HI, 304 bp Sty I, 2.1 kb 
Xho I and 334 bp Hae Ill fragments, which were derived from the original 
plasmids described in sections 2.2.1.(3) and 3.2.1.(2) and sub-cloned into the 
pSK vector. Restriction digests of plasmids containing (a) IL-2 and IL-6, 
(b) IL-3 and IL-10, (c) IL-4 and Ubiquitin, (4) IL-5 and ~-actin and 
(5) GM-CSF sequences were electrophoresed on agarose gels, as shown, 
and immobilized on filters. 
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62 
unstimulated cells (Fig. 3.4.(a)). Transcription of the IL-2, IL-3 and IL-5 genes 
was not detectable in unstimulated EL4.23 cells. Following PMA stimulation , 
transcription of the IL-2, IL-5 and IL-10 genes increased and then declined 
with kinetics broadly similar to their respective steady state m RNA 
accumulation patterns (Fig. 3.4.(b,e)). The rate of transcription of the 
GM-CSF gene, however, did not alter upon stimulation, while transcription of 
the IL-3 gene was only just detectable in stimulated cells. These observations 
suggest that mRNA stabilization may be involved in regulating the 
accumulation of GM-CSF and IL-3 mRNAs in EL4.23 cells, as well as in 
01 O.G4.1 cells. IL-4 and IL-6 mRNAs, and transcription of their respective 
genes, were not detectable in unstimulated or stimulated EL4.23 cells 
(Fig. 3.4.). 
3.3.3. The signalling requirement of lymphokine mRNA 
accumulation in D1 O.G4.1 cells 
In keeping with the role of lymphokines as transient mediators, it might 
be expected that their genes should only be expressed as long as the T cell 
remains in contact with the stimulus, and that their mRNAs should disappear 
soon after removal of the stimulus. To investigate this possibility in 01 O.G4.1 
cells, lymphokine mRNA levels were compared between 01 O.G4.1 cells which 
were continually stimulated with Con A for 9 h, and cells which were washed 
after 6 h stimulation with Con A and subsequently re-cultured for 3 h in 
Con A-free medium containing a-methyl mannoside to inhibit any residual 
Con A from binding. As shown in Fig. 3.5, the removal of Con A led to rapid 
declines in the levels of GM-CSF, IL-3 and IL-6 mRNAs, while a small decline 
in IL-10 mRNA levels was observed (Lanes a,d). In view of the finding that 
increases in the rates of GM-CSF and IL-3 gene transcription may not fully 
account for the accumulation of their mRNAs (section 3.3.1 .), these 
observations provide further evidence that their accumulation in 01 O.G4.1 
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Fig. 3.5. Northern blot analysis of the suppression, super-
induction and stability of lymphokine mRNAs in D1 O.G4.1 cells 
01 O.G4.1 cells were stimulated for 9 h with Con A (5 µg/ml) in the absence 
or presence, from the outset, of Cs A (1 µg/ml) or CHX (20 µg/m I) 
(Lanes a,b,e). 01 O.G4.1 cells were also stimulated for 6 h with Con A and 
subsequently incubated for a further 3 to 6 h with the addition of Cs A, CHX 
or Act O (1 O µg/ml) in the continuing presence of Con A (Lanes c,f,g,h,j,I), or 
in the absence of Con A (Lanes d,i ,k,m). In the latter case, 01 O.G4.1 cells 
were washed twice in warm medium after stimulation with Con A for 6 h and 
subsequently re-cultured in Con A-free medium containing 0.1 M a-methyl 
mannoside to inhibit residual Con A from binding. 01 O.G4.1 cells were also 
stimulated for 3 h with Con A in the absence or presence, from the outset, of 
Act O (Lanes n,o), or stimulated for 9 h with either Con A or CHX 
(Lanes p,q). Treatment of 01 O.G4.1 cells with the inhibitory agents under the 
conditions described above was not observed to exert cytotoxic effects. 
20 µg of total cellular RNA, extracted from 01 O.G4.1 cells, treated in the 
indicated manner, was used to prepare Northern blots which were hybridized 
with the indicated 32P-labeled cONA probes. Northern blots shown in 
Lanes p and q were subjected to a period of autoradiographic exposure of 
approximately three times the length of blots shown in other lanes. 
IL-3 
IL-4 
~ 
........... c~~,~----
-
IL-5 
- IL-6 
IL-10 
GM-CSF 
~-actin 
28S rRNA 
18S rRNA 
Time (hours) a b C d e f g h i j k I m n 0 p q 
Addition of Con A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Removal of Con A 
- - - 6 - - - - 6 - 6 - 6 
Addition of Cs A 
- 0 6 - - - - 6 
Addition of CHX 
- - - - 0 6 6 6 6 - - 6 6 - - - 0 
Addition of Act D 
- - - - - - - - - 6 6 6 6 - 0 
Cell Harvest 9 9 9 9 9 9 12 9 9 9 9 9 9 3 3 9 9 
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cells may largely involve their stabilization by the Con A-mediated signal. 
The observed decline in levels of IL-6 and IL-1 O mRNAs may, however, be 
attributable either to their decreased stability and/or to decreases in the 
transcriptional activity of their genes. In contrast to the other lymphokine 
mRNAs, the levels of IL-4 and IL-5 mRNAs did not significantly decline when 
Con A was removed (Lanes a,d). 
3.3.4. The signalling requirement of lymphokine mRNA 
accumulation in EL4.23 cells 
The signalling requirement of lymphokine mRNA accumulation was 
investigated in EL4.23 cells by comparing lymphokine mRNA accumulation 
patterns between cells which were continually stimulated with PMA for 16 to 
20 h (Fig. 3.6., Lanes a,b) and cells which were washed after 12 h 
stimulation with PMA and subsequently re-cultured for 4 to 8 h in PMA-free 
medium (Fig. 3.6., Lanes c,d). Levels of IL-2, IL-3, IL-1 O and GM-CSF 
mRNAs noticeably declined after the removal of PMA. In view of the findings 
that the rate of GM-CSF gene transcription does not significantly change in 
response to PMA, and that increases in the rate of IL-3 gene transcription may 
not fully account for accumulation of its mRNA (section 3.3.2.), these 
observations provide further evidence that the accumulation of IL-3 and 
GM-CSF mRNAs in EL4.23 cells, as well as in D1 O.G4.1 cells , may largely 
involve their stabilization by cellular signals. The decline in IL-2 and IL-10 
mRNAs observed upon removal of PMA may, however, be attributed either to 
their decreased stability and/or to decreases in the transcriptional activity of 
their genes. In contrast to the other lymphokine mRNAs, IL-5 mRNA levels 
were not significantly reduced when PMA was removed. 
Fig. 3.6. Northern blot analysis of the suppression, super-
induction and stability of lymphokine mRNAs in EL4.23 cells 
EL4.23 cells were stimulated for 16 or 20 h with PMA (50 ng/ml) in the 
absence or presence, from the outset, of Cs A (1 µg/ml) or CHX (20 µg/ml) 
(Lanes a,b,e,h). EL4.23 cells were also stimulated for 12 h with PMA and 
subsequently incubated for a further 4 to 8 h with the addition of Cs A, CHX 
or Act D (10 µg/ml/) in the continuing presence of PMA (Lanes f,g,i,j,m,n,o,q) 
or in the absence of PMA (Lanes c,d,k,1,p,r). In the latter case, EL4.23 cells 
were washed twice in warm medium after stimulation with PMA for 12 h and 
re-cultured in PMA- free medium. EL4.23 cells were also treated with CHX for 
16 h (Lanes). Treatment of EL4.23 cells with the inhibitory agents under the 
conditions described above was not observed to exert cytotoxic effects. 
20 µg of total cellular RNA, extracted from EL4.23 cells treated in the 
indicated manner, was used to prepare Northern blots which were hybridized 
with the indicated 32P-labeled cDNA probes. 
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3.3.5. The differential Cs A-sensitive signalling 
requirement of lymphokine mRNA accumulation 
in D1 O.G4.1 cells 
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As previously observed in Chapter 2, Cs A completely inhibited the 
accumulation of the IL-3, IL-4 and GM-CSF mRNAs in 010.G4.1 cells when 
present from the outset of Con A stimulation (Fig. 3.5., Lanes a,b). Nuclear 
run-off analysis indicated that Cs A inhibits the accumulation of these mRNAs 
at the transcriptional level (Fig. 3.2.(c,f)). The induction of the I L-5, I L-6 and 
IL-10 mRNAs in response to Con A stimulation was, in contrast, relatively 
resistant to Cs A (Fig. 3.5., Lanes a,b)), and transcription of their respective 
genes was not significantly affected by Cs A (Fig. 3.2.(c,f)). These 
observations suggest that the transcription of the IL-3, IL-4 and GM-CSF 
genes, but not the IL-5, IL-6 and IL-10 genes, is activated by signals mediated 
via a Cs A-sensitive pathway. 
Although signals mediated via a Cs A-sensitive pathway appear to 
initially activate IL-3 and IL-4 gene transcription and initially enhance GM-CSF 
gene transcription in 01 O.G4.1 cells, the ongoing expression of these genes 
may require continual signalling via this pathway. To investigate this 
possibility, lymphokine mRNA accumulation patterns were compared between 
01 O.G4.1 cells which were continually stimulated for 9 h with Con A and 
cells which were stimulated with Con A for 6 h and then exposed to Cs A for 
a subsequent 3 h in the continuing presence of Con A. As shown in 
Fig. 3.5., the addition of Cs A after 6h Con A stimulation significantly 
reduced the accumulation of IL-3 and GM-CSF mRNAs (Lanes a,c). A similar 
reduction in levels of these mRNAs was also observed when Con A was 
removed (Lane d). The small declines in the rates of IL-3 and GM-CSF gene 
transcription, which were observed when Cs A was added after 6 h Con A 
stimulation, appeared insufficient to fully account for the reduced 
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accumulation of their mRNAs (Fig. 3.2.(d,g)). These observations suggest 
that signals mediated via a Cs A-sensitive pathway not only initially activate 
IL-3 gene transcription and enhance GM-CSF gene transcription, but may 
also enhance the stabilization of their mRNAs. The addition of Cs A during 
the course of Con A stimulation, in contrast, only slightly reduced the 
accumulation of IL-4 mRNA (Fig. 3.5., Lane c). A significant decrease in IL-4 
gene transcription was, however, observed in corresponding nuclear run-off 
assays (Fig. 3.2.(d,g)). This observation suggests firstly that continual 
signalling via a Cs A-sensitive pathway is required for ongoing IL-4 gene 
transcription, as well as initial activation. Secondly, this observation suggests 
that the IL-4 mRNA is relatively stable, notwithstanding the cessation of 
continual signalling and the consequent abrogation of ongoing transcription of 
its gene. The addition of Cs A during the course of Con A stimulation did not 
significantly affect the transcription of the IL-5, IL-6 or IL-1 O genes nor the 
accumulation of their respective mRNAs (Fig. 3.2.(d,g); Fig. 3.5., Lanes a,c)). 
3.3.6. The differential Cs A-sensitive signalling 
requirement of lymphokine mRNA accumulation 
in EL4.23 cells 
The effect of Cs A upon the initial activation of lymphokine gene 
expression in EL4.23 cells was investigated by examining the effect of the 
presence of Cs A, from the outset of PMA stimulation, upon the transcriptional 
activation of the different lymphokine genes and the induction of their mRNAs. 
The effect of Cs A upon ongoing lymphokine gene expression , once 
induction was under way, was investigated by comparing gene transcription 
and mRNA accumulation patterns between cells continually stimulated with 
PMA for 16 to 20 h, and cells stimulated with PMA for 12 h and then exposed 
to Cs A for a subsequent 4 to 8 h in the continual presence of PMA. As 
shown in Fig. 3.6., the initial induction of IL-5 mRNA (Lanes a,e) and its 
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subsequent accumulation (Lanes a,b,f,g) were relatively resistant to Cs A. 
As shown in Fig. 3.4. , the initial activation of, and ongoing , IL-5 gene 
transcription was also resistant to Cs A (Fig. 3.4.(b,d,e,g). This suggests IL-5 
gene transcription is regulated by a factor(s) which is responsive to signals 
mediated via a Cs A-resistant pathway in EL4.23 cells, as well as in 01 O.G4.1 
cells (section 3.3.5.). 
Cs A inhibited the induction of the IL-2, IL-3, IL-10 and GM-CSF 
mRNAs when present from the outset of PMA stimulation (Fig. 3.6. , 
Lanes a,e). The addition of Cs A after 12 h PMA stimulation led to a 
reduction in the levels of IL-3, IL-1 O and GM-CSF mRNAs, and a significant 
decrease in IL-2 mRNA levels (Fig. 3.6., Lanes a,b ,f,g). Nuclear run-off 
analysis indicated, however, that Cs A abrogates activation of the IL-2 gene 
transcription, but does not significantly affect transcriptional activities of the 
IL-10 and GM-CSF genes when present from the outset of PMA stimulation 
(Fig. 3.4. (b,d)). The addition of Cs A after 12 h PMA stimulation led to a 
significant reduction in the transcriptional activity of the IL-2 gene, but did not 
noticeably affect the transcription rates of the I L-1 O and GM-CS F genes 
(Fig. 3.4.(e,g)). The effect of Cs A upon transcription of the IL-3 gene was 
unable to be determined given the weakness of its activity. 
These observations suggest, firstly , that I L-2 gene transcription is 
induced in EL4.23 cells by a factor(s) which is responsive to signals mediated 
via a Cs A-sensitive pathway, and which requires continual signalling via this 
pathway to mediate ongoing transcription. Activation of IL-1 O gene 
transcription appears to be regulated by a factor(s) which is largely responsive 
to Cs A-resistant signals. The sensitivity of IL-1 O mRNA accumulat ion to 
Cs A suggests, however, that signals mediated via a Cs A-sensitive pathway 
may also regulate its expression. Accumulation of GM-CSF mRNA in EL4.23 
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cells does not appear to involve increases in transcriptional activity, but rather 
enhanced stabilization of its mRNA mediated by a Cs A-sensitive signalling 
pathway. 
3.3.7. The role of signalling in regulating lymphokine 
mRNA stability in D1 O.G4.1 cells 
Observations described above suggest that the patterns of 
accumulation of the IL-4, IL-5, IL-6 and IL-10 mRNAs in D10.G4.1 cells in 
response to Con A-mediated signals may be attributed, to a large degree, to 
changing rates in transcription of their respective genes. Mechanisms other 
than transcription appear to play a significant role in the regulation of GM-CSF 
and IL-3 mRNA accumulation, and may involve stabilization of their mRNAs. 
To investigate the stability of lymphokine mRNAs, their accumulation was 
examined in the absence of ongoing transcription by cellular treatment with 
actinomycin D (Act D), a non-specific inhibitor of transcription. As evidence 
of the effectiveness of Act D in blocking transcription , Act D inhibited 
induction of all six lymphokine mRNAs when added at the outset of stimulation 
(Fig. 3.5., Lanes n,o). 
To investigate the stability of lymphokine mRNAs in 01 O.G4.1 cells , 
their accumulation patterns were compared between cells which were 
stimulated with Con A for 9 h, and cells which were stimulated with Con A 
for 6 h and subsequently exposed to Act D for another 3 h in the continual 
presence of Con A. As shown in Fig. 3.5., the levels of IL-4 and IL-5 mRNAs 
did not significantly decline in the presence of Act D (Lanes a,j) , even though 
Act D was added at a time when their respective genes are maximally 
transcribed (Fig. 3.2.(c)). This suggests that their mRNAs are relatively stable 
in the absence of ongoing transcription. IL-6 mRNA levels were slightly 
reduced in the presence of Act D, while the decline in IL-10 mRNA levels was 
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more marked (Fig. 3.5., Lanes a,j). The levels of IL-3 and GM-CSF mRNAs 
did not significantly decline in the presence of Act 0. Together with previous 
observations demonstrating the relatively weak transcriptional inducibility of 
the I L-3 and GM-CSF genes in response to Con A (Section 3.3.1 .), this 
suggests that stabilization of their mRNAs plays a predominant role in the 
regulating their expression. 
To further investigate the mediation of lymphokine mRNA stabilization 
by T cell activation signals, lymphokine mRNA levels were compared between 
01 O.G4.1 cells which were stimulated for 6 h with Con A, and exposed to 
Act O for a subsequent 3 h either in the absence or continual presence of 
Con A. As shown in Fig. 3.5., the levels of IL-4 and IL-5 mRNAs in the 
presence of Act O did not significantly differ whether Con A was removed or 
remained present (Lanes j,k). This suggests that these two species are 
relatively stable in the absence of ongoing transcription, as well as in the 
absence of continual signalling (section 3.3.3.). The levels of the other 
lymphokine mRNAs in the presence of Act O did not significantly differ 
whether Con A was removed or remained present. It was previously 
observed, however, that, in the absence of Act 0 , accumulation of IL-3, IL-6 
and GM-CSF mRNAs declined rapidly upon removal of Con A (Lane d). 
Act O treatment alone therefore appears to stabilize these m RNAs. These 
observations together imply the existence of two possible mechanisms which 
may coordinately regulate the stability of the IL-3, IL-6 and GM-CSF mRNAs in 
01 O.G4.1 cells. One mechanism may involve enhancement of stability of 
these specific mRNAs by the Con A-mediated signal. Stabilization of these 
mRNAs by Act O may be possibly due its suppression of a labile mechanism 
which mediates their degradation. 
3.3.8. The role of signalling in regulating lymphokine 
mRNA stability in EL4.23 cells 
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Observations described above suggest that the patterns of 
accumulation of the IL-2, IL-5 and IL-1 O mRNAs in EL4.23 cells in response to 
PMA-mediated signals may be attributable, to a large degree, to changing 
rates in transcription of their respective genes. Mechanisms other than 
transcription appear to play a significant role in the regulation of GM-CSF and 
IL-3 mRNA accumulation, and may involve stabilization of their mRNAs. To 
examine the stability of lymphokine mRNAs in EL4.23 cells, their accumulation 
patterns were compared between cells which were stimulated with PMA for 
16 h, and cells which were stimulated with PMA for 12 h and exposed to 
Act D for a subsequent 4 h in the continual presence of PMA. As shown in 
Fig. 3.6., the levels of IL-2, IL-5 and IL-1 O mRNA did not significantly decline 
in the presence of Act D (Lanes a,o), even though Act D was added at a 
time when their respective genes are maximally transcribed (Fig. 3.4.(b)). 
This suggests that their mRNAs are relatively stable in the absence of ongoing 
transcription. The levels of IL-3 and GM-CSF mRNA were also not 
significantly affected by the presence of Act D (Fig. 3.6., Lanes a,o ). 
To investigate the mediation of lymphokine mRNA stabilization by PMA 
signals in EL4.23 cells, lymphokine mRNA levels were compared between 
cells which were stimulated for 12 h with PMA and exposed for a subsequent 
4 h to Act D, either in the absence or continual presence of PMA. As shown 
in Fig. 3.6., the levels of IL-5 mRNA in the presence of Act D did not 
significantly differ whether PMA was removed or remained present 
(Lanes o,p). This provides further evidence that the IL-5 mRNA is relatively 
stable in the absence of ongoing transcription or continual signalling. The 
levels of the IL-2, IL-3, IL-10 and GM-CSF mRNA were marginally higher 
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when PMA was present rather than absent during the course of exposure to 
Act D (Lanes o,p), suggesting that PMA signals may stabilize these mRNAs. 
The levels of these mRNAs did not, however, significantly decline in the 
presence of Act D alone, even when PMA was removed. This suggests that 
Act D itself may stabilize these mRNAs possibly, as previously described in 
section 3.3.7., by suppressing the activity of a specific degradative 
mechanism. 
3.3.9. Requirement of de nova protein synthesis for 
induction of lymphokine gene expression in 
D1 O.G4.1 cells 
As previously described in section 1.1.4., cellular signals may activate 
the expression of eukaryotic genes by either inducing the synthesis of factors 
which regulate their transcription, or by presumably modifying, and thus 
activating, pre-existing factors. The mechanisms by which T cell activation 
signals activate transcription of different lymphokine genes in D1 O.G4.1 cells 
were investigated by examining mRNA accumulation and gene transcription 
patterns when the protein synthesis inhibitor CHX was added at the outset of 
Con A stimulation. As shown in Fig. 3.5., CHX completely inhibited the 
induction of IL-5 mRNA when present from the outset of Con A stimulation 
(Lanes a,e). Nuclear run-off assays demonstrated that CHX completely 
inhibits the activation of IL-5 gene transcription in response to Con A 
(Fig. 3.2.(c,h)). This suggests that a factor(s) (or subunit of a factor) , which is 
obligatory for the induction of IL-5 gene transcription, is synthesized de nova 
in response to Con A-mediated signals. CHX, in contrast , did not significantly 
affect the transcriptional activity of the IL-6 gene nor accumulation of its mRNA. 
This suggests that enhancement of IL-6 gene transcription is largely mediated 
by pre-existing factors whose activity is induced in response to Con A-
mediated signals. 
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The presence of CHX from the outset of Con A stimulation inhibited the 
induction of GM-CSF mRNA (Fig. 3.5., Lanes a,e) and reduced the rate of its 
gene transcription to that observed in unstimulated D1 O.G4.1 cells 
(Fig. 3.2. (c,h)). This suggests that factors synthesized de nova in response 
to Con A stimulation enhance the transcriptional activity of the GM-CSF gene. 
CHX significantly reduced the rate of I L-4 gene transcription, and partially 
decreased the transcriptional activity of the I L-1 O gene (Fig. 3.2. (c,h)). I L-4 
mRNA levels induced by Con A were partially inhibited by CHX, while the 
inhibitory effect of CHX upon IL-10 mRNA accumulation was less marked 
(Fig. 3.5., Lanes a,e). These observations suggest that maximal 
transcriptional activation of the IL-4 and IL-1 O genes in response to Con A 
stimulation requires protein synthesis. The accumulation of IL-3 mRNA, in 
contrast, was noticeably elevated when CHX was present from the outset of 
Con A stimulation (Fig. 3.5., Lanes a,e). This increase in IL-3 mRNA levels 
was not accompanied by any significant change in the transcriptional activity 
of the IL-3 gene (Fig. 3.2.(c,h)). This observation suggests , firstly, that 
transcriptional activation of IL-3 gene expression involves pre-existing factors 
and, secondly, that CHX may stabilize IL-3 mRNA. 
3.3.10. Requirement of de novo protein synthesis for 
induction of lymphokine gene expression in 
EL4.23 cells 
The requirement of de nova protein synthesis for the induction of 
lymphokine gene expression was investigated in EL4.23 cells by examining 
the effect of CHX, when present from the outset of PMA stimulation , upon 
lymphokine mRNA accumulation and gene transcription. As shown in 
Fig. 3.6., CHX severely inhibited the accumulation of IL-2 and IL-5 mRNAs 
and partially inhibited the induction of IL-10 mRNAs (Lanes a,h). Nuclear 
run-off assays demonstrated that CHX virtually abolishes the transcriptional 
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activation of the IL-2 and IL-5 genes, and partially inhibits the activation of 
IL-1 O gene transcription (Fig. 3.4.(b,c)). This suggests that factors which are 
obligatory for the activation of I L-2 and I L-5 gene transcription are synthesized 
de nova in response to PMA stimulation. Protein synthesis also appears to 
be required to fully potentiate IL-10 gene transcription. CHX also inhibited the 
induction of IL-3 mRNA (Fig. 3.6., Lane h). The effect of CHX upon the 
activation of IL-3 gene transcription was unable to be determined given the 
weakness of its activity. The presence of CHX from the outset of PMA 
stimulation did not significantly affect GM-CSF mRNA accumulation nor the 
rate of GM-CSF gene transcription. 
3.3.11. "Superinduction" of specific lymphokine mRNAs 
by suppression of protein synthesis in D1 O.G4.1 
cells 
As previously described in section 3.1., several studies have reported 
that the accumulation of certain lymphokine mRNAs may be enhanced in 
response to cellular treatment with protein synthesis inhibitors , once their 
induction was under way. The nature and specificity of this phenomenon , 
generally referred to as "superinduction", was investigated in D1 O.G4.1 cells 
by examining mRNA accumulation and gene transcription patterns of different 
lymphokines in cells which were stimulated with Con A for 6 h and then 
exposed to CHX for a subsequent 3 to 6 h in the continual presence of 
Con A. As shown in Fig. 3.5., the addition of CHX after 6 h Con A 
stimulation led to significant increases in levels of IL-3 and IL-6 mRNAs, and a 
particularly dramatic increase in GM-CSF mRNA levels (Lanes a,f,g). The 
levels of GM-CSF mRNA induced by CHX remained high at times when 
steady state levels in the absence of CHX were almost undetectable 
(Fig. 3.1.). The addition of CHX, however, did not noticeably affect the 
transcriptional activity of the IL-3, IL-6 and GM-CSF genes (Fig. 3.2.(d ,i)) . 
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These observations suggest that the "superinduction" of their mRNAs by CHX 
may be attributable to decreases in the rate of their degradation. This may 
presumably involve the suppression by CHX of a labile factor(s) which 
mediates their specific degradation. 
In contrast to the GM-CSF, IL-3 and IL-6 genes, significant decreases in 
the rates of IL-4 and IL-5 gene transcription were observed when CHX was 
added after 6 h Con A stimulation (Fig. 3.2.(d,i)). This suggests that ongoing 
IL-4 and IL-5 gene transcription requires continual synthesis of their regulatory 
factors. The addition of CHX after 6 h Con A stimulation did not , however, 
significantly affect the accumulation of IL-5 mRNA and only slightly reduced 
the levels of IL-4 mRNA accumulation (Fig. 3.5., Lanes a,f,g). This supports 
previous observations which suggest that the IL-4 and IL-5 mRNAs are 
relatively stable, compared to those of other lymphokines, notwithstanding the 
abrogation of ongoing transcription of their genes (section 3.3.7.). IL-1 O gene 
expression was slightly inhibited by the addition of CHX, an observation which 
appears consistent with the partial requirement of protein synthesis for 
potentiating its transcriptional activity. 
To verify that CHX enhances the stability of specific lymphokine mRNAs 
in D1 O.G4.1 cells, accumulation patterns were compared between cells which 
were stimulated with Con A for 6 h and subsequently exposed to Act D for 
3 h either in the absence or presence of CHX. As shown in Fig. 3.5. , the 
levels of IL-4, IL-5 and IL-1 O mRNAs in the absence of ongoing transcription 
were not noticeably affected by CHX (Lanes j,I). The levels of IL-3, IL-6 and 
GM-CSF mRNAs were, however, noticeably higher in the presence of Act D 
and CHX, than in the presence of Act D alone. The levels of IL-3, IL-6 and 
GM-CSF mRNAs in the presence of Act D and CHX did not noticeably differ 
whether Con A was continually present or absent (Lanes 1,m). These 
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observations provide further evidence that CHX alone enhances the 
stabilization of these specific mRNAs. As previously described in 
section 3.3.7., the stabilization of IL-3, IL-6 and GM-CSF mRNAs by Act 0 
alone may involve suppression by Act O of the expression of a putative labile 
factor which mediates their specific degradation. The combination of Act 0 
and CHX may be presumably more effective in inhibiting such a factor by 
blocking its synthesis at both the transcriptional and translational levels. 
Act O treatment alone may inhibit transcription of the gene encoding this 
putative factor, but will not prevent the conversion of its steady state 
translatable m RN As into functional proteins. 
Treatment of 01 O.G4.1 cells with CHX alone induced low levels of IL-6, 
GM-CSF and IL-10 mRNAs which were detectable after prolonged 
autoradiographic exposure (Lane q). This induction was not attributable to 
increases in transcription (data not shown). Other lymphokine mRNAs were, 
however, not induced by CHX alone. These observations suggest that CHX 
may stabilize the low levels of IL-6, GM-CSF and IL-1 O transcripts which are 
constitutively expressed in unstimulated 010.G4.1 cells (Fig. 3.2.(a)). The 
labile mechanism which degrades specific lymphokine mRNAs may therefore 
be constitutively active. Although CHX alone appears to stabilize IL-1 O 
transcripts in unstimulated 01 O.G4.1 cells , CHX did not appear to noticeably 
enhance IL-1 O mRNA levels, once their induction in response to Con A was 
under way (Fig. 3.5., Lanes f,g). This may be due to the inhibition by CHX of 
protein synthesis which appears to be required for maximizing the rate of 
IL-1 O gene transcription in response to Con A stimulation (section 3.3.9.). 
As shown in Fig. 3.5., the level of "superinduction" of IL-3 mRNA by 
CHX was significantly reduced in the presence of Cs A (Lane h). The small 
decline in the rate of IL-3 gene transcription which was observed when Cs A 
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was present during the course of CHX treatment appeared insufficient to 
account for the decline in IL-3 mRNA levels (Fig. 3.2.(j)). This provides further 
evidence that Cs A-sensitive signals are required for the stabilization of IL-3 
mRNA. The level of "superinduction" of GM-CSF mRNA by CHX was , 
however, only slightly reduced in the presence of Cs A (Fig. 3.5., Lanes f,h) . 
This suggests that Cs A-sensitive signals may stabilize IL-3 mRNA more 
efficiently than GM-CSF mRNA, and may account for the low steady state 
levels of GM-CSF mRNA, compared to those of IL-3 mRNA, which accumulate 
in response to Con A stimulation (Fig. 3.1.). 
The levels of "superinduction" of IL-6 mRNA by CHX was, in contrast to 
the IL-3 and GM-CSF mRNAs, not noticeably affected by Cs A (Fig. 3.5. , 
Lanes f,h). The absence of the Con A stimulus during the course of CHX 
treatment, however, significantly reduced the level of IL-6 mRNA 
"superinduction" (Lanes f ,i). This suggests that IL-6 mRNA may be stabilized 
by Cs A-resistant signals. Given that Cs A-resistant signals also appear to 
regulate IL-6 gene expression at the transcriptional level (section 3.3.5.) , the 
observed reduction in levels of IL-6 mRNA "superinduction" by the abrogation 
of continual signalling may not only be attributable to a reduction in mRNA 
stability, but also to a reduction in transcriptional activity. 
3.3.12. "Superinduction" of specific lymphokine mRNAs 
by suppression of protein synthesis in EL4.23 
cells 
The nature and specificity of mRNA "superinduction" was investigated 
1n EL4.23 cells by comparing mRNA accumulation and gene transcription 
patterns of different lymphokines between cells which were continually 
stimulated with PMA for 16 to 20 h, and cells which were stimulated with PMA 
for 12 h and then exposed to CHX for a subsequent 4 to 8 h in the cont inua l 
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presence of PMA. As shown in Fig. 3.6., the addition of CHX after 12 h PMA 
stimulation led to dramatic increases in levels of GM-CSF mRNA 
(Lanes a,b,i,j). Quantitation of the relative intensities of the hybridization 
signals by Phospholmager analysis detected an almost 40-fold increase in 
GM-CSF mRNA levels after 8 h exposure to CHX. The addition of CHX, 
however, did not noticeably affect the rate of GM-CSF gene transcription 
(Fig. 3.4.(e,f)). These observations suggest that the "superinduction" of 
GM-CSF mRNA by CHX may be attributable to decreases in the rate of its 
degradation. This may presumably involve the suppression by CHX of a 
labile factor(s) which mediates its specific degradation. 
Given the requirement of signalling for the stabilization of GM-CSF 
mRNA in EL4.23 cells (section 3.3.8.), the effect of signalling abrogation upon 
its "superinduction" by CHX was investigated. As shown in Fig. 3.6., the 
levels of GM-CSF mRNA were slightly reduced when Cs A was present 
during the course of CHX treatment (Lanes i,j,m,n), but remained 
nevertheless signficantly high. These observations suggest that the efficiency 
of GM-CSF mRNA stabilization by Cs A-sensitive signals may be only slightly 
higher than the efficiency of its degradation by a labile mechanism. This may 
account for the low steady state levels of GM-CSF mRNA which accumulate in 
EL4.23 cells in response to PMA, as well as in Con A-stimulated 01 O.G4.1 
cells (section 3.3.11.). 
As shown in Fig. 3.6., the addition of CHX to EL4.23 cells after 12 h 
PMA stimulation also led to increases in IL-3 mRNA levels and significant 
elevation in levels of I L-2 and I L-1 O m R NAs (Lanes a, b, i ,j). In contrast to the 
GM-CSF gene, increases in the transcriptional activities of the IL-3 and IL-1 O 
genes and a significant elevation in the rate of I L-2 gene transcription were 
observed in response to the addition of CHX during the course of PMA 
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stimulation (Fig. 3.4.(e,f)). These observations suggest that the 
"superinduction" of the IL-2, IL-3 and IL-1 O mRNAs by CHX may be 
attributable, at least in part, to stimulation in the transcriptional activities of 
their genes. This may involve the suppression by CHX of a labile repressor 
which regulates their transcription. 
As shown in Fig. 3.4., the increases in IL-2 and IL-3 gene transcription 
which were induced by CHX, were almost completely abolished by Cs A (f,h). 
This is consistent with previous observations which suggest that the 
expression of these two genes are largely regulated by signals mediated via a 
Cs A-sensitive pathway (section 3.3.6.). The presence of Cs A during the 
course of CHX treatment did not, however, reduce the accumulation of the IL-2 
and IL-3 mRNAs to the same extent as transcription of their genes (Fig. 3.6. , 
Lanes i,j,m,n). This raises the possibility that the enhanced accumulation of 
their mRNAs in the presence of CHX may also be attributable to their 
stabilization by CHX, as well as increases in transcriptional activity. 
The stimulation of IL-1 O gene transcription by CHX, and the 
accumulation of its mRNA was also noticeably reduced by Cs A 
(Fig. 3.4.(f,h); Fig. 3.6., Lanes i,j,m,n). The addition of Cs A from the outset 
or during the course of PMA stimulation was previously found , however, not to 
significantly affect the rate of IL-1 O gene transcription (Fig. 3.4.(b,d,e,g)) . This 
observation raises the possibility that Cs A-sensitive signals, as well as Cs A-
resistant signals , may regulate the expression of the I L-1 O gene in EL4.23 
cells. 
In contrast to the IL-2, IL-3 and IL-10 genes, the transcriptional activity 
of the IL-5 gene in EL4.23 cells was almost completely abolished when CHX 
was added during the course of PMA stimulation (Fig. 3.4.(e,f)). Th is 
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suggests that ongoing IL-5 gene transcription in EL4.23 cells, as well as in 
01 O.G4.1 cells (section 3.3.11.), requires continual synthesis of its specific 
regulatory factor(s). The accumulation of IL-5 mRNA was , however, not 
significantly affected by the addition of CHX (Fig. 3.6., Lanes a,b,i,j). This 
supports previous observations which suggest that the IL-5 mRNA is relatively 
stable, compared to those of other lymphokines, notwithstanding the cessation 
of transcription of its gene (section 3.3.8.). 
To further verify the nature of the mechanisms by which CHX 
"superinduces" the levels of GM-CSF, IL-2 , IL-3 and IL-10 mRNAs, their 
accumulation patterns were compared between EL4.23 cells which were 
stimulated with PMA for 12 h and subsequently exposed to Act D for 4 h 
either in the absence or presence of CHX. As shown in Fig. 3.6. , the levels of 
GM-CSF, IL-2, IL-3 and IL-10 mRNAs were noticeably higher in the presence 
of Act D and CHX (Lane q), than in the presence of Act D alone (Lane o). 
Levels of IL-5 mRNA, in the absence of ongoing transcription , were not 
significantly affected by CHX. The levels of GM-CSF, IL-2, IL-3 and IL-10 
mRNAs in the presence of Act D and CHX did not noticeably differ whether 
PMA was continually present or absent (Lanes q,r). These observations 
provide further evidence that CHX alone may stabilize GM-CSF mRNA and 
also IL-2, IL-3 and IL-10 mRNAs. "Superinduction" of the IL-2, IL-3 and IL-10 
mRNAs by CHX may therefore not only involve increases in the transcriptional 
activities of their genes, but also a reduction in the rate of their degradation. 
As previously described in sections 3.3.8. and 3.3 .11. , the stabilizat ion of the 
GM-CSF, IL-2, IL-3 and IL-1 O mRNAs by Act D treatment alone may involve 
suppression of the expression of a labile factor(s) which mediates their 
degradation. The combination of Act D and CHX may be presumably more 
effective in enhancing mRNA stabilization by their inhibiting the expression of 
such a "degradative" factor at both the transcriptional and translational levels. 
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As shown in Fig. 3.6., treatment of EL4.23 cells with CHX alone 
induced low levels of GM-CSF mRNA (Lanes). This induction was not due to 
an increase in the rate of GM-CSF gene transcription (data not shown). Other 
lymphokine mRNAs were not induced by CHX in the absence of PMA 
stimulation. This observation suggests that CHX may stabilize the GM-CSF 
transcripts which are constitutively expressed in unstimulated EL4.23 cells 
(Fig. 3.4.(a)). The labile mechanism which degrades specific mRNAs in 
EL4.23 cells, as well as in D1 O.G4.1 cells (section 3.3.11.) , appears to be 
constitutively active. 
3.3.13. Selective activation of lymphokine gene 
transcription by different signalling pathways in 
D1 O.G4.1 cells 
Studies described in Chapter 2 suggested that intracellular signal 
transduction pathways emanating from stimulation of the TCR/CD3 complex 
and the IL-1 receptor may differentially regulate the accumulation of 
lymphokine mRNAs in D1 O.G4.1 cells. The mechanisms by individual, and 
distinct groups of, lymphokine genes are induced in response to these specific 
signalling pathways were further investigated by Northern blot and nuclear 
run-off analyses. 
As previously observed in Chapter 2, the GM-CSF, IL-3, IL-4, IL-5, IL-6 
and IL-1 O mRNAs were coordinately induced in D1 O.G4.1 cells in response to 
cellular stimulation by either Con A, the antigen recognition site-specific 
antibody 303 or the calcium ionophore A23187 (Fig. 3.7.). Observat ions 
described in section 3.3.1. suggest that the induction of these mRNAs in 
response to Con A may be attributable , at least in part, to increases in the 
transcriptional activity of their respective genes. As shown in Fig. 3.7. , 
A23187 stimulation induced levels of GM-CSF, IL-3, IL-4, IL-6 and IL-10 
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Fig. 3.7. Induction of lymphokine mRNAs in D10.G4.1 cells by 
lectin, antigen recognition site-specific antibody or IL-1 receptor 
stimulation, PKC or adenylate cyclase activation or elevation in 
[ Ca 2+] i, and the effect of protein synthesis inhibition upon their 
induction. 
Total cellular RNA was prepared from D1 O.G4.1 cells stimulated for 3 h at 
2 x 106 cells/ml with either Con A (5 µg/ml), PMA (1 Ong/ml), forskolin 
(20 µM) , A23187 (1 µg/ml), IL-1a (1 ng/ml) or 303 (1:1000 dilution). Cells 
were also stimulated with these activators in the continual presence of CHX 
(20 µg/ml) from the outset of stimulation. mRNA accumulation was analysed 
by Northern blot analysis as previously described. 
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mRNAs comparable to those optimally induced by Con A. Significant 
increases in the transcription rates of their genes were observed in response 
to A23187 (Fig. 3.8.(f)). Only a very small increase in IL-5 gene transcription 
and a low level of IL-5 mRNA accumulation were induced by A23187. This 
suggests that signals other than ca2+ mobilization are required to fully 
potentiate IL-5 gene transcription. The relative increases in transcription of 
the IL-3, IL-4, IL-5, IL-6 and IL-10 genes in response to 303 stimulation 
broadly correlated with the relative increases in accumulation of their mRNAs 
(Fig. 3.7., Lane k; Fig. 3.8.(j)). Only a very low level of GM-CSF mRNA was 
detected in response to 303 and an alteration in the transcriptional activity of 
its gene was not noticeable by nuclear run-off analysis. 
As previously observed in Chapter 2, the IL-5, IL-6 and IL-10 mRNAs 
were selectively induced by cellular stimulation with either PMA, forskolin or 
IL-1a (Fig. 3.7., Lanes b,d,i). Stimulation with either PMA, forskolin or IL-1a 
increased the transcriptional activity of the IL-5, IL-6 and IL-10 genes 
(Fig. 3.8.(b,d,h)). The basal level of GM-CSF gene transcription did not alter 
in response to stimulation by any of these agents, while the IL-3 and IL-4 
genes remained transcriptionally silent. This suggests that the selective 
activation of IL-5, IL-6 and IL-1 O gene expresesion by the PKC- , cAMP- or 
IL-1- dependent signalling pathways is predominantly regulated at the 
transcriptional level. 
3.3.14. Involvement of newly synthesized and pre-
existing factors in the signal-specific activation 
of lymphokine gene transcription in D1 O.G4.1 
cells 
To investigate whether these signalling pathways activate the 
expression of different lymphokine genes by inducing the synthesis of 
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regulatory factors or by activating pre-existing factors, the effect of CHX upon 
their transcriptional activity and mRNA accumulation was examined. As 
shown in Fig. 3.7., the induction of IL-5 mRNA by either PMA, forskolin , 
A23187, IL-1 a or 303 was inhibited by CHX when present from the outset of 
stimulation by these agents. CHX completely inhibited the activation of IL-5 
gene transcription in response to stimulation by all of these agents (Fig. 3.8.). 
This suggests that the activation of IL-5 gene transcription by pathways which 
emanate from TCR/C03 or IL-1 receptor stimulation and which involve either 
Ca2+ mobilization, PKC or adenylate cyclase activation requires the induced 
synthesis of an obligatory transcription factors(s). 
The presence of CHX from the outset of A23187 stimulation inhibited 
the induction of GM-CSF mRNA and partially inhibited levels of IL-4 mRNA 
(Fig. 3.7., Lanes f,g). IL-3 mRNA levels were, however, not significantly 
affected by CHX. CHX reduced the rate of GM-CSF gene transcription to that 
observed in unstimulated 01 O.G4.1 cells (Fig. 3.8.(a,g)) , and decreased the 
level of IL-4 gene transcription. The activation of IL-3 gene transcription in 
response to A23187 was not significantly affected by CHX. These 
observations suggest that the Ca2+ signal induces the synthesis of a factor(s) 
which enhances the transcriptional activity of the GM-CSF gene, and activates 
a pre-existing factor(s) which induces I L-3 gene transcription . Maximal 
activation of IL-4 gene transcription in response to the ca2+ signal appears to 
require protein synthesis. The presence of CHX from the outset of 303 
stimulation, however, led to small increases in the levels of I L-3 , I L-4 and 
GM-CSF mRNAs without any noticeable increase in the transcriptional activity 
of their respective genes (Fig. 3.7. , Lanes k,I; Fig. 3.8.(j,k)) . 
Although IL-1 a did not activate GM-CSF or IL-4 gene transcription 
(Fig. 3.8.(h)) nor induce their mRNAs (Fig. 3.7. , Lanes i), the addition of 
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Fig. 3.8. Differential activation of lymphokine gene transcription 
by multiple signalling pathways in D1 O.G4.1 cells 
Nuclei were isolated from unstimulated 01 O.G4.1 cells (a) or cells stimulated 
for 3 h with either PMA, forskolin, A23187, IL-a or 303 (b,d,f,h,j). Cells were 
also stimulated with these activators in the continual presence of CHX from 
the outset of stimulation (c,e,g, i,k). Cells were treated with these agents under 
the conditions previously indicated in Fig. 3.7. Nascent RNA, initiated 
in vivo, were 32 P-labeled by elongation in isolated nuclei in vitro, extracted 
and hybridized to the indicated sequences. The IL-3, IL-4, Ubiquitin, IL-6, 
IL-10, Ubiquitin, ~-actin, IL-5 and GM-CSF target sequences (from left to right) 
were, respectively, 467 bp Hind 111/Nco I, 242 bp Rsa 1/Pst I, 594 bp 
Bgl II/Hind Ill, 827 bp Nia IV/Ora I, 552 bp Sac 1/Pst I, 594 bp 
Bgl II/Hind Ill, 2.1 kb Xho I, 304 bp Sty I and 334 bp Hae Ill fragments. 
These sequences were derived from the original plasm ids described in 
sections 2.2.1.(3) and 3.2.1.(2), sub-cloned into the pSK vector, re-isolated by 
restriction digestion and agarose gel electrophoresis, as shown, and 
immobilized on filters. 
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CHX, at the outset of IL-1 a stimulation, induced noticeable increases in the 
transcriptional activity of these two genes (Fig. 3.8.(i)) and significant 
accumulation of their mRNAs (Fig. 3.7., Lane j). Transcription of the IL-3 
gene and accumulation of its mRNA, which are also not responsive to IL-1 a 
stimulation alone, were not induced by CHX under the same conditions. 
These observations suggest that a labile transcriptional repressor may 
selectively inhibit the expression of the GM-CSF and IL-4 genes·, but not the 
IL-3 gene, in IL-1-stimulated cells. CHX did not induce GM-CSF or IL-4 gene 
expression in cells stimulated with either PMA or forskolin which alone, like 
I L-1 a, are unable to activate their expression (Fig. 3. 7., Lanes b-e; 
Fig. 3.8.(b-e)). This suggests that the mechanism which suppresses GM-CSF 
and IL-4 gene transcription in IL-1-stimulated cells may be independent of the 
PKC- and cAMP- dependent signalling pathways. 
Increases in IL-1 O gene transcription activated by either PMA, forskolin, 
A23187, IL-1a or 303 were partially inhibited by CHX (Fig. 3.8.). The levels 
of IL-10 mRNA induced by PMA, forskolin or A23187 were partially inhibited 
by CHX to varying degrees, while corresponding decreases in IL-1 a- or 303-
induced mRNA levels were not observed (Fig. 3.7.). Increases in IL-6 gene 
transcription activated by either PMA, forskolin, A23187, IL-1 a or 303 were 
not noticeably affected by CHX. Levels of IL-6 mRNA induced by PMA, IL-1 a 
or 303, but not forskolin nor A23187, were noticeably enhanced by CHX to 
varying degrees. These observations raise the possibility that these mRNAs 
may be stabilized by CHX, and also by different signals to different degrees. 
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3.4. 01scus·s10N 
A number of recent studies have investigated the molecular 
mechanisms which regulate the expression of several individual lymphokine 
genes in activated T cells, in particular those of IL-2 , IL-3 and GM-CSF 
(section 3.1.). Studies which compare the mechanisms by which different 
lymphokine genes are regulated have, however, been very limited. Previous 
studies have, furthermore, been largely conducted using transformed T cell 
lines. As an initial phase of a longer term project to understand how 
numerous, coordinately expressed lymphokine genes regulate immune 
responses as a "network", the studies described in this chapter sought to 
investigate how the expression of a variety of different lymphokine genes are 
regulated in both non-transformed and transformed T cells. These studies 
were conducted in the Th2 clone 01 O.G4.1 and also the transformed T cell 
line EL4.23. As well as the regulation of the IL-2, IL-3 and GM-CSF genes, the 
studies examined the regulation of the IL-4, IL-6 and IL-10 genes and, in 
particular, that of the IL-5 gene, the mechanisms of which were unknown. 
Studies described in this chapter suggest that the accumulation of each 
different lymphokine mRNA species is dynamically regulated by the relative 
rates of its synthesis and degradation. This involves distinct and specific sets 
of transcriptional and/or post-transcriptional control mechanisms. The 
expression of certain lymphokine genes, such as those of IL-4, IL-5 , IL-6 and 
IL-10, appear to be predominantly regulated at the transcriptional level , while 
the regulation of GM-CSF gene expression appears , in contrast , to largely 
involve modulation of its mRNA stability. Expression of certain other genes, 
such as those of IL-2 and IL-3 , appear to be regulated at both the 
transcriptional level and the level of mRNA stability to different degrees. 
84 
These studies also revealed that the expression of many lymphokine 
genes may be dynamically regulated at either the transcriptional or post-
transcriptional level by the relative activities of positive and negative 
regulatory factors. Expression of the I L-2 gene, for example, appears to be 
regulated by coordinately acting factors which activate and repress its 
transcription, while the regulation of GM-CSF gene expression appears to 
involve mechanisms which coordinately enhance stabilization and mediate 
degradation of its mRNA. The specific factors which regulate the expression of 
different lymphokine genes at either the transcriptional or post-transcriptional 
level were also distinguished by whether their synthesis was induced 
de nova in response to specific T cell activation signals, or whether they were 
pre-existing factors whose activities were modulated by specific signalling 
pathways. The nature and characteristics of the mechanisms which appear to 
predominantly regulate the expression of the variety of lymphokine genes in 
D1 O.G4.1 and EL4.23 cells are summarized in Table 3.1., and are described 
in further detail below. 
3.4.1. Transcriptional regulation of lymphokine gene 
expression: Involvement of multiple positively 
and negatively acting mechanisms 
Northern blot analysis indicated that the kinetics of mRNA accumulation 
are largely unique to each lymphokine species. IL-6 and IL-10 mRNAs were 
rapidly induced in D1 O.G4.1 cells soon after the outset of Con A stimulation , 
while maximal levels of IL-3, IL-4 and IL-5 mRNAs were not attained until after 
6 h stimulation (section 3.3.1.). The accumulation of the IL-5 , IL-6 and IL-10 
mRNAs in D10.G4.1 cells was significantly more prolonged than the IL-3, IL-4 
or GM-CSF mRNAs. While maximal levels of IL-2 , IL-3, IL-5, IL-1 O and 
GM-CSF m RN As were attained in EL4.23 cells after 8 to 12 h PMA 
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Table 3.1. Summary of the nature and characteristics of 
mechanisms which appear to predominantly regulate the 
expression of different lymphokine genes in D1 O.G4.1 and EL4.23 
cells 
Regulation at either the transcriptional level or at the level of mRNA stability 
appears, for many lymphokine genes studied, to involve dynamic interplay 
between positively and negatively acting mechanisms which either activate or 
repress transcription, or which mediate stabilization or degradation of mRNA. 
The mechanisms which appear to activate transcription of different genes in 
response to cellular stimulation were distinguished by their requirement for 
protein synthesis. The obligatory requirement of protein synthesis for 
transcriptional activation of genes such as IL-5 and IL-2 is denoted by +++. 
Other genes such as IL-4 and IL-1 O appear to require protein synthesis for 
maximal transcriptional activation, and the variable degrees of this 
requirement are denoted by ++ or+. Transcriptional activation of genes such 
as I L-6, for example, appear to be mediated by a pre-existing factor(s) 
(denoted by -) which is presumably activated by the cellular signal. The 
factors which appear to activate transcription were distinguished by whether 
their syntheses or activities were responsive to signals mediated by a Cs A-
sensitive or Cs A-resistant pathway (denoted by.I). The signalling pathways 
which appear to enhance the stabilization of specific mRNAs were also 
distinguished by their Cs A-sensitivity or resistance. A number of lymphokine 
mRNAs (denoted by .I) also appeared to be specifically degraded by a labile 
mechanism. 
Cell line: D10.G4.1 
Stimulus: Con A 
Regulation of transcription 
* 
* 
Activators 
Labile Repressors 
Requirement for protein synthesis 
Cs A-sensitive 
Cs A-resistant 
Regulation of mRNA stability 
* 
* 
Signal-dependent Cs A-sensitive 
stabilization Cs A-resistant 
Labile degradative 
mechanism 
IL-3 
.,, 
.,, 
.,, 
IL-4 
++ 
.,, 
IL-5 
+++ 
.,, 
IL-6 
.,, 
? 
. 
.,, 
IL-10 GM-CSF 
+ 
.,, 
.,, 
+++ 
.,, 
.,, 
.,, 
Cell line: E L4. 23 
Stimulus: PMA 
Regulation of transcription 
IL-2 
* Activators Requirement for protein synthesis +++ 
* Labile Repressors 
Cs A-sensitive 
Cs A-resistant 
Regulation of mRNA stability 
* 
* 
Signal-dependent Cs A-sensitive 
stabilization Cs A-resistant 
Labile degradative 
mechanism 
./ 
./ 
? 
. 
./ 
IL-3 IL-5 IL-10 GM-CSF 
? 
. +++ ++ 
./ 
./ ./ 
./ ./ 
./ ? . ./ 
./ ./ ./ 
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stimulation, the accumulation of IL-5 mRNA was more prolonged than those of 
other lymphokines (section 3.3.2.). 
While no lymphokine mRNAs were detected in unstimulated D1 O.G4.1 
or EL4.23 cells, low levels of GM-CSF gene transcription were detected in 
these cells. Constitutive transcription of the GM-CSF gene has been 
extensively reported in a variety of cell types which express this gene. These 
include T cells (Bickel et al., 1990; lwai et al. , 1992), B cells (Akahane & 
Plutznik, 1992), macrophages (Thorens et al. , 1987), fibroblasts (Koeffler 
et al., 1988), mast cells (Wodnar-Filipowicz & Moroni, 1990), several myeloid 
cell lines (Schuler & Cole, 1988) and acute myeloblastic leukemia cells (Ernst 
et al., 1989a). A significant level of IL-1 O gene transcription was observed in 
unstimulated D1 O.G4.1 cells, while a low level was also detected in 
unstimulated EL4.23 cells. A low level of IL-6 gene transcription was also 
observed in unstimulated D1 O.G4.1 cells. Other lymphokine genes appeared 
to be transcriptionally silent in both T cell types in the absence of stimuli. 
Nuclear run-off analysis indicated that the patterns of accumulation of 
the IL-4, IL-5, IL-6 and IL-1 O mRNAs in D1 O.G4.1 cells may be attributable, to a 
large degree, to changing rates in transcription of their respective genes 
(section 3.3.1.). The transcriptional activities of these genes appear to be 
differentially regulated by distinct sets of factors , the synthesis or activities of 
which appear to be induced by specific signals (Table 3.1.). In contrast to the 
IL-4, IL-6 and IL-10 genes, the IL-5 gene appears to require signals other than 
those mediated by Ca2+ mobilization to fully potentiate its transcriptional 
activation. Transcription of the I L-5 , IL-6 and IL-1 O genes, in contrast to the 
IL-4 gene, appears to be predominantly regulated by signals mediated via a 
Cs A-resistant pathway(s) . Transcription of these genes may also be 
selectively and independently induced in response to PKC or adenylate 
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cyclase activation or IL-1 receptor stimulation (sections 3.3.5.;3.3.13.). The 
PKC-, cAMP- or IL-1- dependent pathways were previously observed in 
Chapter 2 to be Cs A-resistant. 
In contrast to the I L-6 and I L-1 O genes, the activation of I L-5 gene 
transcription by numerous signalling pathways, including those emanating 
from TCR/CD3 or IL-1 receptor stimulation, appears to require obligatory 
de nova protein synthesis. This may presumably be that of a transcription 
factor(s) (or subunit of a factor) (sections 3.3.9.;3.3.14.). Enhancement of IL-6 
gene transcription by the same signalling pathways appears to be mediated 
by a pre-existing factor(s). Protein synthesis appears to be required for 
maximal transcriptional activation of the I L-4 and I L-1 O genes. Maximal 
transcriptional activation of these genes may require the induction of synthesis 
of a regulatory factor which is distinct from, and cooperatively acts with, a pre-
existing factor. Alternatively, maximal potentiation of transcription may require 
the enhanced expression of a pre-existing factor in response to specific 
activation signals. In contrast to the IL-1 O gene, the syntheses and activities of 
the factors which regulate I L-4 gene transcription appear to be specifically 
regulated by a Cs A-sensitive ca2+-dependent pathway (sections 3.3.5. ; 
3.3.14.). 
Cessation of the syntheses and/or activities of the factors which 
specifically regulate the transcription of the IL-4, IL-5, IL-6 and IL-10 genes 
was observed to rapidly abrogate the transcriptional activities of these genes. 
In contrast to the IL-6 and IL-1 O genes , abrogation of IL-4 and IL-5 gene 
transcription did not lead to a significant reduction in their steady state mRNA 
levels (sections 3.3.5.;3.3.7.;3.3.11.). This suggests that the IL-4 and IL-5 
mRNAs are relatively stable, compared to those of IL-6 and IL-10. 
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The responsiveness· of the IL-5, IL-6 and I L-1 O genes to the variety of 
signalling pathways which emanate from the TCR/CD3 complex or the IL-1 
receptor may be mediated by either one or a combination of two possible 
mechanisms. Transcriptional activation of these genes may involve the 
cooperative action of numerous different factors, the synthesis or activity of 
each of which is responsive to a specific signal. The pleiotropic 
responsiveness of these genes may alternatively be mediated by a factor 
whose synthesis or activity may be induced by numerous different signals. 
One well-characterized example of such a factor is NF-KB, whose 
translocation to the nucleus may be induced in response to a wide variety of 
cellular signals. NF-KB, for example, appears to be involved in mediating the 
transcriptional activation of the IL-2 and GM-CSF genes in response to 
phorbol esters and the HTLV-1 trans-activator tax (Hoyos et al. , 1989; 
Shibuya et al., 1989; Schreck & Baeuerle, 1990), the IL-6 gene in response to 
IL-1 and TNF-a (Shimuzu et al., 1989; Zhang et al., 1990), the TNF-a gene in 
response to lipopolysaccharide and I FN-y (Collart et al., 1990) and the IFN-~ 
gene in response to double-stranded RNA and virus infection (Lenardo et al. , 
1989; Visvanathan & Goodbourn, 1989). 
Specific signalling pathways also appear to negatively modulate the 
expression of specific lymphokine genes at the transcriptional level. 
Observations described in section 3.3.14. suggest that a labile repressor may 
selectively inhibit transcription of the GM-CSF and IL-4 genes in 01 O.G4.1 
cells stimulated with IL-1, but not with other activators including those which 
activate PKC or adenylate cyclase. Furthermore, the transcriptional inactivity 
of the IL-3 gene in IL-1-stimulated cells does not appear to involve such a 
mechanism. 
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The mechanisms which regulate IL-5 gene transcription in EL4.23 cells 
appear similar to those observed in D1 O.G4.1 cells. In EL4.23 cells, 
transcriptional activation of the IL-5 gene also appears to be regulated by a 
factor(s) whose synthesis is induced de nova in response to signals mediated 
via a Cs A-resistant pathway (sections 3.3.6.;3.3.10.) . Furthermore, IL-5 
m RNA also appears to be relatively stable in EL4.23 cells, compared to those 
of other lymphokines, notwithstanding cessation of its gene transcription 
(sections 3.3.8.;3.3.12.). IL-1 O gene transcription in EL4.23 cells , as well as in 
D1 O.G4.1 cells, appears to require protein synthesis for maximal activation. A 
labile repressor appears, however, to be also involved in regulating IL-1 O 
gene transcription in EL4.23 cells. Although signals mediated via a Cs A-
resistant pathway appear to predominantly regulate IL-1 O gene transcription in 
both T cell types, Cs A-sensitive signals may possibly also modulate IL-1 O 
gene transcription in EL4.23 cells (sections 3.3.6.;3.3.12.). 
Transcription of the I L-2 gene in EL4.23 cells appears to be subject to 
the coordinate control of positively and negatively acting regulatory factors. 
The positive regulatory factor(s) appears to be labile and responsive to signals 
mediated via a Cs A-sensitive pathway. The trans-activator NF-AT, which 
plays a critical role in activating IL-2 gene transcription in both human (Durand 
et al., 1988) and mouse (Novak et al., 1990), has recently been reported to 
be comprised of a newly synthesized nuclear subunit and a pre-existing 
cytoplasmic subunit, which is induced to translocate to the nucleus in 
response to Cs A-sensitive signals (Flanagan et al. , 1991; Clipstone & 
Crabtree, 1992; O'Keefe et al., 1992). Studies described in section 3.3.12. 
suggest that the repressor which negatively modulates I L-2 gene transcription 
in EL4.23 cells may also be labile. A negative regulatory element has also 
been identified in the human IL-2 promoter (Nabel et al., 1988). 
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Mechanisms other than transcription appear to predominantly regulate 
the accumulation of IL-3 and GM-CSF mRNAs in both D1 O.G4.1 and EL4.23 
cells. The studies indicate, however, that GM-CSF gene transcription is 
enhanced in D1 O.G4.1 cells by a factor(s) which is synthesized de novo in 
response to signals mediated via a Cs A-resistant ca2+-dependent pathway. 
These signals also appear to activate a pre-existing factor which induces IL-3 
gene transcription in D1 O.G4.1 cells. Transcriptional activation of the I L-3 
gene in EL4.23 cells in response to Cs A-sensitive signals was very weak 
and appeared to be subject to the control of a labile repressor. Both positive 
and negative regulatory mechanisms also appear to coordinately control 
human I L-3 gene transcription (Mathey-Prevot et al., 1990; Shoemaker et al. , 
1990). The strength of the activity of the repressor relative to that of the 
positive regulator may account for, at least in part, the low levels of IL-3 mRNA 
which accumulate in EL4.23 cells. 
3.4.2. Regulation of lymphokine mRNA stability: 
Specific enhancement and degradation 
Results of the current study suggest that the expression of the GM-CSF 
gene is predominantly regulated at the level of mRNA stability in both 
D1 O.G4.1 and EL4.23 cells. Only a modest increase in GM-CSF gene 
transcription was detected upon stimulation of D1 O.G4.1 cells , while no 
significant change in the rate of GM-CSF gene transcription was observed 
upon stimulation of EL4.23 cells (sections 3.3.1.;3.3.2.). Regulation at the 
level of mRNA stability has been reported to be a predominant mode of control 
of GM-CSF gene expression in several T cell systems and other non-T cell 
types which express this gene (Thorens et al. , 1987; Bickel et al., 1990; 
Akahane & Plutznik, 1992; lwai et al., 1992). Enhanced stabilization of IL-3 
mRNA also appears to be an important mechanism in the control of its 
accumulation in both D1 O.G4.1 and EL4.23 cells. Regulation of IL-3 gene 
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expression at the level of mRNA stability has also been recently reported in 
transformed human T cells (Ryan et al., 1991) and mast cells (Wodnar-
Filipowicz & Moroni, 1990). 
Signals mediated via a Cs A-sensitive pathway appear to coordinately 
enhance the stability of GM-CSF and IL-3 mRNAs in both D1 O.G4.1 and 
EL4.23 cells. Furthermore, these signals appear to stabilize IL-3 mRNA more 
efficiently than GM-CSF mRNA (sections 3.3.5.; 3.3.6.; 3.3.11.; 3.3.12.). 
Although expression of the IL-6 gene appears to be predominantly regulated 
at the transcriptional level in D1 O.G4.1 cells, the possibility that Cs A-resistant 
pathways may also enhance the stability of its m RNA cannot be discounted. 
Several recent studies indicate that certain cellular signals may either 
coordinately or selectively modulate the stability of different cytokine mRNAs in 
a given cell type. CD28-mediated signals, for example, appear to stabilize 
IL-2, GM-CSF, IFN-y and TNF-a mRNAs in human peripheral blood 
lymphocytes (Lindsten et al., 1989). Both the G-CSF and M-CSF mRNAs are 
coordinately stabilized in monocytes by phorbol esters. G-CSF mRNA, 
however, is selectively stabilized by lipopolysaccharide while M-CSF mRNA is 
selectively stabilized by IL-3 or GM-CSF (Ernst et al. , 1989b). 
The stability of a given mRNA species may also be modulated by 
different signals to different degrees in a given cell type. Phorbol ester 
treatment, for example, is reported to be more effective than lectin stimulation 
in stabilizing GM-CSF mRNA in a murine T cell line (lwai et al., 1992) . 
Phorbol ester also appears to stabilize IL-1 p mRNA in fibroblasts to a greater 
degree than TNF-a stimulation (Yamato et al., 1989). ca2+ ionophore, 
however, appears more effective than phorbol ester in stabilizing IL-3 mRNA 
in mast cells (Wodnar-Filipowicz & Moroni , 1990). Studies described in 
section 3.3.14. suggest that IL-6 mRNA may be stabilized by phorbol ester to 
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a greater degree than Ca2+ ionophore in 01 O.G4.1 cells. The modulation of 
stability of different lymphokine mRNAs in 01 O.G4.1 cells by different 
signalling pathways requires more detailed investigation, including 
examination of their relative mRNA levels, induced by different activators , in 
the presence of Act D. 
The stability of a number of labile mRNAs encoding inducible regulators 
of cellular growth and differentiation have been reported to be enhanced by 
cellular treatment with protein synthesis inhibitors, once their induction is 
under way. These include oncogenes such as c-myc, c-fos and c-myb (Dani 
et al., 1984; Mitchell et al., 1985; Thompson et al., 1986; Brewer & Ross , 
1989) and several cytokines such as IL-1 p (Yamato et al. , 1989), IFN-P (Raj & 
Pitha, 1981 ), G-CSF and M-CSF (Ernst et al. , 1989a,b). Such enhanced 
stabilization has been generally ascribed to the suppression by protein 
synthesis inhibitors of a labile mechanism which mediates the degradation of 
these specific mRNAs. Once initial induction was under way, GM-CSF mRNA 
levels were able to be dramatically elevated (or "superinduced") in both 
01 O.G4.1 and EL4.23 cells by the addition of CHX without any significant 
change in the rate of GM-CSF gene transcription (sections 3.3.11 .;3.3.12.) . 
Significant increases in IL-3 and IL-6 mRNA levels were also induced in 
01 O.G4.1 cells without noticeable alterations in the transcription rates of their 
genes. These three mRNA species were also stabilized by CHX alone when 
transcription of their genes was inhibited by Act D. CHX has been reported to 
enhance the stabilization of GM-CSF mRNA in fibroblasts (Shaw & Kamen , 
1986; Koeffler et al. , 1988; Akashi et al. , 1991) and IL-3 mRNA in mast cells 
(Wodnar-Filipowicz & Moroni , 1990). Observations of the current study 
suggest that the stability of GM-CSF mRNA in 01 O.G4.1 and EL4.23 cells and 
of IL-3 and IL-6 mRNAs in 01 O.G4.1 cells is dynamically regulated by a labi le 
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mechanism which selectively mediates their degradation and by specific 
signal-dependent mechanisms which enhance their stabilization (Table 3.1.). 
A labile mechanism also appears to mediate the specific degradation of 
the IL-2, IL-3 and IL-10 mRNAs in EL4.23 cells (section 3.3.12.). In contrast to 
the GM-CSF mRNA, the observed "superinduction" of the IL-2, IL-3 and IL-1 O 
mRNAs by CHX appears partially attributable to an increase in the 
transcription rates of their genes, as well as to a reduction in the rate of their 
degradation. Previous reports in a different EL4 variant (Shaw et al., 1987; 
1988a) and other T cell systems (Kronke et al., 1985; Kaempfer et al., 1987) 
have, however, observed no stimulatory effect of CHX upon the rate of IL-2 
gene transcription and suggest that "superinduction" of its m RNA may be 
largely attributable to a reduction in the rate of its degradation. 
Observations in the current study suggest that the labile mechanism 
which degrades specific lymphokine mRNAs in both 01 O.G4.1 and EL4.23 
cells may be constitutively active. CHX alone, in the absence of stimuli , 
appeared to stabilize the small pools of GM-CSF, IL-6 and IL-1 O transcripts 
which are expressed in unstimulated 01 O.G4.1 cells and are normally 
undetectable because of their rapid turnover. CHX alone also stabilized the 
GM-CSF transcripts which are constitutively expressed at a constant rate in 
EL4.23 cells. Stabilization by CHX of the very low basal levels of IL-1 O 
transcripts in unstimulated EL4.23 cells may require detection methods more 
sensitive than Northern blot analysis such as PCR analysis to verify this 
proposal. 
One structural characteristic shared by many labile oncogene and 
cytokine mRNAs is a conserved region in their 3'-UTRs which contains 
sever a I, often tandem , copies of the motif AU U U A (Cap ut et a I. , 1 9 8 6) . 
93 
Insertion of the AU-rich region from the 3'-UTR of the GM-CSF mRNA into the 
3'-UTR of the ~-globin mRNA has been demonstrated to destabilize the 
normally stable ~-globin mRNA (Shaw & Kamen, 1986). Conversely, deletion 
of the AU-rich region from the 3'-UTR of the c-fos mRNA renders it more stable 
than its unmodified counterpart (Wilson & Treisman, 1988). Instability 
conferred by these AU-rich sequences has been shown to be alleviated by 
cellular treatment with CHX (Shaw & Kamen, 1986; Akashi et al. , 1991 ). 
Recent RNA-protein binding studies have identified cellular factors which 
specifically bind to these AUUUA motifs (Malter, 1989; Bohjanen et al., 
1991; 1992; Vakalopoulou et al., 1991 ). The !ability of these factors appears, 
as yet, unknown. A recent model proposes that these AU-rich sequences are 
not a target for a specific "RNase"-like molecule per se, but rather a binding 
site for a specific protein(s), the interaction of which destabilizes the 
association of PABP with the poly(A) tail. Such destabilization of the 
PABP/poly(A) complex reduces its ability to protect the poly(A) tail and mRNA 
body from degradation, presumably by endogenous non-specific RNases 
(Bernstein & Ross, 1989). The results of the current study appear largely 
consistent with this proposed model. Lymphokine mRNAs, such as those of 
GM-CSF, IL-2, IL-3, IL-6 and IL-10, which were highly labile and stabilized by 
CHX, appear to contain multiple, often tandem , repeats of the AUUUA motif in 
their 3'-UTRs. The IL-4 and IL-5 mRNAs appear to contain only a few widely 
dispersed single copies of this motif in their 3'-UTRs. These two mRNA 
species were observed to be significantly more stable than the other 
lymphokine mRNAs and their stabilities were not enhanced by CHX. The 
minimum number of AUUUA repeats, which confer instability and are required 
for protein binding, has as yet not been determined. Observations in this study 
suggest that the presence of single dispersed copies may be insufficient. 
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Stabilization of GM-CSF mRNA by several cellular activators, as well as 
CHX, has been recently reported to be mediated via these AU-rich sequences 
in its 3'-UTR (Akashi et al. , 1991 ). While no possible mechanism was 
speculated by the authors, it is possible that cellular signals may inhibit the 
synthesis of the labile "destabilizing" factor which binds to these sequences. 
Cellular signals may alternatively inactivate this factor by direct modification or 
by mediating its sequestration by a signal-induced inhibitory ligand. Akashi 
eta/. (1991) reported, however, that TNF-a stimulation, unlike CHX, IL-1~ or 
activators of PKC and G proteins, appears to enhance GM-CSF mRNA 
stabilization by a mechanism which is independent of these AU-rich 
sequences. Several other lines of evidence indicate that other elements, 
apart from the AU-rich sequences, may be involved in regulating the stability 
of several labile mRNAs (Rabbitts et al., 1985; Jones & Cole, 1987; Kabnick & 
Housman, 1988; Band et al., 1990; lwai et al., 1991; Ross et al., 1991 ). 
These reports implicate the involvement of numerous common and unique cis-
acting elements and trans-acting factors in the control of mRNA stability. 
A maJor objective in recent years has been the identification and 
characterization of the cis-acting elements which regulate the expression of 
lymphokine genes at either the transcriptional and/or post-transcriptional 
levels, and of the regulatory factors which interact with these control regions. 
The following two chapters describe investigations of DNA-protein interactions 
which may be involved in regulating the transcription of the murine IL-5 gene. 
CHAPTER 4: 
REGULATION OF MURINE IL-5 GENE EXPRESSION: 
4.1. 
ROLE OF CHROMATIN STRUCTURE IN 
TRANSCRIPTIONAL ACTIVITY 
INTRODUCTION 
Previous studies, described in Chapters 2 and 3, have suggested that 
the expression of a number of lymphokine genes in activated murine T 
lymphocytes may be coordinately and/or differentially regulated by distinct 
sets of transcriptional mechanisms in response to specific activation signals in 
different T cell systems. As previously described in section 1.1.1., molecular 
"programs" for modulating the expression patterns of individual, or groups of, 
eukaryotic genes at the transcriptional level are believed to be conferred by 
the particular composition and spatial organisation of the multiple DNA 
elements utilized by, and frequently located 5' to, a given gene. These cis-
acting elements appear to interact with specific DNA-binding proteins, the 
activities and/or syntheses of which may be modulated by specific signals in 
specific cell types. 
IL-5 has been the subject of considerable interest in the laboratory in 
recent years, particularly given the linkage between the cell-specific nature of 
eosinophilia and IL-5 expression (Coffman et al. , 1989; Limaye et al. , 1989; 
Owen et al., 1989; Sanderson , 1992). Such clinical observations implied the 
existence of regulatory mechanisms specific to IL-5 gene expression , which , 
at the commencement of the current project, had not been extensively 
characterized. Studies described in Chapters 2 and 3 indicated that IL-5 gene 
expression is predominantly regulated at the transcriptional level by a variety 
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of different signalling pathways. Furthermore, the activation of IL-5 gene 
transcription by these various pathways appears to be differentially modulated 
from other lymphokine genes by its dependence upon de nova synthesis of 
an obligatory trans-activating factor(s) . These observations imply the 
existence of specific molecular "programs" which may be unique to regulation 
of IL-5 gene transcription. 
The development of techniques enabling expression of exogenous 
DNA in both cell-free and cellular systems have been major methodological 
advances in the identification and characterization of transcriptional control 
elements. The general scheme in both systems involves assaying the effect of 
modification of the native cloned sequence by deletion or mutation upon 
transcription of an appropriate "reporter" to which these sequences are linked. 
Transcription of the "reporter" may be measured either (i) directly in in vitro 
systems, comprising of soluble cellular extracts which accurately initiate 
transcription of the exogenous DNA construct (Dignam et al. , 1983; Manley 
et al. , 1980, Manley, 1985) or (ii) by reference to the biological activity of the 
reporter gene product after the exogenous DNA construct has been 
introduced into, and transiently expressed in , eukaryotic cells (Banerji & 
Schaffner, 1983; Spandidos & Wilkie, 1985). 
In preliminary investigations, two commonly used cell-free systems, 
originally described by Manley et al. (1980) and Dignam et al. (1983) , were 
utilized by the investigator to identify potential elements which may regulate 
murine IL-5 gene transcription in response to T cell activation signals. 
Soluble nuclear and whole-cell extracts were prepared from unstimulated and 
Con A-stimulated 01 O.G4.1 cells , and from unstimulated and PMA-st imulated 
EL4.23 cells . All of these extracts were assayed for transcriptional activity 
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under the direction of the Adenovirus 2 maJor late (AdML) promoter1 , a 
commonly used positive control for the transcriptional competence of cell-free 
systems (Gorski et al., 1986; Flanagan et al., 1991 ). A series of progressive 
5' deletion mutants of the murine IL-5 gene were constructed. These 
contained sequences from -3724, -1707, -1481 , -1173, -458 , -312, -172 and 
-88 to + 162, and generated a "run-off transcript" of 162 bp when assayed 
in vitro. No significance difference in transcriptional activity between cell-free 
systems prepared from unstimulated or stimulated T cells was detected using 
any of these various constructs, and using either nuclear or whole-cell extracts 
prepared from either 01 O.G4.1 or EL4.23 cells. In preliminary experiments 
conducted by other members of the laboratory, 5'-flanking sequences of the 
murine IL-5 gene, similar to those described above but extending to +26, were 
linked to the CAT reporter gene and transfected into 01 O.G4.1 and EL4.23 
cells (P. Bourke, pers. comm.). No significant difference in transcriptional 
activity was detected between unstimulated and stimulated T cells , in which 
these various constructs were transiently expressed. 
The inability to detect increases in murine IL-5 gene transcription in 
response to T cell activation signals in either the cell-free or transient 
expression systems contrasts markedly with the significant activation of I L-5 
gene transcription which was observed by nuclear run-off analys is described 
in Chapter 3. Inherent differences in the premises upon which these various 
methodologies are based may account for these preliminary observations . 
The use of exogenous DNA as templates for transcription in either cell-free or 
transient expression systems relies upon the ability of putative regulatory 
factors , together with basal transcription factors , to interact with one another 
and sequences of the naked DNA to accurately initiate transcription . The 
nuclear run-off analysis , in contrast , uses endogenous chromatin as the 
1. AdML constructs were kindly provided by Dr.D.Tremethick (JCSMR) 
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template for transcription ·and measures levels of nascent RNA, initiated 
in vivo and elongated in isolated intact nuclei, in which the chromatin integrity 
is maintained in its native state. Such correlation between methodological 
premise and observation implies the critical role which chromatin structure 
may play in regulating transcription of the IL-5 gene. 
A large body of structural and functional evidence over the past decade 
suggests that the transcriptional regulation of gene expression may be 
ultimately controlled by the packaging of DNA into nucleosomes and higher 
order chromatin structures, an intrinsically dynamic phenomenon specific to 
eukaryotes. Studies using in vitro chromatin assembly systems have 
demonstrated that nucleosome assembly over promoter sequences may 
render a DNA template refractory to transcription , while the formation of 
transcriptional preinitiation complexes on DNA templates prior to or during 
nucleosome assembly may alleviate promoter repression (Knezetic & Luse, 
1986; Matsui, 1987; Workman & Roeder , 1987). Transcriptionally active 
chromatin demonstrates preferential "hypersensitivity" to non-specific 
nucleases such as DNase I, a phenomenon generally attributed to local 
disruption of nucleosomal organisation and which suggests that "open" 
chromatin structures may enable accessibility of the gene to the transcriptional 
machinery (reviewed in Eissenberg et al., 1985; Yaniv & Cereghin i, 1986; 
Elgin, 1988; Gross & Garrard , 1988; Grunstein , 1990). Furthermore, such 
"hypersensitive" sites have frequently been found to correspond to putative 
regulatory sequences. The immediate 200 bp region sur rounding a 
hypersensitive site that was reportedly induced in the 5'-flanking reg ions of 
the IL-2 gene in response to T cell activation signals (Siebenlist et al., 1986) 
has subsequently been found to contain multiple cis-acting elements wh ich 
are critical for activation of I L-2 gene transcription , including those wh ich bind 
NF-AT, NF-KB, AP-1 and Oct-1 (Durand et al., 1988; Shaw et al. , 1988b; 
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Emmel et al., 1989; Hoyos et al. , 1989; Serfling et al. , 1989; Kamps et al. , 
1990). 
Analysis of DNase I hypersensitive sites, as markers of non-
nucleosomal organisation, is therefore a useful tool to initially "map" 
approximate locations of putative regulatory regions of genes in their native 
chromatin environment. Such analysis is particularly relevant in respect of the 
I L-5 gene, given the apparent importance of chromatin structure in its 
transcriptional regulation. In the current study, alterations in chromatin 
structure of the IL-5 gene in response to mitogenic stimulation of 01 O.G4.1 
cells were investigated by DNase I hypersensitivity analysis. 
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4.2. MATERIALS AND METHODS 
The source and maintenance of the murine Th2 clone 01 O.G4.1. has 
been previously described in section 2.2.1. (2). Subcloning , isolat ion , 
restriction digestion and agarose gel electrophoresis of plasmid DNA has 
been previously described in section 2.2.2. 
4.2.1. Genomic DNA probes 
IL-5 genomic sequences which were used as probes in DNase I 
hypersensitivity studies were derived from a 10.0 kb Hind Ill fragment 
containing the murine IL-5 gene (Campbell et al. , 1988). The 2.15 kb 
Hind Ill/Eco RI , 1.54 kb Sac I/Hind Ill and 0.7 kb Stu I/Eco RI fragments 
were isolated by the investigator from the original 1 O kb genomic clone and 
subcloned into plasmid vectors which , upon subsequent digestion with 
appropriate restriction enzymes, released the inserts with suitable single 
recessed 3' ends for 32P-end-labeling. 
4.2.2. DNase I hypersensitivity analysis 
( 1) Isolation of nuclei and DNase I digestion 
Nuclei were isolated from unstimulated and stimulated cells and 
digested with DNase I, and genomic DNA subsequently purified as described 
by Wu (1980) with modifications. Cells were harvested , washed in ice-cold 
PBS and lysed at 2 x 1 o7 cells/ml in ice-cold lysis buffer (60 mM KCI ; 
15 mM NaCl; 15 mM Tris-Cl [pH 7.4]; 0.5 mM OTT; 3 mM MgCl2 ; 0.1 mM 
ethylene glycol bis(~-am inoethylether)-N, N, N', N'-tetraacetic acid (EGTA); 
0.5 mM spermidine; 0.25 M sucrose and 0.2°/o Nonidet P-40). Following 
centrifugation at 800 x g for 5 min at 4°C, the nuclear pellet was 
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resuspended at 1 x 108 nuclei/ml in digestion buffer (60 mM KCI; 15 mM 
NaCl; 15 mM Tris-Cl [pH 7.4]; 0.5 mM OTT; 3 mM MgCl2; 0.5 mM 
spermidine; 0.25 M sucrose; 0.05 mM CaCl2). Various amounts of DNase I 
(RQ1, Promega) were added to the resuspended nuclei and incubated at 
37°C for 3 min. The reaction was terminated by addition of EDTA and SOS to 
12.5 m M and 0.5°/o respectively. The DNA was purified by proteinase K 
digestion (100 µg/ml) and repeated extraction with phenol and 
chloroform:isoamylalcohol (24: 1 ). The DNA was precipitated by the addition 
of sodium acetate [pH 5.2] and ethanol to 0.3 M and 70°/o respectively and 
resuspended at a concentration of 1-2 mg/ml. 
( 2) Southern blot analysis of genomic DNA 
Restriction enzyme digestion of genomic DNA was carried out 
according to manufacturers' directions. Agarose gel electrophoresis and 
Southern transfer of DNA to nylon membrane (Hybond N+, Amersham) has 
been previously described in sections 2.2.2. (3) and 3.2.2. (3) respectively. The 
nylon membrane was prehybridized for 2 to 16 h at 65°C in hybridization 
solution containing 5 x SSPE (0.75 M NaCl; 1 O mM sodium phosphate 
[pH 7.0]; 1 mM EDTA); 5 x Denhardt's solution; 0.5°/o SOS and 500 µg/ml 
denatured salmon sperm DNA. Fresh hybridization solution was added prior 
to addition of the 32P-end-labeled probe (see below) and hybridization 
allowed to proceed for 16 to 24 h at 65°C. Following hybridization , the filter 
was washed as previously described in section 2.2.3.(4). 
(3) 32P-end-labeling of recessed 3' ends 
The recessed 3' end of the isolated DNA fragment was filled and 32p_ 
labeled according to Maniatis et al. (1989) with modifications. 1 µg of 
purified fragment was incubated in a total volume of 50 µI containing 50 m M 
Tris-Cl [pH 7.2]; 10 mM MgS04 ; 0.1 mM OTT; 50 µg/ml BSA; 40 µC i 
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[a-32p] dATP (3000 Ci/mniole, Amersham) and 40 µM each of dGTP, dCTP 
and dTTP with 5 units of Kienow DNA Polymerase (Pharmacia) for 30 min at 
room temperature. The reaction was stopped by addition of EDTA to 20 mM 
and unincorporated labeled nucleotides were removed by chromatography as 
described previously in section 2.2.3.(5). The probe was denatured by boiling 
for 5 min prior to addition to the hybridization solution . 
4.3. 
4.3.1. 
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RESULT·S 
Low resolution analysis of chromatin structure of 
the IL-5 gene before and after mitogenic 
stimulation. 
Nuclei were isolated from unstimulated D1 O.G4.1 cells and cells 
stimulated for 6 h with Con A (5 µg/ml), conditions which were previously 
found to induce maximal transcriptional activity of the IL-5 gene (Chapter 3). 
Nuclei were incubated with different concentrations of DNase I (0, 1 or 
3 units) and the DNA was isolated and subsequently digested with Hind Ill. 
Southern blots containing Hind Ill-digested genomic DNA, derived from 
unstimulated and stimulated cells, were hybridized with a 2.15 kb 
I 
Hind Ill/Eco RI fragment, which contains sequences 5' to the IL-5 gene and 
was 32P-labeled at the 5' abutting Hind Ill end (Table 4.1.). As shown in 
Fig. 4.1.(A), the 2.15 kb Hind Ill/Eco RI probe hybridized to the original 
10.0 kb Hind Ill genomic DNA fragment, in addition to several sub-fragments 
generated by partial digestion with DNase I which became more visible with 
increasing amounts of DNase I. The size of sub-fragments generated by 
partial DNase I digestion differed between DNA isolated from unstimulated 
and stimulated cells, and the location of putative hypersensitive sites were 
mapped relative to the 5' Hind Ill site by reference to the size of these bands 
(Table 4.1.). A putative inducible hypersensitive site was mapped to a 
position just 5' of the cap site by reference to a 3.7 kb sub-fragment which 
was detectable in stimulated T cell DNA and absent in unstimulated T cell 
DNA (Fig. 4.1.(A)). 
To verify these initial results and identify any other hypersensitive sites, 
genomic DNA, isolated from DNase I-treated chromatin and digested with 
Hind Ill, was hybridized with a 1.54 kb Sac I/Hind Ill fragment whose 32p_ 
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Fig.4.1. Analysis of DNase I hypersensitive sites in chromatin of the 
murine I L-5 gene. 
(A) 3 x 1 o? nuclei , isolated from unstimulated or Con A-stimulated D1 O.G4.1 
cells , were digested with either 0, 1 or 3 units DNase I under the conditions 
described in section 4.2.2. Genomic DNA was purified, 30 µg of which was 
digested with Hind 111 , electrophoresed on 1.2°/o agarose gels, transferred on to 
nylon membrane and hybridized with the 32 P-end-labeled 2. 15 kb 
Hind Ill/Eco RI fragment. The original 10.0 kb Hind Ill genomic DNA fragment 
and the sizes of sub-fragments generated by DNase I cleavage are indicated. 
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Fig.4.1. Analysis of DNase I hypersensitive sites in chromatin of the 
murine IL-5 gene 
(8) Genomic DNA, purified from DNase I-treated nuclei of unstimulated or 
Con A-stimulated D10.G4.1 cells, were digested with Hind Ill and hybridized 
with the 32P-end-labeled 1.54 kb Sac I/Hind Ill fragment. The original 10.0 kb 
Hind Ill genomic DNA fragment and sizes of sub-fragments generated by 
DNase I cleaveage are indicated. 
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labeled end abuts the 3' Hind Ill site downstream of the IL-5 gene 
(Table 4.1.). In addition to the original 10.0 kb Hind Ill genomic DNA 
fragment, a number of sub-fragments generated by DNase I digestion were 
detected (Fig. 4.1.(B)). The faint 5.2 kb sub-fragment detected in 
unstimulated T cell DNA and the 6.5 kb and 3.7 kb sub-fragments detected in 
stimulated T cell DNA verified the location of hypersensitive sites identified 
using the previous 2.15 kb Hind Ill/Eco RI probe (Table 4.1.). Three smaller 
sub-fragments of 2.9 kb, 2.0 kb and 1.6 kb were particularly distinct in 
stimulated T cell DNA (Fig. 4.1.(B)). The size of the 1.6 kb sub-fragment 
maps a putative hypersensitive site just 3' of the IL-5 gene (Table 4.1.). 
4.2.2. Higher resolution analysis of chromatin structure 
of the 5'- flanking region of the IL-5 gene 
In view of the large body of evidence indicating that transcriptional 
control elements are frequently located in the 5'-flanking regions of eukaryotic 
genes (reviewed in Breathnach & Chambon, 1981; Yan iv, 1984; Serfling 
et al., 1985; Maniatis et al., 1987; Johnson & McKnight, 1989; Mitchell & 
Tijan, 1989), the hypersensitive site induced in the proximal promoter region 
of the IL-5 gene by mitogenic stimulation was further analysed at higher 
resolution. Genomic DNA, extracted from nuclei isolated from unstimulated or 
stimulated cells as described above, were digested with Eco RI. A Southern 
blot containing Eco RI-digested genomic DNA was hybridized with a 0.7 kb 
Stu I/Eco RI fragment which was 32P-labeled at the 3' abutting Eco RI end 
(Table 4.1.). This probe hybridized to the original 3.6 kb Eco RI genomic 
DNA fragment in both unstimulated and stimulated T cell DNA and to a distinct 
DNase I-generated 2.1 kb sub-fragment which was present in stimulated T 
cell DNA but absent in unstimulated T cell DNA (Fig. 4.1.(C)). By reference to 
the size of this sub-fragment, the position of the inducible hypersensitive site 
in the 5'-flanking region proximal to the cap site was verified (Table 4.1 .). The 
Fig.4.1. Analysis of DNase I hypersensitive sites in chromatin of the 
murine IL-5 gene 
(C) Genomic DNA, purified from DNase I-treated nuclei of unstimulated or 
Con A-stimulated D1 O.G4.1 cells, were digested with Eco RI and hybridized 
with the 32P-end-labeled 0.7 kb Stu I/Eco RI fragment. The original 3.6 kb 
Eco RI genomic DNA fragment and the 2.1 kb sub-fragment generated by 
DNase I cleavage are indicated. 
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DNase I hypersensitive site in the intron 1 which was mapped by reference 
to the very faint bands observed in unstimulated T cell DNA by previous low 
resolution analysis (section 4.3.1.) was, however, not observed using th is 
shorter probe. 
Table 4.1. Mapping of DNase I hypersensitive sites in chromatin of the 
murine IL-5 locus in unstimulated or activated T cells. 
The location of restriction sites within the murine IL-5 gene (pink box) and its 5'-
and 3'- flanking regions are indicated. The restriction fragments used as 
probes in this study, (A) 2.15 kb Hind Ill/Eco RI, (B) 1.54 kb Sac I/Hind Ill and 
(C) 0.7 kb Stu I/Eco RI, are indicated by white boxes, and the ends which were 
32P-labeled are denoted by black dots. Also shown are the sub-fragments 
which were generated by DNase I cleavage of chromatin isolated from 
unstimulated (white lines) or stimulated (black lines) 01 O.G4.1 cells, and 
hybridized to the respective probes. The positions of DNase I hypersensitive 
sites, which were generated in chromatin of unstimulated cells (white arrows) or 
stimulated cells (black arrows), were localized by reference to the sizes of these 
sub-fragments. 
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4.4. DISCUSSION 
Transcriptional regulation of eukaryotic gene expression is a complex 
mechanism which involves multiple, specific DNA-protein and protein-protein 
interactions. These coordinate interactions appear to be regulated, at one 
level, by the particular sequences, composition and spatial organisation of 
multiple DNA elements which may be utilized by a given gene, and the 
expression and/or activities of the specific regulatory factors which may be 
modulated as a function of cell state or type. Such multiple interactions 
appear, however, to be ultimately governed by the organisation of DNA into 
nucleosomes and higher order chromatin structures, which may regulate the 
accessibility of a gene to the transcriptional machinery. While the correlation 
between the dynamic nature of chromatin and transcriptional activity has been 
well established, the underlying mechanisms which govern the intrinsic nature 
of their relationship remain unclear (section 1.1.2.). 
Preliminary experiments described in section 4.1. suggested that the 
dynamic nature of chromatin structure and the nuclear micro-environment may 
play a critical role in regulating transcription of the murine IL-5 gene. 
Induction of IL-5 gene transcription in response to T cell activation signals was 
observed in nuclear run-off assays, where endogenous chromatin was used 
as the template for transcription (Chapter 3). Transcriptional activation was, 
however, not induced in cell-free (in vitro transcription) systems nor in 
transient expression systems where exogenous naked DNA was used as the 
transcriptional template. Higher order structure and topology, apart from 
specific DNA-protein and protein-protein interactions , therefore appear 
necessary to activate IL-5 gene transcription . This proposal has been 
supported by recent findings which demonstrate inducibility of the I L-5 gene 
promoter in response to T cell activation signals under conditions where the 
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exogenous DNA is stably in.tegrated into the chromosomes of eukaryotic host 
cells, as opposed to being transiently expressed (P. Bourke, unpublished 
results). 
Studies described in this chapter indicate that the chromatin structure of 
the m urine I L-5 gene undergoes significant alterations in response to T cell 
activation signals. Increased hypersensitivity to DNase I correlated strongly 
with increased transcriptional activity of the I L-5 gene. Such hypersensitivity 
is generally believed to be attributable to decondensation in chromatin 
structure, by the local disruptions in nucleosomal organisation. Such dynamic 
alterations in chromatin structure are believed to allow accessibility of the 
gene to trans-activating factors, a proposal supported by the frequent 
association of hypersensitive sites with protein-binding regulatory regions of 
genes (reviewed in Eissenberg et al., 1985; Yaniv & Cereghini , 1986; Elgin , 
1988; Gross & Garrard, 1988; Grunstein, 1990). 
Mitogenic stimulation of 01 O.G4.1 cells induced several novel DNase I 
hypersensitive sites in the non-coding regions of the I L-5 gene, including one 
site in the large second intron and three sites in the 3'-UTR, two being 
proximal to the polyadenylation signal (Table 4.1.). One inducible 
hypersensitive site was identified just upstream of the cap site. A large body 
of recent evidence indicates that cis-acting regulatory elements of severa l 
lymphokine genes, including the IL-2 (Durand et al., 1988; Brunvand et al., 
1988; Emmel et al., 1989; Serfling et al., 1989), IL-3 (Mathey-Prevot et al. , 
1990; Shoemaker et al. , 1990), IL-4 (Abe et al., 1992) and GM-CSF 
(Miyatake et al. , 1988a,b, 1991; Nim er et al. , 1988, 1989a, 1990) genes, 
which mediate responsiveness to T cell activation signals , are general ly 
located within a 300 bp region 5' of their respect ive cap sites . Given the ir 
proximity to the cap site of the IL-5 gene, the sequences wh ich surround the 
I,_ 
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observed inducible hypersensitive site may therefore be of significant interest 
as they may contain putative regulatory elements. 
The reported proximal 5'-flanking sequences of the I L-5 gene 
demonstrate overall poor homology to those of other lymphokine genes with 
the notable exception of a short region extending just 5' of the TAT A boxes of 
the murine and human genes encoding IL-5, IL-4 and GM-CSF (Campbell 
et al., 1988). This highly conserved region in the GM-CSF gene has been 
demonstrated to bind specific nuclear proteins (Nimer et al. , 1988; Miyatake 
et al., 1991) and mediate inducibility of human GM-CSF promoter activity in T 
cell lines (Nimer et al., 1988, 1989a, 1990), fibroblasts (Nimer et al. , 1989b) 
and endothelial cells (Kaushansky, 1989). The regulatory role of these 
conserved sequences in GM-CSF gene transcription, the similar positioning of 
these sequences relative to the TATA boxes and the fact that lymphokine 
genes demonstrate very limited homology in their 5'-flanking regions, give this 
conserved region additional significance as a potential transcriptional control 
element of the murine IL-5 gene which may bind specific regulatory factors. 
Investigations of the interactions between these DNA sequences and specific 
nuclear proteins are described in the following chapter. 
CHAPTER 5: 
REGULATION OF MURINE IL-5 GENE EXPRESSION: 
IDENTIFICATION AND POTENTIAL INVOLVEMENT OF 
MULTIPLE, SPECIFIC DNA-PROTEIN INTERACTIONS 
5.1. INTRODUCTION 
As previously discussed, the underlying mechanisms by which many 
sequence-specific DNA-binding proteins may regulate the spatial, temporal or 
inducible expression patterns of many eukaryotic genes at the transcriptional 
level appear to be inextricably associated with their being intracellular 
"downstream" targets for signals emanating from events external to the 
genomic micro-environment. In this regard, the identification and 
characterization of these DNA-binding proteins is a major approach in 
elucidating the complex linkage between the transduction of cellular signals 
and consequent modulation of the genetic program. 
The development of techniques enabling the detection of DNA-protein 
interactions in vitro using crude cellular extracts have been major 
methodological advances in the identification and characterization of DNA-
binding regulatory factors and has, in recent years, led to the subsequent 
purification of several factors and cloning of their respective genes (Kadonga 
eta!., 1987; Singh eta!. , 1988; Staudt eta!., 1988; Meyer eta!. , 1991). 
Early DNA-protein binding assays included the nitrocellulose filter binding 
assay, which involves the separation of stable DNA-protein complexes by 
filtration through nitrocellulose (Riggs et al., 1970) and south-western blotting, 
which involves hybridization of DNA to proteins separated by electrophoresis 
and immobilized on to nitrocellulose membrane (Bowen et al. , 1980; 
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Miskimins et al., 1985). One of the most sensitive and popular methods is the 
gel shift (retardation) assay which is based on the differential electrophoretic 
mobilities of DNA-protein complexes versus free unbound DNA (Hendrickson , 
1985; Garner & Revzin, 1986; Crothers, 1987; Revzin, 1989). This assay 
allows determination of the abundance and relative affinity or specificity of 
DNA-binding proteins by assessing qualitative and quantitative changes in 
DNA-protein interactions when complex formations are challenged by 
unlabeled competitor DNA containing sequences identical or non-
homologous to the labeled recognition element. Other strategies to identify 
specific DNA sequences involved in protein binding include protection and 
interference assays. Protection or "footprinting" assays determine the 
influence of protein binding on the subsequent reactivity of DNA molecules to 
non-specific cleavage by chemical agents such as methidiumpropyl-EDTA-
lron(II) (MPE) (Van Dyke et al., 1988; Landolfi et al., 1989), or nucleases 
such as Exonuclease Ill (Wu, 1985; Cordingley & Hager, 1988) or DNase I 
(Galas & Schmitz, 1978; Jones et al., 1985). Interference assays, conversely, 
determine the influence of DNA modification, for example, by methylation , 
upon the subsequent binding of proteins (Hendrickson & Schleif, 1985). 
As previously discussed in Chapter 4, studies using cell-free or 
transient expression systems were unable to identify sequences involved in 
the transcriptional regulation of the IL-5 gene in murine T cells. DNase I 
hypersensitivity studies of endogenous chromatin , however, identified a 
region of non-nucleosomal organisation just 5' of the cap site of the IL-5 gene 
in activated, but not unstimulated, T cells, which may represent a site of 
inducible sequence-specific protein-DNA interactions. The sequences 
surrounding this inducible hypersensitive site in the IL-5 gene are highly 
homologous to corresponding regions in the GM-CSF and IL-4 genes 
(Table 5.1.), which otherwise demonstrate little significant homology in their 
1 1 1 
5'-flanking regions. This h.ighly conserved region in the GM-CSF gene has 
been demonstrated to bind specific nuclear proteins (Nimer et al., 1988; 
Miyatake et al., 1991) and mediate inducibility of human GM-CSF promoter 
activity in several GM-CSF-expressing cells including T cells, fibroblasts and 
endothelial cells in response to stimulation by mitogens, the HTLV-1 tax 
protein and IL-1 (Kaushansky, 1989; Nimer et al., 1988; 1989a,b; 1990). 
In addition to the regulatory role of these highly conserved sequences 
in GM-CSF gene transcription, several other features give these conserved 
sequences considerable significance as a potential transcriptional control 
element of IL-5 gene expression which may bind specific regulatory factors . 
These include the similar positioning of these sequences relative to the TATA 
boxes of the IL-5, GM-CSF and IL-4 genes (Table 5.1.) and the fact that these 
lymphokine genes otherwise demonstrate very limited homology in their 5 '-
flanking regions. Several recent lines of evidence suggest a strong 
correlation between regulatory functionality and conservation of non-coding 
sequences. Conserved NF-KB binding sites, which are located proximally to 
the TATA boxes of the IL-2 (Hoyos et al., 1989; Shibuya et al. , 1989), IL-6 
(Shimuzu et al., 1990; Zhang et al., 1990) and GM-CSF (Schreck & 
Baeuerle, 1990), and AP-1 sites sites located upstream of the IL-2 (Emmel 
et al., 1989) and IL-3 (Mathey-Prevot et al., 1990; Shoemaker et al. , 1990) 
genes appear, for example, to play important regulatory roles in mediating the 
transcriptional activation of these genes in response to cellular signals. It 
seemed pertinent, therefore, to identify and characterize the possible 
interactions of specific nuclear proteins with these DNA sequences in the 
murine IL-5 gene, and investigate the possible modulation of such interactions 
by specific T cell activation signals. 
Table 5.1. Comparison of 5'-flanking sequences of the murine and 
human genes encoding IL-5, GM-CSF and IL-4. 
Positions of upstream sequences, relative to the cap sites of the respective 
genes, are indicated. The "TATA" boxes and conserved CA TI(A/T) motifs are 
underlined. Two sub-regions in the murine IL-5 gene, termed mll-5A 
(-61 to -41) and mll-58 (-76 to -62), are indicated. Oligonucleotide probes 
containing sequences of these two sub-regions were used in gel shift analysis. 
Oligonucleotide probes containing sequences of the murine GM-CSF and IL-4 
genes which exhibit high homology to the mll-5A region (-60 to -40 and 
-70 to -50 respectively) were also used in gel shift analysis. 
mIL-5 
hIL-5 
mGM-CSF 
hGM-CSF 
mIL-4 
hIL-4 
,-
's 
mIL-SB j mIL-SA 
TCCTCTATCTGATTGTTAGCAATTATTCATTTCCTCAGAGAGAGAATAAA 
I\ I\ I\ 
-76 -61 -41 
TTCTCTATCTGATTGTTAGAAATTATTC-ATTTCCTCAAAGACAGACAATAAA 
I\ 
-42 
CCCTGGAGTTCTGTGGTCACCATTAATCATTTCCTCTAACTGTGTATATAA 
I\ I\ 
-60 -40 
CCCTGGCATTTTGTGGTCACCATTAATCATTTCCTCTGTGTATTTAA 
I\ 
-33 
TGTAA-TAAAATTTTCCAATGTAAACTCATTTTCCCTT-20bp-TATATATA 
I\ I\ 
-70 -50 
TGTAACGAAAA-TTTCCAATGTAAACTCATTTTCCCTC-20bp-TATATATA 
I\ 
-50 
,-
\ 
I 
I, 
- ' 
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5.2. MATERIALS AND METHODS 
The sources and preparation of reagents used to treat tissue cultu re 
cells in this study have been previously in section 2.2.1. (1 ). Isolation and 
Northern blot analysis of total cellular RNA has been previously described in 
section 2.2.3. 
5.2.1. Cell lines 
The source and maintenance of the conalbumin-specific Th2 clone 
D1 O.G4.1 (Kaye et al., 1983) has been previously described in section 
2.2.1.(2). HDK-1 is a keyhole limpets hemocyanin-specific Th1 clone derived 
from Balb/c mice (Cherwinski et al., 1987) and was obtained from DNAX. 
HDK-1 cells were stimulated at 5 x 1 o5 cells/ml every 1 O days with a 10-fold 
excess of irradiated Balb/c spleen cells and keyhole limpets hemocyanin 
(150 µg/ml) (Sigma), and maintained 1n DMEM medium (GIBCO) , 
supplemented with 10°/o fetal calf serum (CSL), 1 mM sodium pyruvate, 
2 mM glutamine, 0.05 mM p-mercaptoethanol , 100 units/ml penicillin , 
100 µg/ml streptomycin and recombinant IL-2 (50 units/ml). The source of 
IL-2 has been previously described in section 2.2.1.(2). 
5.2.2. Preparation of cell extracts 
Crude nuclear and cytoplasmic extracts were prepared from 
unstimulated or stimulated cells as described by Miskimins et al. (1985) with 
modifications. Cells were harvested, washed in ice-cold PBS and lysed at 
4 x 1 O 7 cells/ml in ice-cold lysis buffer (1 O mM N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid (HEPES)-KOH [pH 8.0] ; 50 mM NaCl ; 0.5 M 
sucrose; 0.1 mM EDTA; 0.5°/o Triton X-100; 1 mM OTT and 5 mM MgCl2) . 
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Following centrifugation at 800 x g for 5 min at 4°C, the cytoplasmic 
supernatant was retained on ice and the nuclear pellet was resuspended in 
lysis buffer at 8 x 1 o? nuclei/ml. Spermidine and NaCl were added to final 
concentrations of 5 mM and 0.42 M respectively. The suspension was 
incubated on ice for 30 min with gentle stirring and then centrifuged at 
150,000 x g for 15 min at 4°C. The nuclear and cytoplasmic supernatants 
were dialysed against 500 volumes of dialysis buffer (10 mM HEP ES-KOH 
[pH 8.0]; 50 mM NaCl; 50°/o glycerol (vol/vol); 1 mM OTT and 1 mM MgCl2) 
for 12 h at 4 °C. The dialysates were centrifuged at 12,000 x g for 1 O min at 
4°C and aliquots of the supernatants frozen in liquid nitrogen until use. The 
protein concentrations of cellular extracts were determined using the BioRad 
Bradford Protein Assay Kit. 
5.2.3. Oligonucleotide probes 
( 1) Oligonucleotide synthesis 
Oligonucleotides were synthesized by Dr. P. Milburn and Mr. C. 
Mccrae (Biomolecular Resource Facility) on an Applied Biosystems Model 
380A DNA Synthesizer using the phosphoramidite method and purified by 
HPLC. Pairs of synthetic oligonucleotides containing complementary 
sequences were annealed by boiling equimolar concentrations of each strand 
for 1 O min and allowing the mixture to slowly cool in the water bath to room 
temperature. 
(2) Synthesis of 32P-end-labeled DNA probes 
Four pmoles of annealed oligonucleotides were incubated in a 50 µI 
reaction containing 50 mM Tris-Cl [pH 7.5]; 1 O mM MgCl2; 5 mM OTT, 
50 µg/ml BSA; 150 µCi [y-32p] ATP with 10 units of T4 polynucleotide 
kinase (Pharmacia) for 30 min at 37°C. The reaction was terminated by 
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addition of EDTA to 20 mM .and unincorporated nucleotides were removed by 
chromatography as described previously in section 2.2.3.(5). For in vitro 
DNase I footprinting reactions, one oligonucleotide strand was labeled at the 
5' terminus by T4 polynucleotide kinase and annealed to an equimolar 
concentration of unlabeled oligonucleotide strands containing complementary 
sequences. 
5.2.4. Gel shift analysis 
Gel shift analysis was performed essentially according to Singh et al. 
(1986) with modifications. 1 O fmole of 32P-end-labeled oligonucleotides 
were incubated in a 20 µI reaction containing 1 O mM Tris-Cl [pH 7.9]; 1 mM 
EDTA; 1 mM OTT; 10°/o glycerol; 100 mM NaCl; 5 mM MgCl2; 1 µg 
poly(dl.dC).poly(dl.dC) (Pharmacia) with 8 µg of crude cellular extracts for 
20 min at room temperature. In competition experiments , a 10 to 200 molar 
excess of unlabeled oligonucleotides, relative to the probe, was added to the 
binding reaction. Following incubation, bromophenol blue and xylene cyanol 
were added to 0.05°/o and resulting complexes were resolved on low ionic 
strength 6°/o polyacrylamide gels (acrylamide:bisacrylamide we ight ratio 30: 1) 
containing 6.7 mM Tris-Cl [pH 7.9]; 3.3 mM sodium acetate and 1 mM 
EDTA by electrophoresis at 11 Vcm-1 at room temperature. The gel was 
subsequently dried and exposed to X-ray film (Kodak XAR) at -70°C. 
5.2.5. In vitro DNase I footprinting 
In vitro DNase I footprinting analysis was performed essentially 
according to Henninghausen & Lubon (1987) with modifications. 1 O fmole of 
32P-end-labeled DNA was incubated in a 50 µI reaction containing 1 O mM 
Tris-Cl [pH 7.9]; 1 mM EDTA; 1 mM OTT; 10°/o glycerol ; 100 mM NaCl ; 
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5 mM MgCl2; 1 µg poly(dl.dC).poly(dl.dC) (Pharmacia) with O to 100 µg of 
crude cellular extracts for 20 min at room temperature. As a control , end-
labeled DNA was incubated with BSA instead of cellular extracts under the 
same conditions. CaCl2 was added to 1 mM and DNase I (RQ1, Promega) 
was added to 1 to 3 units/ml. After incubation for 1 min at 37°C, the reaction 
was terminated by addition of Tris-Cl [pH 8.0], NaCl , EDTA, SOS and yeast 
tRNA to final concentrations of 100 mM , 100 mM, 1 O mM , 0.5°/o and 
100 µg/ml respectively. The mixture was incubated with proteinase K 
( 100 µg/ml) for 20 min at 50 °C, followed by phenol and 
chloroform:isoamylalcohol (24: 1) extractions and ethanol precipitation. The 
reaction products were resuspended in 90°/o formamide containing 0.05°/o 
bromophenol blue and xylene cyanol and resolved by electrophoresis on 
denaturing 8 M urea/12°/o polyacrylamide gels containing 0.089 M Tris-base, 
0.089 M boric acid and 2 mM EDTA. The gel was subsequently dried and 
exposed to X-ray film at -70°C. 
_, 
5.3. 
5.3.1. 
RESULTS 
DNase I footprinting analysis of protein 
interactions with 5'- flanking sequences of the 
murine IL-5 gene 
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DNase I footprinting analysis was initially performed to identify any 
qualitative differences in the interactions between nuclear proteins extracted 
from unstimulated or stimulated T cells and 5'-flanking regions of the murine 
IL-5 gene. Of particular interest was the region immediately 5' of the TATA 
box which is highly conserved in the GM-CSF, IL-4 and human IL-5 genes 
(Table 5.1.) and includes sequences homologous to those reported to be 
involved in inducing GM-CSF gene transcription (Kaushansky, 1989; Nimer 
et al., 1988; 1989a,b; 1990). A unlabeled synthetic oligonucleotide 
containing sequences from -107 to -32 of the murine IL-5 gene was annealed 
to a 32P-end-labeled oligonucleotide containing complementary (non-coding) 
sequences. This duplex was incubated with crude nuclear extracts prepared 
from unstimulated 01 O.G4.1 cells or cells which were stimulated with Con A 
for 6 h. These stimulatory conditions were previously found to induce 
maximal transcriptional activity of the IL-5 gene (Chapter 3) and thus may 
involve temporally elevated levels of potential DNA-binding trans-activating 
factors. Although numerous reports have demonstrated DNase I protection 
using enriched or purified sequence-specific DNA-binding proteins, this 
analysis has been successfully extended to using crude nuclear extracts 
(Ohlsson & Edlund, 1986; Nimer et al., 1988). The free and protein-bound 
DNA was subjected to limiting DNase I digestion and purified DNA resolved 
by denaturing gel electrophoresis. 
As shown in Fig. 5.1.(A) , incubation of the DNA with crude nuclear 
extracts prepared from unstimulated 01 O.G4.1 cells resulted , upon DNase I 
Fig. 5.1. DNase I footprinting analysis of protein interactions with 
sequences upstream of the murine IL-5 gene. 
The non-coding strand (A) or coding strand (B) of DNA sequences from -107 to 
-32 were 32P-end-labeled. 10 fmole of DNA was incubated with 30 µg or 
100 µg of either BSA or crude nuclear extracts prepared from unstimulated or 
Con A-stimulated 01 O.G4.1 cells, as indicated below, under the conditions 
described in section 5.2.5. Unbound and protein-bound DNA was subjected to 
digestion with DNase I at 1 or 3 units/ml as indicated, and the DNA was 
subsequently purified and resolved by denaturing gel electrophoresis. The 
positions of sequences protected from DNase I digestion are indicated. 
(A) (a) 
(b) 
(c) 
(d) 
(e) 
(f) 
(g) 
(B) ( a) 
(b) 
(c) 
(d) 
Protein 
BSA 
BSA 
unstimulated 
unstimulated 
BSA 
stimulated 
stimulated 
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unstimulated 
stimulated 
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DNase I 
30 µg 1 unit/ml 
30 µg 3 units/ml 
30 µg 1 unit/ml 
30 µg 3 units/ml 
30 µg 3 units/ml 
30 µg 3 units/ml 
100 µg 3 units/ml 
30 µg 3 units/ml 
30 µg 3 units/ml 
30 µg 3 units/ml 
100 µg 3 units/ml 
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digestion and resolution by gel electrophoresis, in a pattern of bands not 
dissimilar to the pattern resulting from incubation of the probe with non-
specific proteins such as BSA (Lanes a-d). Incubation of the probe with 
crude nuclear extracts prepared from Con A-stimulated 01 O.G4.1 cells , 
however, resulted in a considerably different pattern (Lanes f,g). The 
presence and position of an observable "gap" in the resultant ladder of bands 
suggests that sequences between -68 and -4 7 are protected from ONase I 
digestion by the binding of a specific nuclear protein(s) which is present only 
in stimulated, but not unstimulated, 01 O.G4.1 cells. 
Footprinting analysis was repeated using a probe composed of the 
32P-end-labeled coding strand annealed to the unlabeled non-coding strand. 
As shown in Fig. 5.1.(B), sequences between -69 and -44 were protected from 
ONase I digestion when incubated with nuclear extracts prepared from 
Con A-stimulated 01 O.G4.1 cells (Lanes c,d), but not from unstimulated cells 
nor with BSA (Lanes a,b). No other protein interactions were observed with 
sequences extending further upstream to -107 using nuclear extracts 
prepared from either unstimulated or stimulated 01 O.G4.1 cells. 
5.3.2. Gel shift analysis of protein interactions with two 
discrete elements in the proximal 5'- flanking 
region 
To further investigate the interactions between sequences upstream of 
the murine IL-5 gene and the putative inducible nuclear protein(s) identified 
by ONase I footprinting analysis, gel shift assays were performed. A synthetic 
oligonucleotide containing sequences from -76 to -41 , which include those 
protected from ONase I digestion , was annealed to a second oligonucleotide 
containing complementary sequences. The resulting duplex, termed 
mlL-5(-76/-41) was 32P-end-labeled , incubated with either BSA or crude 
--
_, 
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nuclear extracts prepared from unstimulated or Con A-stimulated 01 O.G4.1 
cells and unbound and protein-bound DNA resolved by native gel 
electrophoresis. As shown in Fig. 5.2., no DNA probe was bound when 
incubated with either BSA or nuclear extracts prepared from unstimulated 
01 O.G4.1 cells (Lanes 2,3). Incubation of the probe with nuclear extracts 
prepared from Con A-stimulated 01 O.G4.1 cells resulted , however, in the 
formation of several DNA-protein complexes of different electrophoretic 
mobilities (Lane 1 ). 
To resolve the DNA-protein complexes associated with sequences 
located between -76 and -41, gel shift assays were conducted using two 
shorter oligonucleotide probes, termed mlL-5A(-61/-41) and mlL-58(-76/-62) , 
which respectively contain sequences of adjacent sub-regions tentatively 
referred to here as mlL-5A (-61 to -41) and mlL-58 (-76 to -62). Sequences of 
mlL-5A are highly homologous to those of corresponding regions in the 
GM-CSF and IL-4 genes (Table 5.1.). Sequences of the adjacent mlL-58 
sub-region are highly conserved between the murine and human IL-5 genes, 
but do not demonstrate significant homology to corresponding regions in other 
lymphokine genes. 
Distinct complexes of different electrophoretic mobilities we re observed 
to form independently to oligonucleotides mlL-5A (-61/-41) and 
mlL-58(-76/-62) using crude nuclear extracts prepared from Con A-stimulated 
01 O.G4.1 cells (Fig. 5.2. , Lanes 4,7). The proteins associated with these 
complexes , respectively termed NF-IL-5A and NF-IL-58 , appeared to be 
present (or demonstrate active DNA-binding ability) only in the nuclei of 
activated 01 O.G4.1 cells. No protein interactions with either of these two 
oligonucleotides were detected using cytoplasmic extracts prepared from 
Fig. 5.2. Gel shift analysis of interactions between sequences 5' of the 
murine IL-5 gene and nuclear proteins extracted from unstimulated or 
stimulated D1 O.G4.1 cells. 
32P-labeled DNA containing sequences of the murine IL-5 gene from -76 to -41 
(mlL-5(-76/-41)) (Lanes 1-3), from -61 to -41 (mlL-5A(-61/-41)) (Lanes 4-6) or 
from -76 to -62 (m I L-58(-76/-62)) (Lanes 7-9) were incubated with either BSA 
(Lanes 3,6,9) or nuclear extracts prepared from unstimulated (Lanes 2,5,8) or 
Con A-stimulated (Lanes 1,4,7) D1 O.G4.1 cells under the conditions described 
in section 5.2.4. Unbound and protein-bound DNA was resolved by native gel 
elect roph ores is. 
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Fig. 5.3. Inducible nuclear protein interactions with mil-SA and 
mll-58, two discrete DNA elements located 51 of the murine IL-5 gene. 
32P-labeled oligonucleotide probes containing sequences (a) from -61 to -41 
(mlL-SA(-61/-41)) or (b) from -76 to -62 (mlL-5B(-76/-62)) were incubated with 
either BSA (Lane 1) or cytoplasmic or nuclear extracts prepared from 
unstimulated (Lanes 2,4) or Con A-stimulated (Lanes 3,5) 01 O.G4.1 cells. 
DNA-protein complexes formed with mlL-SA(-61/-41) and mlL-5B(-76/-62)) are 
respectively termed NF-IL-5A and NF-IL-5B. 
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unstimulated or stimulated D1 O.G4.1 cells or unstimulated nuclear extracts 
(Fig. 5.3.(a)(b)). 
To investigate the sequence-specificity of protein interactions with the 
mlL-5A and mlL-5B elements, competition assays were performed. The 
addition to the binding reaction of increasing amounts of unlabeled competitor 
DNA, containing the same sequences as the probe, increasingly inhibited 
protein interactions with either mlL-5A(-61/-41) (Fig. 5.4.(a), Lanes 3-5) or 
mlL-5B(-76/-62) (Fig. 5.4.(b), Lanes 3-5). The addition to the binding 
reaction of the same increasing amounts of unlabeled competitor DNA, 
containing sequences non-homologous to those of either probe was, in 
contrast, significantly less effective in perturbing the formation of the NF-IL-5A 
or NF-IL-5B complexes (Fig. 5.4.(a)(b), Lanes 6-8). These non-homologous 
or "non-specific" competitor sequences themselves were observed not to 
specifically bind proteins (data not shown). 
The addition of increasing amounts of unlabeled mlL-5B(-76/-62) to the 
binding reaction did not significantly perturb formation of NF-IL-5A 
(Fig. 5.4.(a), Lanes 10-12), when compared with competition assays using 
the same increasing amounts of sequences non-homologous to either 
mlL-5B(-76/-62) or mlL-5A(-61/-41) (Fig. 5.4.(b), Lanes 6-8). Conversely, the 
addition of increasing amounts of unlabeled mlL-5A(-61/-41) did not 
significantly perturb formation of NF-IL-5B (Fig. 5.4.(b), Lanes 10-12), when 
compared with competition assays using non-homologous sequences 
(Fig. 5.4.(b), Lanes 6-8). These competition assays together suggest that 
two discrete adjacent elements, described here as mlL-5A (-61 to -41) and 
mlL-5B (-76 to -62), specifically and independently form distinct complexes, 
respectively termed NF-IL-5A and NF-IL-5B, with putatively different nuclear 
Fig. 5.4. Specificity of inducible nuclear protein interactions with the 
mil-SA and mll-58 elements. 
32P-labeled mlL-SA(-61/-41) (a) or mlL-58(-76/-62) (b) were incubated with 
either BSA (Lane 1) or Con A-stimulated 01 O.G4.1 nuclear extracts in the 
absence of competitor DNA (Lane 2) or presence of the indicated molar excess, 
relative to the probe, of unlabeled competitor DNA containing sequences 
identical to those of the respective probes (Lane 3-5) or sequences non-
homologous ("non-specific") to those of either probe (Lanes 6-8). These "non-
specific" competitors were of the same lengths as the probe used and their 
sequences are indicated below. Protein interactions with m I L-5A(-61 /-41) 
(NF-IL-5A) were also challenged by addition to the binding reaction of the 
indicated molar excess of unlabeled mlL-58(-76/-62) (a, Lanes 9-12), while 
protein interactions with mlL-58(-76/-62) (NF-IL-58) were challenged with the 
same increasing molar excesses of unlabeled mlL-SA(-61/-41) (b, Lanes 9-12). 
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proteins which are present (or active) 1n stimulated, but not unstimulated, 
01 O.G4.1 cells. 
5.3.3. Protein interactions with the conserved TCATTT-
containing element in the IL-5, GM-CSF and IL-4 
genes 
As shown in Table 5.1., sequences of the mlL-5A region (-61 to -41) are 
highly homologous to analogous regions present in the GM-CSF (-60 to -40) 
and IL-4 (-70 to -50) genes and include a 100°/o conserved TCATTT motif. To 
determine whether nuclear proteins associated with the NF-IL-5A complex 
also interact with the highly conserved sequences in other lymphokine 
promoters, gel shift assays were performed using Con A-stimulated 01 O.G4.1 
nuclear extracts to compare protein interactions with mlL-5A(-61/-41) and 
homologous sequences in the murine GM-CSF (mGM-CSF(-60/-40)) and IL-4 
(mlL-4(-70/-50)) genes. As shown in Fig. 5.5.A., DNA-protein interactions of 
similar electrophoretic mobility and affinity to NF-IL-5A were observed to form 
with mGM-CSF(-60/-40) , while only weak interactions were observed to 
m I L-4(-70/-50). 
Competition assays were subsequently performed to further assess the 
affinity of nuclear proteins for these lymphokine elements. As shown in 
Fig. 5.5.B., NF-IL-5A formation was increasingly inhibited by increasing 
amounts of unlabeled mlL-5A(-61/-41) (Lanes 2,3) and inhibited to a slightly 
lesser degree by the same increasing amounts of unlabeled 
mGM-CSF(-60/-40) (Lanes 4,5). Unlabeled mlL-4(-70/-50), in comparison , 
only weakly inhibited protein interactions with mlL-5A(-61/-41) (Lanes 6,7) , 
though not as weakly as sequences non-homologous to any of these 
elements (Lanes 8,9). 
Fig. 5.5. Comparison of DNA-protein complex formations associated 
with mil-SA and homologous elements in the murine GM-CSF and IL-4 
genes. 
A. The indicated oligonucleotide probes containing sequences from -61 to 
-41 of the mu rine I L-5 gene (m I L-5A(-61 /-41)) (Lane 1), from -60 to -40 of the 
murine GM-CSF gene (mGM-CSF(-60/-40)) (Lane 2) or from -70 to -50 of the 
murine IL-4 gene (mlL-4(-70/-50)) (Lane 3) were incubated with nuclear 
extracts from Con A-stimulated 01 O.G4.1 cells. 
5' 3' 
mIL-SA (-61/-41) TTAGCAATTATTCATTTCCTC 
mGM-CSF (-60/-40) GTCACCATTAATCATTTCCTC 
mIL-4(-70/-50) CCAATGTAAACTCATTTTCCC 
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Fig. 5.5. Comparison of DNA-protein complex formations associated 
with mil-SA and homologous elements in the murine GM-CSF and IL-4 
genes. 
B. 32P-labeled mlL-5A(-61/-41) was incubated with Con A-stimulated 
01 O.G4.1 nuclear extracts either in the absence of competitor DNA (Lane 1) or 
presence of the indicated molar excess, relative to the probe, of unlabeled 
mlL-5A(-61/-41) (Lanes 2,3), mGM-CSF(-60/-40) (Lanes 4,5), mlL-4(-70/-50) 
(lanes 6, 7) or sequences non-homologous to any of these elements ("non-
specific") (Lanes 8,9). These "non-specific" competitor sequences have been 
previously described in Fig. 5.4. 
C. 32P-labeled mGM-CSF(-60/-40) was incubated with Con A-stimulated 
01 O.G4.1 nuclear extracts either in the absence of competitor DNA (Lane 1) or 
presence of the indicated molar excess of unlabeled mGM-CSF(-60/-40) 
(Lanes 2,3), mlL-5A(-61/-41) (Lanes 4,5), mlL-4(-70/-50) (Lanes 6,7) or 
sequences non-homologous to any of these elements (non-specific) 
(Lanes 8,9). The "non-specific" competitor was the same as that used against 
mlL-5A(-61/-41 ). 
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In a converse experiment, protein interactions with mGM-CSF(-60/-40) 
were found to be increasingly inhibited by increasing amounts of unlabeled 
sequences identical to the probe (Fig. 5.5.C., Lanes 2,3), to a slightly lesser 
degree by mlL-5A(-61/-41) (Lanes 4,5) and only weakly by mlL-4(-70/-50) 
(Lanes 6,7). These results indicate that nuclear proteins associated with the 
NF-IL-5A complex bind with highest affinity to mlL-5A(-61/-41) , with slightly 
reduced affinity to mGM-CSF(-60/-40) and with significantly weaker affinity to 
the less conserved analogous element in the murine IL-4 gene. Furthermore, 
these results suggest that similar and closely related, but possibly not 
identical, proteins may recognise the conserved element in the IL-5 and 
GM-CSF genes. 
The significantly weak affinity of nuclear proteins for mlL-4(-70/-50) 
suggests that other sequences apart from, and located 5' to , the 100°/o 
conserved TCATTT motif, may be critical for binding of inducible nuclear 
proteins. Such sequences are highly conserved between the IL-5 and 
GM-CSF genes, and are less conserved in the IL-4 gene (Table 5.1., 
Fig. 5.5.A.). A report published during the course of this study indicated, 
however, that mutations of the TCATTT motif eliminated inducible human 
GM-CSF promoter activity in T cells (Nimer et al. , 1990). To determine 
whether the TCATTT motif was critical for recognition by the inducible 
proteins, competition assays were performed using murine IL-5 and GM-CSF 
sequences which contained the same base-substitutions introduced into the 
TCATTT motif as those reported by Nimer et al. (1990) (Fig. 5.6.). These 
TCATTT mutants were respectively termed mlL-5(-61/-41)(mut) and 
mGM-CSF(-60/-40)(mut) . Both of these mutant recognition elements failed to 
bind nuclear proteins (Fig. 5.6.A. , Lane 1; Fig. 5.6.B., Lane 1 ). NF-IL-5A 
complex formation with the wild-type element (mlL-5(-61/-41 )(wt)) was weakly 
perturbed by increasing amounts of mutated sequences (mlL-5(-61/-41)(mut)) 
Fig. 5.6. Effect upon protein-binding of substitution mutations in the 
conserved TCATTT motif in the murine IL-5 and GM-CSF genes. 
A. Oligonucleotide probes containing wild type sequences of the murine 
I L-5 gene from -61 to -41 (m I L-5(-61 /-41 )(wt)) (Lane 8) or harboring substitution 
mutations in the conserved TCATTT motif (mlL-5(-61/-41)(mut)) (indicated 
below) (Lane 1) were incubated with Con A-stimulated 01 O.G4.1 nuclear 
extracts. Protein interactions with the wild type sequences (mlL-5(-61/-41 )(wt)) 
were challenged by addition to the binding reaction of the indicated molar 
excess of unlabeled oligonucleotides containing the mutated binding site 
(Lanes 4,5), the wild type binding site (Lanes 6, 7) or sequences non-
homologous to either the wild-type or mutated sequences (Lanes 2,3). The 
"non-specific" competitor was the same as that previously described in Fig. 5.4. 
8. Oligonucleotide probes containing wild type sequences of the murine 
GM-CSF gene from -60 to -40 (mGM-CSF(-60/-40)(wt)) (Lane 8) or harboring 
the indicated substitution mutations in the conserved TCATTT motif 
(mGM-CSF(-60/-40)(mut)) (Lane 1) were incubated with Con A-stimulated 
01 O.G4.1 nuclear extracts. Protein interactions with the wild type sequences 
(mGM-CSF(-60/-40)(wt)) were challenged by the indicated molar excess of 
unlabeled oligonucleotides containing the mutated binding site (Lanes 4,5), the 
wild type binding site (Lanes 6, 7) or sequences non-homologous to either the 
wild type or mutated sequences (Lanes 2,3). 
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(Fig. 5.6.A., Lanes 4,5), though inhibition was stronger than that observed in 
analogous competition assays using sequences non-homologous to either 
the wild-type or mutant elements (Lanes 2,3). Similarly, complex formation 
with wild-type GM-CSF sequences (mGM-CSF(-60/-40)(wt)) was only weakly 
inhibited by increasing amounts of mutated GM-CSF sequences 
(mGM-CSF(-60/-40)(mut)) (Fig. 5.6.B., Lanes 4,5). These results together 
suggest that the intact TCATTT motif and several adjacent bases 51 to this 
motif are both required for recognition by inducible nuclear DNA-binding 
factors .. 
5.3.4. Signal modulation and cell-specificity of protein 
interactions with the conserved TCATTT-
containing element 
Studies described in Chapter 3 indicated that the GM-CSF gene is 
constitutively transcribed in unstimulated 01 O.G4.1 cells while the IL-5 gene is 
transcriptionally silent. While the transcriptional activities of both genes were 
coordinately elevated in response to Con A stimulation, activation of GM-CSF 
gene transcription, but not IL-5 gene transcription, appeared to be regulated 
by a Cs A-sensitive mechanism. Furthermore, I L-5 gene transcription was 
independently activated in response to PMA stimulation and appeared 
dependent upon an obligatory factor(s) synthesized de nova in response to 
Con A or PMA stimulation. Enhancement of GM-CSF gene transcription in 
response to Con A stimulation also appeared to be dependent upon a newly 
synthesized factor(s). These studies suggested that transcription of the IL-5 
and GM-CSF genes was differentially regulated in 01 O.G4.1 cells. It seemed 
pertinent, therefore , to investigate whether protein interactions with the 
conserved TCATTT-containing element in these two genes could be 
differentially modulated by these different signalling pathways. 
1( 
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As previously shown in Fig. 5.5.A., complexes of similar electrophoretic 
mobilities and affinities were observed to form with mlL-5A(-61/-41) and 
mGM-CSF(-60/-40) using crude nuclear extracts prepared from Con A-
stimulated D1 O.G4.1 cells. As shown in Fig. 5. 7. , no protein interactions were 
detected to mlL-5A(-61/-41) using unstimulated nuclear extracts. A complex 
was observed to form with mGM-CSF(-60/-40) using unstimulated nuclear 
extracts, the electrophoretic mobility of which was slower than the complex 
formed using stimulated nuclear extracts (Lanes 1,2). This suggests that the 
TCATTT-containing element in the GM-CSF gene, but not the IL-5 gene, forms 
a complex with a constitutive factor(s), which may be distinct from the 
inducible factor(s) which recognises this element in both genes. No protein 
interactions were detected to m I L-5A(-61 /-41) using extracts prepared from 
D1 O.G4.1 cells which were stimulated with Con A in the presence, from the 
outset, of CHX (Fig. 5.7.A., Lane 4). Incubation of these extracts with 
mGM-CSF(-60/-40) resulted in a binding pattern similar to that observed using 
unstimulated extracts (Fig. 5.7.B., Lane 4). This suggests that similar, related 
nuclear proteins which recognises the TCATTT-containing element in the IL-5 
and GM-CSF genes may be synthesized de nova in response to Con A 
stimulation. 
As shown in Fig. 5.7.A., complexes of similar electrophoretic mobilities 
were formed with mlL-5A(-61/-41) using extracts prepared from D1 O.G4.1 cells 
which were stimulated with either Con A or PMA (Lanes 2,5). This suggests 
that activation pathways mediated by these two agents may induce the 
synthesis of at least similar, if not the same, factor(s) which binds specifically 
to this IL-5 element. Incubation of mGM-CSF(-60/-40) with extracts prepared 
from PMA-stimulated D1 O.G4.1 extracts, however, resulted in a binding 
pattern more similar to that observed using extracts prepared from 
unstimulated rather than Con A-stimulated cells (Fig. 5.7.B. , Lanes 1,2,5). 
..... 
Fig. 5. 7. Signal-induced modulation of protein interactions with the 
conserved TCATTT-containing elements in the murine IL-5 and GM-CSF 
genes. 
32P-labeled mlL-5A(-61/-41) (A) or mGM-CSF(-60/-40) (B) were incubated with 
nuclear extracts prepared from unstimulated D1 O.G4.1 cells (Lane 1 ), D1 O.G4.1 
cells stimulated for 6 h with Con A in the absence or presence of either Cs A or 
CHX (Lanes 2,3 ,4), or D1 O.G4.1 cells stimulated for 6 h with PMA in the 
absence or presence of CHX (Lanes 5,6). 
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NF-I L-5A complex formation was observed using extracts prepared from 
01 O.G4.1 cells which were stimulated with Con A in the presence, from the 
outset, of Cs A (Fig. 5.7.A., Lanes 2,3). Incubation of mGM-CSF(-60/-40) 
with these extracts, however, resulted in a binding pattern more similar to that 
observed using unstimulated rather than Con A-stimulated extracts 
(Fig. 5.7.B., Lanes 1,2,3). 
The inducible DNA-protein interactions were also investigated in the 
Th 1 helper clone HDK-1, which was found, by Northern blot analysis , to 
express the GM-CSF but not the IL-5 gene in response to Con A stimulation 
(Fig. 5.8.A.). As observed in assays using unstimulated 01 O.G4.1 nuclear 
extracts, a complex of slow electrophoretic mobility was observed to form with 
mGM-CSF(-60/-40) using extracts prepared from unstimulated HDK-1 cells 
(Fig. 5.8.C., Lanes 2,4). Complexes of higher electrophoretic mobility were 
observed to associate with mGM-CSF(-60/-40) using extracts prepared from 
01 O.G4.1 or HDK-1 cells stimulated with Con A (Fig. 5.8.C. , Lanes 1,3). The 
NF-IL-5A complex was not observed to form with mlL-5A(-61/-41) using 
unstimulated or stimulated HDK-1 extracts (Fig. 5.8.B. , Lanes 3,4). 
These observations together suggest that signalling pathways which 
differentially modulate the expression patterns of the IL-5 and GM-CSF genes 
in murine Th clones may also differentially modulate the nature of nuclear 
protein interactions with the conserved TCATTT-containing element present in 
the 5'-flanking regions of these two genes. The strong correlation between 
signal-dependent and cell-specific modulation of gene expression patterns 
and DNA-protein interactions implicates the potential role which these DNA-
binding proteins and their recognition sequences may play in the transduction 
of intracellular activation signals to the transcriptional machinery of these 
genes. 
Fig. 5.8. Cell-specificity of gene expression patterns and protein 
interactions with the conserved TCATTT-containing elements in the 
murine IL-5 and GM-CSF genes. 
A. 20 µg of total cellular RNA, prepared from unstimulated D1 O.G4.1 
(Lane 2) or HDK-1 (Lane 4) cells, or cells stimulated for 6 h with Con A 
(Lanes 1,3) , were used to prepare Northern blots which were hybridized with 
the 32P-labeled murine IL-5 and GM-CSF cDNA probes. Northern blots were 
also hybridized with the 32 P-labeled ~-act in cDNA probe as a control for 
constitutive mRNA accumulation. Equalization of RNA content was confirmed 
by visualization of 28S and 18S ribosomal RNAs (rRNA) on ethidium bromide-
stained RNA gels. 
B,C. 32P-labeled mlL-5A(-61/-41) (B) or mGM-CSF(-60/-40) (C) were 
incubated with nuclear extracts prepared from unstimulated D1 O.G4.1 (Lane 2) 
or HDK-1 (Lane 4) cells , or cells stimulated for 6 h with Con A (Lanes 1,3). 
Unbound and protein-bound DNA was resolved by native gel electrophoresis. 
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5.3.5. Protein interactions with the putatively unique 
mlL-58 element 
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Modulation of protein interactions with the adjacent m I L-58 element 
(-76 to -62) by different signalling pathways was also investigated. As shown 
in Fig. 5.9.A., no protein interactions were detected to mlL-58(-76/-62) using 
unstimulated D1 O.G4.1 extracts (Lane 1 ), while complexes of similar 
electrophoretic mobility were observed using extracts prepared from D1 O.G4.1 
cells which were stimulated with PMA or Con A either in absence or presence 
of Cs A (Lanes 2,3,5). These inducible DNA-protein interactions were, 
however, not observed using extracts prepared from D1 O.G4.1 cells which 
were stimulated with either Con A or PMA in the presence of CHX 
(Lanes 4,6). This suggests that the nuclear protein(s) associated with the 
NF-IL-58 complex is synthesized de nova in response to signalling pathways 
activated by Con A or PMA stimulation. The NF-IL-58 complex was not 
detected using extracts prepared from unstimulated or Con A-stimulated 
HDK-1 cells which do not express the IL-5 gene (Fig. 5.9.B .. Lanes 3,4). The 
correlation between the patterns of transcriptional activity of the I L-5 gene and 
the modulation of nuclear protein interactions with the mlL-58 reg ion suggests 
that the DNA-binding protein(s) which specifically bind to mlL-58 may, 
together with those which interact with the TCATTT-containing mlL-5A 
element, play a role in coordinating the induction of IL-5 gene transcr iption in 
D1 O.G4.1 cells. 
Fig. 5.9. Gel shift analysis of signal-modulation and cell-specificity of 
protein interactions with the mll-58 element. 
A. 32P-labeled mlL-5B(-76/-62) was incubated with nuclear extracts 
prepared from unstimulated D1 O.G4.1 cells (Lane 1 ), D1 O.G4.1 cells stimulated 
for 6 h with Con A in the absence or presence of Cs A or CHX (Lanes 2,3,4) or 
D1 O.G4.1 cells stimulated for 6 h with PMA in the absence or presence of CHX 
(Lanes 5,6). 
B. 32P-labeled mlL-5B(-76/-62) was incubated with nuclear extracts 
prepared from unstimulated D10.G4.1 (Lane 2) or HDK-1 (Lane 4) cells, or cells 
stimulated for 6 h with Con A (Lanes 1,3). 
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5.4. DISCUSSION 
In recent years, a number of DNA elements have been identified in the 
5'-flanking regions of several lymphokine genes which appear to mediate 
their transcriptional activation in response to T cell activation signals. These 
DNA sequences are generally located proximally to the TAT A boxes of these 
genes and appear to specifically interact with numerous constitutive or 
inducible DNA-binding factors. While the overall DNA homology between 5'-
flanking regions of different lymphokine genes is relatively poor, conserved 
sequences have frequently been identified as putative cis-acting elements 
which specifically bind trans-activating regulatory factors. The ubiquitous 
factors NF-KB, AP-1 and Oct-1 , for example, appear to bind recognition 
elements which are conserved in several lymphokine genes, and 
co-operatively interact with one another and other factors to mediate the 
transcriptional activation of these respective genes (Emmel et al., 1989; 
Hoyos et al., 1989; Serfling et al., 1989; Shibuya et al., 1989; Kamps et al., 
1990; Mathey-Prevot et al., 1990; Schreck & Baeuerle, 1990; Sugimoto 
et al., 1990). Regulation of lymphokine gene transcription also appears to 
involve more specific mechanisms. NF-AT, which plays a critical role in 
mediating induction of IL-2 gene transcription, for example, appears to be a T 
cell-specific factor (Durand et al., 1988; Shaw et al. , 1988b) , while 
transcriptional activation of the IL-4 gene appears to be mediated by an 
enhancer element which may be unique to this particular gene (Abe et al. , 
1992). 
Results of the current study demonstrate that cell-specific inducible 
nuclear proteins specifically interact with two distinct, adjacent DNA elements 
located just 5' of the TATA box of the murine IL-5 gene. One element, referred 
to here as mil-SA (-61 to -41), is highly conserved at similar positions in 
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human and murine genes encoding IL-5, GM-CSF and IL-4 (Table 5.2.) and 
has recently been termed conserved lymphokine element O (CLEO) (Miyatake 
et al., 1991 ). The other element, referred to here as mlL-5B (-76 to -62) , is 
highly conserved between the murine and human IL-5 genes , but 
demonstrates little significant homology to corresponding regions in other 
lymphokine genes. Distinct nuclear proteins in Con A- or PMA- stimulated 
D1 O.G4.1 cells, which express the IL-5 gene (Chapter 2), specifically and 
independently bound to the mlL-5A (or IL-5 CLEO) and mlL-5B elements, No 
protein interactions with either of these two elements were detected using 
extracts prepared from unstimulated D1 O.G4.1 cells in which the IL-5 gene is 
transcriptionally inactive (Chapter 3). The synthesis of nuclear proteins which 
specifically recognised mlL-5A (IL-5 CLEO) and mlL-5B appeared to be 
induced de nova in D1 O.G4.1. cells in response to Con A or PMA stimulation, 
and their syntheses and/or activities appeared to be regulated by Cs A-
resistant signalling pathways. Furthermore, nuclear protein interactions with 
either of these two elements were not observed using extracts prepared from 
unstimulated or stimulated HDK-1 cells which do not express the IL-5 gene. 
The strong correlation between signal-dependent and cell-specific modulation 
of the transcriptional activity of the IL-5 gene and of specific nuclear protein 
interactions with these two elements implicates the potential role which these 
DNA-protein interactions may play in the transduction of activation signals to 
the transcriptional machinery of the IL-5 gene. 
The regulatory role of the CLEO element in mediating induction of 
human GM-CSF gene transcription has been extensively studied in a variety 
of cell systems. Unlike the IL-5 gene, the analogous region in the human 
GM-CSF gene contains three repeats of the CATT(A/T) motif (Table 5.2.). 
Sequences up to -53, which include the two downstream motifs , have been 
demonstrated to be sufficient to mediate cell-specific induction of human 
Table 5.2. Location of putative cis-acting regulatory elements in the 
proximal 5'-flanking regions of the murine and human genes encoding 
IL-5, GM-CSF and IL-4. 
Positions of upstream sequences, relative to the cap sites of the respective 
genes, are indicated. The "TATA" boxes and conserved CA TI(A/T) motifs are 
underlined. Two protein-binding sites in the murine IL-5 gene, termed mlL-5A 
(-61 to -41) and mlL-58 (-76 to -62), were identified in this study to bind 
inducible nuclear factors and are indicated respectively by pink and green 
boxes. Also indicated by green boxes are the CLE2/GC box elements (-94 to 
-73) and P-element (-79 to -69) which respectively are reported to be critical for 
mediating transcriptional activation of the murine GM-CSF (Miyatake et al., 
1988a,b) and human IL-4 (Abe et al., 1992) genes in response to T cell 
activation signals. Sequences which are reported to mediate inducibility of 
human GM-CSF promoter activity and to be protected from DNase I digestion 
by the binding of nuclear proteins in activated T cells (Nimer et al., 1988, 
1989a, 1990) are also indicated. The region defined by Miyatake et al. (1991) 
in these lymphokine genes as the CLEO element is denoted by the blue box. 
Sequences within the CLEO element of the murine GM-CSF gene, which are 
reported to be required for the formation of the NF-CLEOa and NF-CLEOb 
complexes (Miyatake et al., 1991) are indicated by pink boxes. 
C. ..-., 
'· ' 
:r:_;;: ~ : , f. . . 
,t_,-
·mIL-5B 
mIL-5 GACTCGCCTTTATTAGGTGTCCTCTATCTGATTGTTAGCAATTATTCATTTCCTCAGAGAGAGAATAAA 
. - . . . 
-76 -61 -55 -41 
hIL-5 GATATGCCATTATTAGGCATTCTCTATCTGATTGTTAGAAATTATTCATTTCCTCAAAGACAGACAATAAA 
• • 
-56 -42 
\ ·, ~,,, .... ,:.;;.1NF-CLE0b 
CLE2 GC box ,:fa;,,~ ,.;,.,-."g: .NF-CLEOa 
mGM-CSF TCAGGTAGTTCCCCCGCCCCCCTGGAGTTCTGTGGTCACCATTAATCATTTCCTCTAACTGTGTATATAA 
* - ~ • • ~ I • 
- 9 4 - 8 4 - 7 3 - 6 0 - 5";g - 4 0 
hGM-CSF TCAGGTAGTTCCCCCGCCTCCCTGGCATTTTGTGGTCACCATTAATCATTTCCTCTGTGTATTTAA 
.. .... - ,;A. 
-53 - 47 -33 
mIL-4 AGAATAACTGACAATCTGGTGTAA-TAAAATTTTCCAATGTAAACTCATTTTCCCTT-20bp-TATATATA 
• • • 
hIL-4 
-70 - 64 -50 
P-element 
CAAGTGACTGACAATCTGGTGTAACGAAAA-TTTCCAATGTAAACTCATTTTCCCTC-20bp-TATATATA 
• A.I • • 
-79 -69 - 64 - so 
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GM-CSF gene transcription in T cells or fibroblasts in response to stimulation 
by mitogen or the HTLV-1 tax protein (Nimeret al., 1988; 1989a,b; 1990). The 
third upstream CATT(A/T) motif appears to be additionally required for 
activation of human GM-CSF gene transcription in endothelial cells in 
response to I L-1 (Kaushansky, 1989). Several other reports indicate, 
however, that deletion or mutation of other sequences, located ·. upstream of 
the CLEO element, abolishes inducibility of the murine GM-CSF promoter in 
response to mitogenic or tax stimulation (Miyatake et al., 1988a,b). 
Comparison of regulatory mechanisms between species is somewhat 
ambiguous as these upstream regulatory elements in the murine GM-CSF 
gene (-95 to -73), termed conserved lymphokine element 2 (CLE2) and the 
GC box (Table 5.2.), were delineated by transient expression studies in a 
human T cell line. These elements appear to specifically interact with a 
number of constitutive and inducible DNA-binding proteins (Shannon et al. , 
1988; Sugimoto et al., 1990), the latter of which may be related to NF-KB 
(Schreck & Baeuerle, 1990; Sugimoto et al. , 1990). Although the CLE2 and 
GC box elements are also highly conserved in the IL-3 gene, recent studies 
suggest that other additional upstream elements, including conserved AP-1 
sites, may be required in activating IL-3 gene transcription in response to 
mitogenic stimulation (Mathey-Prevot et al. , 1990; Shoemaker et al., 1990; 
Nishida et al., 1991 ). 
While the CLE2 and GC box elements appear critical for the activation 
of murine GM-CSF gene transcription (Miyatake et al., 1988a,b) , a recent 
report published during the course of the current study demonstrated that 
substitution mutations of every single base in the 3' half of the CLEO element 
(-49 to -39) abolishes the ability of the murine GM-CSF promoter to respond to 
T cell activation signals despite the presence of intact CLE2 and GC box 
elements (Miyatake et al., 1991 ). Mutations in the 5' half of the CLEO element 
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(-52 to -50) appeared, however, to upregulate both basal and inducible 
promoter activity. The CLEO element was observed to form an inducible DNA-
protein complex NF-CLEO, which consisted of two complexes of slightly 
different electrophoretic mobilities. The recognition sequences of the higher 
mobility complex, NF-CLEOa, (-47 to -42) appear to be required for induction 
of promoter activity, while the recognition sequences of the lower mobility 
complex, NF-CLEOb (-53 to -46) includes sequences which suppress 
promoter activity (Table 5.2.). These results imply that NF-CLEOb may serve 
as a repressor, while NF-CLEOa may function as a positive regulator. 
An earlier report demonstrated that sequences between -57 and -24 of 
the human GM-CSF promoter are protected from DNase I digestion by the 
binding of specific nuclear proteins in unstimulated T cells, while a shorter 
region (-52 to -34) is protected in activated T cells (Nimer et al. , 1988; 
Table 5.2.). This may reflect displacement of a constitutive repressor in 
response to cellular activation. Signal-induced modulation of nuclear protein 
interactions with the murine GM-CSF CLEO element was also observed by gel 
shift analysis in the current study. A complex of slower mobility was observed 
using extracts prepared from unstimulated D1 O.G4.1 cells under conditions in 
which the GM-CSF gene is constitutively transcribed at a low basal level , 
while a complex of higher mobility was observed using extracts prepared from 
stimulated cells in which transcriptional activity of the GM-CSF gene is 
enhanced (section 5.3.4.). Furthermore, the slower mobility complex was not 
observed to form with the murine IL-5 CLEO element (mlL-5A) in extracts 
prepared from HDK-1 cells, or unstimulated or CHX-treated D1 O.G4.1 cells in 
which the IL-5 gene is transcriptionally inactive. These observations bear 
interesting correlation to recent findings of Miyatake et al. (1991) which 
demonstrate only weak affinity of the putative repressor complex NF-CLEOb to 
the IL-5 CLEO element despite its high homology to the GM-CSF CLEO 
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element (Table 5.2.). These observations together suggest that interactions 
of a putative repressor with the CLEO element in the GM-CSF gene may be 
involved in regulating its constitutive transcription at a low basal rate in 
unstimulated T cells. This repressor may be displaced in response to specific 
T cell activation signals by inducible positive regulators. 
As expected from the homology data (Table 5.2.), the affinity of the 
CLEO elements in the GM-CSF and IL-5 genes for the inducible NF-CLEO 
complex was higher than that of the analogous IL-4 CLEO element (section 
5.3.3.). A recent study has identified a unique 11 bp motif termed the 
P-element (-79 to -69) upstream of, and adjacent to, the CLEO element in the 
human IL-4 gene, which confers responsiveness to T cell activation signals 
(Abe et al., 1992; Table 5.2.). Data , available at the time of thesis 
preparation , from stable transfection studies using the murine thymoma cell 
line EL4.23 in this laboratory, indicate that the CLEO element alone is 
insufficient to mediate inducibility of the IL-5 promoter (P. Bourke, unpublished 
results). Substitution mutations in the conserved TCATTT motif, which were 
found in the current study to abolish formation of inducible DNA-protein 
complexes (section 5.3.3.) , however, diminished responsiveness to T cell 
activation signals conferred by other sequences further upstream . Detailed 
stable transfection studies in the 01 O.G4.1 cell system are, however, essential 
to establish the regulatory role of the CLEO element and delineate other 
elements which may regulate IL-5 gene transcription. One likely candidate is 
the adjacent mlL-58 region (-76 to -62) which was found in this study to form 
complexes with inducible, cell-specific nuclear proteins (section 5.3.5.). 
Another feature which gives the mlL-58 region additional significance as a 
potential regulatory element is its position relative to the CLEO element, given 
that elements in the IL-4 and GM-CSF genes which confer responsiveness to 
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T cell activation signals have been identified in similar locations (Miyatake 
et al., 1988a,b; 1991; Abe et al., 1992; Table 5.2.). 
Although the CLEO element alone appears insufficient to confer 
responsiveness of the GM-CSF, IL-5 and IL-4 promoters to T cell activation 
signals, the conserved spatial organisation of the CLEO elements relative to 
the TATA boxes of these genes and its apparently critical requirement for 
induction of their promoters suggests that inducible factors which specifically 
interact with the CLEO element in these genes may function to co-operatively 
link the basal transcriptional machinery at the "core promoter" with other 
multiple regulatory factors which bind to other, possibly gene-specific, 
elements further upstream. This hypothesized model may be analysed by 
investigating the effect, upon promoter inducibility, of alterations in the relative 
spatial organisation of the TATA boxes, CLEO elements and other cis-acting 
regulatory sites. 
CHAPTER 6: 
DISCUSSION 
Alterations in patterns of cellular growth and differentiation may 
essentially be regarded as manifestations of the dynamic interactions between 
the genetic program and information external to the genomic micro-
environment, the generation and/or transmission of which may largely involve 
inter-cellular communication and cell-to-cell interactions. In this regard, the role 
of the T lymphocyte in "inducible haemopoiesis" may essentially be envisaged 
as that of a "signal transducer" which converts specific signals , largely 
communicated by antigen-presenting cells, into pleiotropic mediators which 
interact with, and thereby modulate the genetic programs of, numerous 
haemopoietic target cells. In effecting this critical response to immunological 
stress, the genetic program of the T lymphocyte is itself dynamically modulated, 
the most significant manifestation of which being the expression of a battery of 
lymphokine genes. 
In Chapter 1, several broad concepts were described and espoused as 
general underlying themes for the studies conducted in this thesis. One 
included the notion of the intrinsically dynamic and "integrated" nature of 
mechanisms which regulate gene expression in eukaryotic systems. Another 
involved the increasing conceptualization of lymphokines as coordinating 
"inducible" haemopoiesis as a "network". In the light of such concepts, this 
thesis, as an initial phase of a longer term project, sought to investigate and 
compare the mechanisms which regulate the expression of the IL-5 gene and a 
variety of other different lymphokine genes in murine T lymphocytes. This 
broader comparative perspective was somewhat of a departure from the 
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approach adopted by the majority of previous studies which have tended to 
focus upon investigating mechanisms which regulate a specific individual 
lymphokine gene in isolation. Furthermore, while a number of previous studies 
have been conducted using transformed T cell lines, the mechanisms which 
regulate the expression of a variety of different lymphokine genes were 
investigated in this project in both non-transformed and transformed T cells. 
The studies described in this thesis essentially investigated the 
mechanisms which regulate the synthesis of steady state translatable 
lymphokine mRNAs. Although earlier studies largely investigated the regulation 
of synthesis of a particular lymphokine in terms of its bioactivity, such biological 
analysis would be more complex and less specific if applied to a broader 
comparative investigation of a number of different lymphokines. While it cannot 
be discounted that the synthesis of a biologically active lymphokine gene 
product may be influenced by mechanisms including translation, glycosylation 
and secretion, various studies have demonstrated strong correlation between 
the steady state levels of mRNA and bioactivity of a number of lymphokines 
induced in response to stimulation by several of the cellular activators in the T 
cell systems studied in this project (Cherwinski et al., 1987; Lichtman et al., 
1987; Shaw et al., 1988a; Bickel et al., 1990; Zubiaga et al., 1990). 
The findings of the various studies described in the bulk of this thesis 
essentially suggest that the expression of the IL-5 gene and a number of other 
lymphokine genes are differentially regulated in T lymphocytes by specific 
signalling pathways emanating from distinct cell surface events, which are 
either dependent or independent of TCR/CD3 stimulation. Such differential 
control appears to be largely mediated at either the transcriptional level and/or 
at the level of mRNA stability. Studies described in the remainder of the thesis 
describe the identification and characterization of DNA-protein interactions 
134 
which may be potentially involved in regulating IL-5 gene expression at the 
transcriptional level. The following sections seek to further discuss these 
various regulatory mechanisms in the context of their coordination and 
integration, and the significance of such coordination and integration in vivo. 
6.1. Differential regulation of lymphokine gene expression by 
signalling pathways emanating from distinct cell surface 
events 
The inducibility of expression of a variety of lymphokine genes in 
response to TCR/CD3 stimulation has been well-established by a number of 
studies conducted in murine T cell clones (Cherwinski et al., 1987; Bohjanen 
et al., 1990; Gajewski et al. , 1990). Studies described in Chapter 2 suggest 
that the expression of the IL-3, IL-4 and GM-CSF genes in the murine Th2 
clone 01 O.G4.1 is exclusively regulated by TCR/CD3-dependent mechanisms. 
The expression of the IL-5, IL-6 and IL-1 O genes appears , however, to be 
additionally and selectively regulated by cell surface mediated-mechanisms 
independent of direct TCR/CD3 stimulation. These include signalling pathways 
emanating from the CD45 or CO2 cell surface molecules or the IL-1 receptor. 
The exclusive control of IL-4 gene expression in 01 O.G4.1 cells by 
TCR/CD3-dependent mechanisms may be functionally associated with the 
ability of IL-4 to act as an autocrine factor which regulates the clonal expansion 
of Th2 cells following antigenic stimulation (Kupper et al., 1987; Lichtman et al., 
1987). The gene encoding IL-2, which is exclusively expressed in, and is 
believed to act as an autocrine factor for, Th 1 cells, also appears to be 
exclusively controlled by TCR/CD3-dependent mechanisms (Herold et al., 
1986; Lichtman et al., 1988). Furthermore, IL-4 also appears to selectively 
induce the expression of the IL-5 (Bohjanen et al., 1990), IL-6 and IL-1 O genes 
(H. Naora, unpublished observations) in 01 O.G4.1 cells. The prolonged nature 
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of the kinetics of IL-5, IL-6 and IL-1 O gene expression, compared to those of the 
IL-3, IL-4 and GM-CSF genes (Chapter 3), may be partially attributable to their 
"additional" regulation via the autocrine IL-4 pathway. IL-3 and GM-CSF are not 
known to be autocrine factors for T cells and the restriction of their gene 
regulation to TCR/CD3-dependent mechanisms may be linked to their 
coordinate expression by both Th 1 and Th2 populations. The flexibility and 
multiplicity of signalling mechanisms which regulate the expression of the IL-5 , 
IL-6 and IL-10 genes, in contrast, may be functionally associated with their 
expression being restricted to the Th2 subset. 
The ability to "mimick" TCR/CD3-mediated responses by simultaneously 
activating PKC and inducing elevation in [Ca2+]i has been well-established 
(Truneh et al. , 1985; Weiss et al. , 1986; Kumagai et al., 1987). Studies 
described in Chapter 2 indicate, however, that these two intracellular second 
messanger pathways which emanate from the TCR/CD3 complex may 
differentially regulate the expression of lymphokine genes in 01 O.G4.1 cells . 
Signals mediated by a Cs A-sensitive ca2+-dependent pathway appear 
obligatory for the induction of IL-3, IL-4 and GM-CSF gene expression . Such a 
pathway may involve the Cs A-sensitive Ca2+/calmodulin-dependent 
phosphatase calcineurin (Takahashi et al., 1989; Liu et al. , 1991; Clipstone & 
Crabtree, 1992; Fruman et al., 1992). In contrast to the IL-3 and IL-4 genes, 
the GM-CSF gene appears to additionally require PKG-mediated signals for 
maximal induction. PKG-mediated signals may, however, selectively and 
independently of Ca2+ mobilization , induce the expression of the IL-5, IL-6 and 
IL-1 O genes. A basis for the differential control of these genes may lie in the 
ability of TCR/CD3 stimulation to induce significantly lower [Ca2+]i in Th2 cells 
than in Th 1 cells, as recently reported by Gajewski et al. (1990). Furthermore, 
Ca2+-dependent and PKG-mediated signals appear to synergize for optimal 
induction of the IL-5 and IL-6 genes, but not the IL-10 gene. PKG-mediated 
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signals appear obligatory for the inducibility of the IL-5 gene which , in 
comparison to the other five- lymphokine genes studied, was very weak in 
response to the Ca2+ signal alone. A recent study suggests that the inhibition 
of human IL-5 gene expression by dexamethasone may involve its interference 
with a PKC-dependent pathway (Rolfe et al., 1992). 
Although the nature of the IL-1 signal transduction pathway and its role 
as an additional , TCR/CD3-independent signal in T cell activation have been 
extensively studied (Mizel, 1982; 1990; Abraham et al. , 1987; Rosoff et al. , 
1988; Shirakawa et al., 1988), the modulation of lymphokine gene expression 
by the IL-1 signal has been little studied to date. Studies described in 
Chapter 2 suggest that IL-1 may selectively, and independently of TCR/CD3 
stimulation , induce the expression of the IL-5, IL-6 and IL-1 O genes. The 
selective inducibility of these Th2-specific lymphokine genes by the IL-1 signal 
may be inherently and functionally associated with the fact that Th2, but not 
Th1, cells express IL-1 receptors on their surface (Lichtman et al. , 1988). 
The studies described in Chapter 2 suggest that the I L-1 receptor is 
coupled to a variety of signal transduction pathways which appear to 
differentially regulate the expression of the IL-5, IL-6 and IL-1 O genes. While a 
number of studies suggest that the IL-1 receptor is coupled to the PKA pathway 
(Shirakawa et al., 1988; Chedid et al., 1989; Chedid & Mizel , 1990), a recent 
study in the 01 O.A sub-line demonstrates that IL-1 stimulation induces both 
PKC activation and elevation in [cAMP]i (Munoz et al. , 1990). In the parental 
clone, both the PKC- and PKA- dependent pathways emanating from the IL-1 
receptor appear to regulate IL-6 gene expression , while the PKC-dependent 
pathway appears to predominantly regulate the expression of the IL-5 gene. 
Other pathways, possibly independent of PKC and PKA activation , appear to 
regulate IL-1 O gene expression in response to IL-1 stimulation. The 
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involvement of kinases other than PKC or PKA in IL-1 signal transduction has 
been suggested by O'Neill et al. (1990). The PKA involvement in I L-1 signal 
transduction in D1 O.G4.1 cells observed in this study may explain the weaker 
antagonistic effect of PKA pathway activators upon Th2 proliferation , compared 
to Th 1 proliferation as reported by Gajewski et al. (1990). 
A number of recent lines of evidence have implicated the role of CD45 in 
T cell activation as essentially that of an integral intermediary which couples the 
TCR/CD3 complex and also the CO2 molecule to the PIP2 signal transduction 
pathway (Mustelin et al., 1989; 1992; Koretzy et al. , 1990; 1991; Danielian et al. , 
1991 ). Studies described in Chapter 2 indicate that CD45 may, independently 
of direct stimulation of either the TCR/CD3 complex or CO2, selectively induce 
the expression of the IL-5, IL-6 and IL-1 O genes in D1 O.G4.1 cells. These 
observations suggests that the CD45 molecule may initiate and/or regulate 
signal transduction pathways that are distinct from those activated by TCR/CD3 
or CO2 stimulation. The physiological significance of this CD45-mediated 
mechanism and the possibility that different CD45 isoforms may regulate 
different signalling pathways in T cells remains to be elucidated. Furthermore, 
the ability of CO2 to also selectively induce I L-5 , I L-6 and I L-1 O gene 
expression, independently of direct TCR/CD3 stimulation, raises the possibility 
that it may regulate a pathway which may be independent of PIP2 hydrolysis. 
Of potential significance to the gene-specificity of CO2 modulation may be the 
recently reported ability of IL-6 to act as an accessory signal in CO2-mediated, 
but not TCR/CD3-mediated, T cell proliferation (Lorre et al., 1990). The role 
which CO2 plays in T cell activation and the nature of its functional inter-
relationship with the TCR/CD3 complex remains to be clarified. It will be of 
interest in future studies to investigate if and how CD45 and CO2 modulate 
TCR/CD3-induced lymphokine gene expression in Th 1 cells , and whether they 
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may regulate signalling pathways, independently of direct TCR/CD3 stimulation, 
in this subset. 
Another interesting basis for future studies is the possibility that CD28 
stimulation may differentially modulate the expression of a variety of 
lymphokine genes. This accessory molecule has gained increasing attention 
over recent years and is believed to initiate and/or regulate a signal 
transduction pathway that is distinct from those emanating from the TCR/CD3 
complex (June et al., 1987; 1989). CD28-mediated signals have been shown to 
synergize with those mediated by CO2 in T cell proliferation (Pierres et al. , 
1988; Van Lier et al., 1988). Furthermore, CD28-mediated signals appear to 
augment TCR/CD3-induced expression of the IL-2, TNF-a, LT, IFN-y and 
GM-CSF genes, but not that of the IL-4 gene, in normal human T lymphocytes 
(Thompson et al., 1989). Although human T cell populations appear not to be 
distinguished by Th1/Th2 phenotypes, it is of significant interest to note that the 
genes whose expression were reportedly enhanced by CD28-mediated signals 
are expressed by the Th1 subset in the murine system. Furthermore, CD28 
surface expression does not appear to be restricted to the Th1 subset (June 
et al., 1990b; Galvin et al., 1992). The basis of possible differential control may, 
however, not lie in the heterogeneity of Th 1 /Th2 phenotypes per se. CD28-
mediated signals appear to augment TCR/CD3-induced expression of the IL-2, 
TN F-a, LT, IFN-y and GM-CSF genes largely via a mechanism involving 
stabilization of their mRNAs (Lindsten et al., 1989). Observations described in 
Chapter 3, and elaborated upon in further detail below, suggest that signal-
dependent mechanisms which enhance mRNA stabilization are not involved in 
regulating IL-4 and IL-5 gene expression. 
Another interesting corollary which emerges from the comparative 
studies described in this thesis is the physiological implication of the ability of 
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phorbol esters to activate pathways in transformed T cell lines such as EL4.23, 
which appear analogous to those activated in T cell clones by TCR/CD3 or 
lectin stimulation. PMA stimulation appears to activate both Cs A-resistant and 
Cs A-sensitive pathways in EL4.23 cells. This may involve the activation of 
"cross-talk" between the PKC- and ca2+_ dependent pathways, and suggests 
that signalling pathways in transformed cell lines may be less discrete. 
"Promiscuous" utilization of signal transduction mechanisms may be a feature 
of cellular transformation. 
6.2. Differential regulation of lymphokine gene expression by 
multiple transcriptional and post-transcriptional 
mechanisms 
The comparative studies described in Chapter 3 essentially suggest that 
the accumulation of each different lymphokine mRNA species is dynamically 
and differentially regulated by the relative rates of its synthesis and 
degradation. This appears to involve distinct and specific sets of transcriptional 
and post-transcriptional control mechanisms. Transcriptional and/or post-
transcriptional control of many of the lymphokine genes studied appears to 
involve dynamic interplay between positively and negatively acting factors. 
These specific factors were distinguished by whether their synthesis was 
induced de nova in response to specific T cell activation signals, or whether 
they were pre-existing factors whose activities were presumably modulated by 
specific signalling pathways. 
The expression of the IL-4, IL-5, IL-6 and IL-10 genes appears to be 
predominantly regulated at the transcriptional level in 01 O.G4.1 cells. Whether 
this is functionally significant or merely coincidental to their Th2-specificity 
remains to be elucidated. Transcription of the IL-5, IL-6 and IL-10 genes may 
be independently activated by largely Cs A-resistant signalling pathways 
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emanating from the TCR/CD3 complex and the IL-1 receptor. In EL4.23 cells, 
the expression of the IL-5 and IL-10 genes also appear to be predominantly 
regulated at the transcriptional level by Cs A-resistant signalling pathways. IL-5 
gene transcription appears to require signals other than those mediated by 
ca2+ mobilization for maximal activation in D1 O.G4.1 cells, and requires 
obligatory de nova protein synthesis in both T cell systems, presumably that of 
a transcription factor(s). Enhancement of IL-6 gene transcription in D1 O.G4.1 
cells appears, in contrast, to be mediated by pre-existing factors. Protein 
synthesis of putative regulatory factors appears to be required for maximal 
activation of IL-1 O gene transcription in both D1 O.G4.1 and EL4.23 cells. A 
labile repressor may also be involved in regulating IL-10 gene transcription in 
EL4.23 cells. Transcription of the IL-2 gene in EL4.23 cells also appears to be 
subject to the coordinate control of labile positively and negatively acting 
factors, the labile positive regulator being responsive to Cs A-sensitive signals. 
Both negatively acting and labile Cs A-sensitive positively acting mechanisms 
have been reported to coordinately control human I L-2 gene transcription 
(Durand et al., 1988; Nabel et al., 1988; Shaw et al., 1988b; Emmel et al. , 1989; 
Williams et al., 1991 ). 
In contrast to the IL-5, IL-6 and IL-1 O genes, transcription of the IL-4 
gene appears to be exclusively regulated in D1 O.G4.1 cells by signals mediated 
by a Cs A-sensitive, Ca2+-dependent pathway. Its maximal activation , like that 
of the IL-10 gene, appears to require protein synthesis. This may involve the 
induction of synthesis of a regulatory factor which is distinct from, and 
cooperatively acts with, a pre-existing factor. Alternatively maximal 
transcriptional activation may require the enhanced expression of a pre-existing 
positive regulator. Specific signals may also negatively modulate the 
expression of specific lymphokine genes at the transcriptional level. A labile 
repressor appears to selectively inhibit GM-CSF and IL-4 gene transcription in 
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IL-1-stimulated D10.G4.1 cells. The transcriptional inactivity of the IL-3 gene in 
IL-1-stimulated cells does not appear, however, to involve a similar mechanism. 
Transcription of the IL-3 and GM-CSF genes in D1 O.G4.1 cells, like that 
of the IL-4 gene, also appears to be exclusively regulated by Cs A-sensitive, 
Ca2+-dependent signals. Enhancement of GM-CSF gene transcription 
appears, however, to be mediated by a newly synthesized factor(s), while 
activation of I L-3 gene transcription largely involves a pre-existing factor(s). 
IL-3 gene transcription is similarly regulated in EL4.23 cells by a Cs A-sensitive 
pathway, and also appears to involve a labile repressor. Both positively and 
negatively acting mechanisms are reported to coordinately regulate IL-3 gene 
transcription in transformed human T cell lines (Mathey-Prevot et al. , 1990; 
Shoemaker et al., 1990). The expression of the IL-3 gene in both D1 O.G4.1 
and EL4.23 cells, and of the GM-CSF gene in D1 O.G4.1 cells also appear to be 
regulated at the level of mRNA stability. This mode of control appears to be the 
predominant mechanism in the regulation of GM-CSF gene expression in 
EL4.23 cells. 
In both T cell systems studied, the IL-3 and GM-CSF mRNAs appear to 
be stabilized by Cs A-sensitive signals, I L-3 m RNA being more efficiently 
stabilized than GM-CSF mRNA. The dynamic regulation of the stability of these 
two species appears, however, not only to involve their enhanced stabilization 
by signal-dependent mechanisms, but also their specific degradation by a labile 
mechanism. IL-2 , IL-6 and IL-1 O mRNAs also appear to be selectively 
degraded by a labile mechanism. Furthermore, this labile mechanism appears 
to be constitutively active and may be involved in regulating the rapid turnover 
of the GM-CSF, IL-6 and IL-1 O transcripts which are expressed in unstimulated 
T cells. Constitutive transcription of the GM-CSF gene has been extensively 
reported in a variety of cell types which express this gene (Thorens et al., 1987; 
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Koeffler et al., 1988; Schuler & Cole, 1988; Ernst et al., 1989a; Bickel et al. , 
1990; Wodnar-Filipowicz & Moroni, 1990; Akahane & Plutznik, 1992; lwai et al. , 
1992). Constitutive transcription of the I L-6 and I L-10 genes in other T and 
non-T cell types which express these genes has not been reported , and the 
significance of the gene-specificity of this phenomenon remains to be 
elucidated. 
Regulation of mRNA stability is generally believed to be a predominantly 
cytoplasmic phenomenon (Nevins, 1983, Hentze, 1991 ), although signal-
dependent modulation of the stability of certain intranuclear RNA precursors 
has been reported (Akahane & Plutznik, 1992). The studies described in 
Chapter 3 support a growing body of evidence which implicates conserved 
AUUUA motifs in the 3'-UTRs of many unstable, inducible eukaryotic mRNAs 
as targets for a labile cytoplasmic mechanism which mediates their specific 
degradation (Caput et al., 1986; Shaw & Kamen , 1986; Wilson & Treisman , 
1988; Shaw et al., 1988a; Brewer & Ross, 1989; Akashi et al. , 1991 ). Such a 
mechanism has been proposed not to involve a specific "RNase"-like molecule 
per se, but rather destabilization of the PABP/poly(A) complex by the interaction 
of a specific protein(s) with these AU-rich sequences (Bernstein & Ross, 1989; 
Malter, 1989; Bohjanen et al., 1991 ). Although the minimum number of AUUUA 
motifs required for the mediation of mRNA instability has yet to be determined, 
the studies described in Chapter 3 suggest that single, dispersed copies of this 
motif may be insufficient. GM-CSF, IL-2, IL-3, IL-6 and IL-10 mRNAs, which 
are highly labile and stabilized by CHX, contain multiple, often tandem , repeats 
of the AUUUA motif in their 3'-UTRs. In contrast , the IL-4 and IL-5 mRNAs, 
which are significantly more stable than the other lymphokine mRNAs studied 
and whose stabilities are not affected by CHX, contain only a few, widely 
dispersed single copies of this motif in their 3'-UTRs. 
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At least two models may be proposed for the dynamic and specific 
regulation of lymphokine mRNA stability. Firstly, cellular signals may stabilize 
specific mRNAs by inhibiting the synthesis of the labile "destabilizing" factor, or 
inactivating this factor either by direct modification or by mediating its 
sequestration by a signal-induced inhibitory ligand. A recent study, which 
demonstrates the ability of a variety of cellular signals, as well as CHX, to 
stabilize GM-CSF mRNA via the AU-rich sequences in its 3'-UTR (Akashi et al., 
1991 ), may arguably support this model. Alternatively, the regulation of mRNA 
stability may involve the coordinate actions of two operationally independent 
mechanisms, namely a signal-dependent mechanism which enhances 
stabilization of specific mRNAs and a distinct labile mechanism which mediates 
their specific degradation. This model implicates the involvement of specific 
elements other than the AU-rich sequences in the regulation of mRNA stability. 
A number of elements , apart from the AU-rich sequences, appear to be 
involved in regulating the stability of several labile mRNAs (Rabbitts et al., 
1985; Jones & Cole, 1987; Kabnick & Housman , 1988; Band et al., 1990; lwai 
et al., 1991; Ross et al. , 1991 ). 
The molecular basis for the plasticity and specificity of eukaryotic gene 
expression essentially lies in the particular sequence, unique composition and 
spatial organisation of regulatory elements constituting the complex set utilized 
by a given gene. Utilization of common elements by different genes potentiates 
a basis for coordinate control. The recognition element of NF-KB, for example, 
is highly conserved in, and is involved in regulating the transcription of, 
numerous inducible eukaryotic genes (reviewed in Lenardo & Baltimore, 1989), 
while AUUUA repeats, conserved in the 3'-UTRs of a variety of inducible 
eukaryotic mRNAs, appear to mediate their instability as previously described. 
Essentially similar paradigms involving multiple specific, nucleotide-protein and 
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protein-protein interactions have been proposed for the mechanisms of 
transcriptional control and the ·regulation of mRNA stability. 
The DNA-protein and protein-protein interactions which regulate 
eukaryotic gene expression at the transcriptional level are inherently more 
complex as they are inextricably associated with two dynamic phenomena 
intrinsic to all eukaryotic systems. The first feature concerns the packaging of 
DNA into nucleosomes and higher order chromatin structures , which are 
generally believed to regulate the accessibility of a gene to the transcriptional 
machinery (reviewed in Reeves, 1984; Eissenberg et al. , 1985; Yaniv & 
Cereghini, 1986; Gross & Garrard, 1988; Grunstein, 1990). As described in 
Chapter 4, the ability to activate IL-5 gene transcription in nuclear run-off 
assays using endogenous chromatin as the template for transcription vis-a-vis 
the inability to activate IL-5 gene transcription in either cell-free or transient 
expression systems using exogenous "naked" DNA as the template, suggests 
that IL-5 gene transcription is dynamically regulated in T lymphocytes by higher 
order chromatin structures. For this reason , the analysis of DNase I 
hypersensitive sites, as "markers" of non-nucleosomal organisation , was a 
particularly relevant means of initially identifying approximate locations of 
putative protein-binding regulatory regions of the IL-5 gene in its native 
chromatin environment. The significance of these regions is discussed in 
further detail below. 
The second "intrinsically eukaryotic" phenomenon pertaining to 
transcriptional regulation concerns "inter-compartmental communication". The 
factors which activate lymphokine gene transcription may essentially be 
regarded as integral "downstream" nuclear targets in a progression of signalling 
events emanating from the cell surface, and their identification and 
characterization is an important approach in understanding the transduction of 
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specific T cell activation signals to the nucleus. The responsiveness of the IL-5, 
IL-6 and IL-1 O genes to the variety of signalling pathways which emanate from 
the TCR/CD3 complex, IL-1 receptor and the CD45 and CO2 molecules, may 
be mediated by either one or a combination of two possible mechanisms. 
Under a "divergent" model, transcriptional activation of these genes may involve 
the cooperative action of numerous different factors, the synthesis or activity of 
each of which is responsive to a specific signal. Under a more "convergent" 
model, the pleiotropic responsiveness of these genes may be mediated by a 
more limited number of factors, one or several of which may be responsive to a 
broad range of signals. One example of a particularly "promiscuous" inducible 
factor is NF-KB, which is activated in response to a variety of different signals in 
a range of cell types (reviewed in Lenardo & Baltimore, 1989). A basis for its 
pleiotropic responsiveness may lie in the ability of different kinases, such as 
PKC and PKA, to phosphorylate, and thereby induce the dissociation of, its 
inhibitory ligand, IKB (Baeuerle & Baltimore, 1988a,b; Shirakawa & Mizel, 1989; 
Ghosh & Baltimore, 1990). 
The synthesis or activity of certain other transcription factors may, 
however, be regulated by highly specific signal-dependent mechanisms. The 
activity of NF-AT, for example, which plays a critical regulatory role in IL-2 gene 
transcription (Durand et al., 1988; Shaw et al., 1988b) and has recently been 
demonstrated to enhance transcription of the human IL-3 and GM-CSF genes 
(Cockerill et al., 1993), appears to require the two second messangers 
generated by TCR/CD3-mediated PIP2 hydrolysis (Hivroz-Burgaud et al., 
1991 ). These intracellular pathways appear to independently regulate two 
critical components of NF-AT: (i) a pre-existing T cell-specific cytoplasmic 
subunit which is induced to translocate to the nucleus by signals delivered by a 
Cs A-sensitive Ca2+-dependent pathway, involving the ca2+/calmodulin-
dependent phosphatase calcineurin (Flanagan et al. , 1991; Clipstone & 
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Crabtree, 1992; O'Keefe et al. , 1992) , and (ii) a nuclear subunit which is 
synthesized de nova in response to Cs A-insensitive signals . Recent studies, 
which demonstrate that this nuclear subunit may comprise of AP-1 , suggest 
that its synthesis may be regulated by PKC activation (Jain et al. , 1992; 
Cockerill et al., 1993). 
The assembly of heterologous subunits, the synthesis and/or activity of 
each of which may be independently regulated by different signals , to form 
multimeric transcription factors such as NF-AT, potentiates a versatile 
mechanism by which different signalling pathways may effectively cross-talk 
and coordinately modulate the expression of a gene via a specific individual 
element. Both pleiotropic and specific responsiveness of an inducible gene 
may be potentially mediated by numerous unique combinations of a relatively 
limited number of "interchangeable" components , each of wh ich may be 
responsive to a particular signal. The pleiotropic responsiveness of the I L-5 , 
IL-6 and IL-10 genes may involve such an alternative "convergent" paradigm. 
The utilization of different, but closely related , factors which interact with 
a common recognition element may potentiate another versatile transcriptional 
control mechanism. Recent evidence of relationships between several 
components of NF-KB (Blank et al. , 1992) , Ets-related proteins (Thompson 
et al., 1992) or octamer factors , which themselves are members of a larger 
family of homeodomain proteins (Wright et al., 1989; Kemler & Schaffner, 
1990), suggest that such "regulatory factor families" may be an integral feature 
of eukaryotic gene regulation. Studies described in Chapter 5 suggest that the 
factors which recognise the highly conserved CLEO element in the proximal 5'-
flanking regions of the IL-5, GM-CSF and IL-4 genes may be closely related , 
but differentially modulated, members of a regulatory factor family. The strong 
correlation observed between the differential cell-specificity and signal-
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dependent modulation of transcription of the IL-5 and GM-CSF genes, and of 
the specific inducible nuclear protein interactions with the CLEO elements in 
these respective genes, implicates the potential involvement of these DNA-
protein interactions in the transduction of specific activation signals to the 
transcriptional machinery of these two genes. 
The CLEO element alone appears insufficient to confer responsiveness 
of the IL-5 (P. Bourke, pers. comm.), GM-CSF (Miyatake et al. , 1988a,b; 1991) 
or IL-4 (Abe et al., 1992) promoters to T cell activation signals. Mutations in the 
CLEO elements of the IL-5 and GM-CSF genes were , however, found in the 
studies described in Chapter 5 to abolish their interactions with inducible 
nuclear proteins, and also appear to diminish the inducibility of the IL-5 
(P. Bourke, pers. comm.) and GM-CSF (Miyatake et al. , 1991) promoters 
conferred by sequences further upstream. Given the critical requirement of the 
CLEO elements for the activity of the IL-5 and GM-CSF promoters, and also 
possibly the IL-4 promoter, and the conserved spatial organisation of the CLEO 
elements relative to the TATA boxes of these genes, the inducible factors which 
specifically interact with the CLEO elements in these genes may be essential in 
cooperatively linking the core promoter machinery with regulatory factors which 
interact with possibly gene-specific enhancer elements further upstream. One 
likely candidate is the mlL-5B element, which is located immediately upstream 
of the CLEO element and appears unique to the IL-5 gene. The strong 
correlation observed between the patterns of IL-5 gene transcription and the 
modulation of inducible nuclear protein interactions with the mlL-5B element, 
suggests that this element may cooperatively act with the CLEO element in 
regulating IL-5 gene transcription. Although the functional significance of the 
mlL-5B element and the nature of its inter-relationship with the CLEO element 
require investigation in transcriptional assays , another feature which gives the 
mlL-5B element additional significance as a potential regulatory element is its 
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position relative to the CLEO element, given that enhancer elements in the 
GM-CSF and IL-4 genes have been identified in similar locations (Miyatake 
et al., 1988a,b; 1991; Abe et al. , 1992). 
6.3. Concluding remarks 
In the light of recent suggestions that Th 1 /Th2 phenotypes may, at least 
in the murine system, represent mature stages of helper T cells (Swain et al., 
1988; Mosmann & Coffman, 1989a,b), the differential utilization of multiple 
signal transduction mechanisms observed in the Th2 clone D1 O.G4.1 may be 
reflective of the development of heterogenous mature T cell populations. 
Furthermore, such differential utilization of signal transduction mechanisms in 
the regulation of expression of different lymphokine genes may be functionally 
significant in the provision by heterogenous T cell populations of an 
appropriately "balanced" network of mediators to coordinate immune 
responses. 
A current perplexing question is one pertaining to the cell-specificity of 
mechanisms which regulate lymphokine gene expression in T lymphocytes. 
Similar mechanisms of control appear to regulate the expression of several 
lymphokine genes in other non-T cell types which express these genes. IL-3 
gene expression, for example, also appears to be regulated by a Ca2+_ 
dependent pathway at the level of mRNA stability in mast cells (Wodnar-
Filipowicz & Moroni, 1990). Signal-dependent stabilization mechan isms also 
appear to play a predominant role in regulating the accumulation of GM-CSF 
mRNA in macrophages, fibroblasts , mast cells and B cells (Thorens et al., 
1987; Koeffler et al., 1988; Wodnar-Filipowicz & Moroni , 1990; Akahane & 
Plutznik, 1992). Furthermore , the labile mechanism which mediates 
degradation of specific lymphokine mRNAs in T cells , appears to med iate the 
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degradation of several other unstable mRNAs in a variety of other cell types as 
described earlier. NF-KB, which appears to be involved in the transcriptional 
regulation of the IL-2 and GM-CSF genes in T cells (Hoyos et al., 1989; 
Shibuya et al., 1989; Schreck & Baeuerle, 1990), also appears to be involved in 
regulating the transcription of the IL-6 (Shimuzu et al., 1990; Zhang et al. , 1990) 
and TNF-a (Collart et al., 1990) genes (and also a number of other cellular 
genes) in non-T cell types. Furthermore, the CLEO element has been reported 
to be involved in regulating GM-CSF gene transcription in fibroblasts and 
endothelial cells, as well as in T cells (Nimer et al., 1988; 1989a, b; 1990; 
Kaushansky, 1989). The cytoplasmic subunit of NF-AT appears to be the only 
well-established T cell-specific regulatory factor reported to date (Flanagan 
et al., 1991; Clipstone & Crabtree, 1992; O'Keefe et al., 1992). 
Given that a number of receptors expressed on the surfaces of a variety 
of non-haemopoietic cells appear, like the TCR/CD3 complex, to be coupled to 
the PIP2 signal transduction pathway (Berridge, 1987; Nishizuka, 1986; 1988), 
the identification and characterization of T cell-specific regulatory factors 
"downstream" of the early signal transduction events, and the investigation of 
their roles in regulating the expression of a variety of lymphokine genes is 
central to understanding the molecular basis of T cell activation . The isolation 
and use of signal transduction mutant T cells will be of enormous value in future 
studies. "Piecing" together these "missing components" of the downstream 
signal transduction events will in the longer term expand our understanding of 
the molecular basis of development of many haemopoietic disorders and 
dysfunctional immune responses, given that many such disorders appear to be 
attributable to an aberrantly "balanced" network of lymphokines. 
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